Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023351	s-dpteroe	— (—)	4429	4610	100.00%	Distribution not available
3023351	s-dpteroe	u/ml (u/ml)	4064	4395	2.23%
3023351	d.pteronys	— (—)	578	607	100.00%	Distribution not available
3023351	s-pölyryh	u/ml (—)	221	224	100.00%	Distribution not available
3023351	s-p�lyry	u/ml (—)	216	220	100.00%	Distribution not available
3023351	s-pölyt	u/ml (—)	175	175	100.00%	Distribution not available
3023351	s-pöly-s	u/ml (—)	142	163	100.00%	Distribution not available
3023351	s-pölyerittely	u/ml (—)	110	111	100.00%	Distribution not available
3023351	d.pteronys	u/ml (u/ml)	108	111	0.00%
3023351	s-pölyerittely,igevasta-aineet	u/ml (—)	89	90	100.00%	Distribution not available
3023351	pölyerittely,ige:vat(s-)	u/ml (—)	79	83	100.00%	Distribution not available
3023351	s-pölyryhmä	u/ml (—)	72	72	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Conjunctivitis

2006

6902

2.61

321.14

1.1

1.71

1.85

u/ml

0.18

1012

2767

Dermatitis and eczema

2484

6874

2.42

320.57

1.1

2.02

1.55

u/ml

1.21

1251

2628

Desensitization to allergens

475

722

8.01

309.59

1.2

1.1

2.16

1.86

u/ml

0.14

289

309

Other diseases of upper respiratory tract

2399

4684

2.73

307.65

1.2

1.1

1.80

1.70

u/ml

0.16

1172

1678

Asthma, unspecified (mode)

1223

2535

3.94

307.65

1.2

1.1

1.87

1.79

u/ml

0.07

581

795

Vasomotor and allergic rhinitis

2160

3407

6.85

307.65

1.2

1.1

2.11

1.72

u/ml

0.66

1250

1245

Asthma, hospital admission 2, infections

1692

4373

3.96

307.65

1.2

1.1

2.07

1.52

u/ml

1.12

963

1615

Asthma (only as main-diagnosis)

2608

3039

5.42

307.65

1.2

1.1

2.02

1.79

u/ml

0.33

1414

965

Asthma-related infections

1692

4373

3.96

307.65

1.2

1.1

2.07

1.52

u/ml

1.12

963

1615

Asthma, hospital admissions , main diagnosis only

2767

6483

3.99

307.65

1.2

1.1

1.99

1.68

u/ml

0.64

1538

2369

Asthma, excluding more controls

2739

3001

5.08

307.65

1.2

1.1

2.16

1.81

u/ml

0.55

1453

950

Allergic rhinitis

2056

3360

6.79

307.65

1.2

1.1

2.15

1.66

u/ml

0.92

1218

1229

Asthma

2757

3039

5.08

307.65

1.2

1.1

2.15

1.79

u/ml

0.59

1457

965

Pollen allergy

1595

2387

7.79

307.65

1.2

1.1

1.96

1.95

u/ml

0.01

969

937

Allergic asthma (mode)

1399

1878

8.02

307.65

1.2

1.1

2.27

1.83

u/ml

0.53

903

615

Allergic conjunctivitis

1701

5836

2.98

307.65

1.1

1.64

1.86

u/ml

0.30

873

2236

Asthma (diagnoses ohter than nonallergic)

2844

6356

3.99

307.65

1.2

1.1

2.10

1.61

u/ml

1.22

1596

2303

Chronic lower respiratory diseases

3594

5858

3.43

307.65

1.2

1.1

2.08

1.50

u/ml

1.82

1844

2108

Asthma and allergy

1014

1145

10.04

307.65

1.2

1.1

2.64

1.94

u/ml

0.67

672

378

Atopic dermatitis

1850

5600

2.93

307.65

1.2

1.1

2.51

1.69

u/ml

1.93

995

2162

Asthma (only as main-diagnosis), excluding more controls

2602

3001

5.42

307.65

1.2

1.1

2.02

1.81

u/ml

0.30

1410

950

Asthma/COPD (KELA code 203)

2824

5801

3.55

307.65

1.2

1.1

2.14

1.49

u/ml

1.83

1458

2085

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1642

5514

3.04

307.65

1.1

1.50

1.84

u/ml

0.55

839

2090

1473

3685

4.16

307.65

1.2

1.1

1.81

1.60

u/ml

0.33

828

1382

Asthma and allergy, excluding more controls

1015

1162

9.90

307.65

1.2

1.1

2.64

1.94

u/ml

0.67

673

382

Asthma, unspecified (mode), excluding more controls

1222

2511

3.94

307.65

1.2

1.1

1.87

1.81

u/ml

0.06

580

785

Allergic asthma (mode), excluding more controls

1399

1875

8.03

307.65

1.2

1.1

2.27

1.83

u/ml

0.54

903

616

Asthma (mode)

2753

3049

5.18

307.65

1.2

1.1

2.14

1.79

u/ml

0.58

1463

969

Asthma, including avohilmo

3920

5572

4.26

307.65

1.2

1.1

2.04

1.53

u/ml

1.47

1954

2018

Disorders of conjunctiva

2053

7068

2.50

298.61

1.1

1.72

1.84

u/ml

0.17

1033

2828

Chronic rhinitis, nasopharyngitis and pharyngitis

841

2111

4.15

298.03

1.1

1.13

1.55

u/ml

0.71

398

739

Chronic sinusitis

999

2827

3.65

296.64

1.2

1.1

0.61

1.43

u/ml

3.99

475

939

Atopic dermatitis, strict definition with reimbursement

1200

3744

3.28

291.52

1.2

1.1

2.62

1.72

u/ml

1.65

734

1493

Suggestive for eosinophilic asthma

327

361

9.85

272.33

1.3

1.1

0.68

1.09

u/ml

0.80

213

116

Nasal polyp

477

825

6.06

264.03

1.2

1.1

0.66

1.63

u/ml

1.43

269

273

Obesity related asthma

750

1920

4.05

258.37

1.2

1.1

1.35

0.96

u/ml

0.71

379

620

Other pulmonary diagnosis

1664

3090

2.75

255.68

1.1

1.70

1.81

u/ml

0.13

759

988

ILD differential diagnosis

1641

3049

2.75

251.81

1.1

1.69

1.79

u/ml

0.12

748

969

COPD differential diagnosis

1641

3050

2.75

251.68

1.1

1.69

1.79

u/ml

0.12

749

969

Excluding asthma or asthma-COPD overlap

1644

3090

2.71

247.07

1.1

1.66

1.81

u/ml

0.19

751

988

Atopic dermatitis, strict definition

1159

4102

2.91

230.30

1.2

1.1

2.59

1.74

u/ml

1.52

725

1703

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

987

3288

3.01

215.07

1.1

1.66

1.58

u/ml

0.08

434

1106

Childhood asthma (age<16)

639

1269

4.25

213.91

1.2

1.1

3.36

2.12

u/ml

1.01

399

464

Childhood asthma (age<16), excluding more controls

639

1269

4.25

213.76

1.2

1.1

3.36

2.13

u/ml

1.01

399

463

Cough

919

2983

3.04

201.99

1.2

1.1

1.23

2.20

u/ml

2.23

438

1176

Diseases of the respiratory system

1231

2293

2.74

188.24

1.1

1.81

1.64

u/ml

0.18

545

727

Oral corticosteroids

2062

6159

2.06

178.53

1.2

1.1

1.68

1.63

u/ml

0.07

1003

2337

ILD medications: prednisolone, methylprednisolone, prednisone

2199

6347

1.99

170.45

1.2

1.1

1.62

1.73

u/ml

0.16

1056

2473

Undetermined asthma, excluding more controls

319

572

5.83

169.97

1.2

1.1

0.97

0.96

u/ml

0.01

150

172

Undetermined asthma

319

573

5.82

169.65

1.2

1.1

0.97

0.93

u/ml

0.05

150

173

Asthma, hospital admissions 3, pneumonia

627

1898

3.38

167.22

1.2

1.1

2.81

1.15

u/ml

2.05

370

679

Asthma-related pneumonia or sepsis

627

1898

3.38

167.22

1.2

1.1

2.81

1.15

u/ml

2.05

370

679

Asthma-related pneumonia

625

1889

3.39

167.12

1.2

1.1

2.82

1.16

u/ml

2.04

369

674

Childhood allergy (age < 16)

802

2326

3.04

162.28

1.2

1.1

2.66

2.05

u/ml

0.55

522

1010

Abnormalities of breathing

1911

5777

2.00

151.95

1.2

1.1

1.71

1.97

u/ml

0.38

877

2292

Symptoms and signs involving the circulatory and respiratory systems

2152

5833

1.88

136.98

1.1

1.43

1.96

u/ml

1.49

975

2316

ILD medications

2225

6747

1.83

135.47

1.2

1.1

1.55

1.82

u/ml

0.56

1062

2695

Inflammatory bowel disease treatment related agents

2186

6892

1.83

132.21

1.2

1.1

1.64

1.74

u/ml

0.14

1031

2735

Deviated nasal septum

524

1648

3.25

131.47

1.2

1.1

1.67

1.66

u/ml

0.00

229

545

First line medication for Crohn's disease

2146

6647

1.78

119.25

1.2

1.1

1.52

1.83

u/ml

0.67

1016

2659

Chronic diseases of tonsils and adenoids

1427

4540

2.02

119.17

1.1

1.85

1.71

u/ml

0.16

630

1638

FESS (DNB20)

335

898

3.92

109.16

1.3

1.1

0.50

1.49

u/ml

2.38

186

338

Adverse effects, not elsewhere classified

553

2031

2.84

106.77

1.2

1.1

2.24

1.50

u/ml

0.86

347

848

Ethmoidectomy

338

933

3.80

105.48

1.2

1.1

0.50

1.51

u/ml

2.53

188

347

Biological medicines for asthma

14.78

101.87

1.3

1.1

4.82

1.00

u/ml

1.07

Dermatitis due to ingested food

272

650

4.66

101.30

1.3

1.1

2.88

3.54

u/ml

0.25

210

335

Acute upper respiratory infections

1792

6493

1.75

96.56

1.2

1.1

1.72

1.82

u/ml

0.13

781

2622

Personal history of allergy to analgesic agent

28.07

93.47

1.5

1.2

0.49

0.84

u/ml

0.45

Dyspnoea

1373

5834

1.82

88.81

1.2

1.1

1.79

1.70

u/ml

0.08

632

2310

Non-allergic asthma (mode)

324

959

3.43

88.54

1.2

1.1

0.97

1.56

u/ml

0.58

127

304

Non-allergic asthma (mode), excluding more controls

324

962

3.41

88.10

1.2

1.1

0.97

1.55

u/ml

0.57

127

304

Urticaria

711

3224

2.27

86.58

1.2

1.1

1.67

1.92

u/ml

0.30

401

1332

Diseases of the skin and subcutaneous tissue

1822

5397

1.71

86.55

1.1

2.00

1.57

u/ml

0.79

890

1974

Urticaria and erythema

787

3762

2.14

83.57

1.2

1.1

1.64

1.86

u/ml

0.27

436

1545

Other medical care

564

2357

2.38

77.69

1.2

1.1

2.50

1.60

u/ml

0.66

322

916

Other and unspecified effects of external causes

660

3046

2.23

77.06

1.2

1.1

2.04

1.69

u/ml

0.36

394

1267

Personal history of allergy to drugs, medicaments and biological substances

12.72

75.18

1.5

1.1

0.49

2.83

u/ml

0.85

Polypectomy (DHB20)

158

321

5.17

73.79

1.3

1.1

0.53

1.81

u/ml

1.91

122

1840

6035

1.63

73.16

1.2

1.1

1.62

1.72

u/ml

0.13

807

2346

Acute upper respiratory infections of multiple and unspecified sites

1375

6057

1.72

72.80

1.2

1.1

1.94

1.87

u/ml

0.08

630

2462

Diseases of the eye and adnexa

1754

5451

1.63

69.45

1.1

1.74

1.90

u/ml

0.22

821

2202

Acute sinusitis

999

5122

1.85

69.35

1.2

1.1

1.08

1.80

u/ml

1.83

428

2039

Bronchitis

1765

7300

1.60

69.11

1.2

1.1

1.95

1.73

u/ml

0.34

809

2908

Any reimbursement code in KELA

1444

4337

1.69

65.59

1.1

2.03

1.50

u/ml

0.92

676

1682

Dermatitis

837

4532

1.87

61.60

1.1

2.14

1.44

u/ml

0.61

399

1681

D07AA Corticosteroids, weak (group I)

440

1914

2.38

59.63

1.2

1.1

2.57

2.16

u/ml

0.31

281

862

Allergic contact dermatitis

302

1111

2.81

58.19

1.1

1.66

0.94

u/ml

0.52

140

388

Sleep apnoea, including avohilmo

1326

5409

1.60

52.68

1.1

0.96

1.57

u/ml

2.51

551

2105

Asthma mixed form (mode), excluding more controls

111

232

4.96

50.06

1.2

1.1

2.03

1.13

u/ml

0.44

Asthma mixed form (mode)

111

233

4.94

49.82

1.2

1.1

2.03

1.12

u/ml

0.45

Other and unspecified dermatitis

691

3776

1.85

49.59

1.1

2.34

1.33

u/ml

0.81

327

1405

Pain in joint

989

3973

1.67

45.69

1.1

1.24

1.94

u/ml

1.83

430

1657

Other acute lower respiratory infections

831

4689

1.71

45.17

1.2

1.1

2.28

1.77

u/ml

0.61

437

2010

Early onset COPD, excluding more controls

191

627

3.08

44.85

1.1

1.42

1.36

u/ml

0.03

173

Recurrent or chronic depression

780

3248

1.76

44.44

1.1

1.23

2.08

u/ml

1.85

326

1314

Gastro-oesophageal reflux disease

898

4823

1.66

43.75

1.1

1.73

1.63

u/ml

0.09

362

1920

Headache

1154

6252

1.56

42.29

1.2

1.1

1.51

1.80

u/ml

0.42

482

2568

Medical observation and evaluation for suspected diseases and conditions

1128

3657

1.59

41.60

1.1

1.15

1.93

u/ml

2.15

567

1397

COPD/asthma related infections

1667

5742

1.46

41.55

1.1

1.70

1.75

u/ml

0.06

719

2250

COPD/asthma/ILD related infections

1667

5742

1.46

41.55

1.1

1.70

1.75

u/ml

0.06

719

2250

Sleep apnoea

1164

5113

1.56

41.17

1.1

1.01

1.58

u/ml

2.00

497

1975

Other and unspecified urticaria

408

2012

2.08

40.36

1.2

1.1

1.69

1.89

u/ml

0.17

219

833

Other special examinations and investigations of persons without complaint or reported diagnosis

1131

3657

1.58

40.01

1.1

1.79

1.93

u/ml

0.14

517

1397

Depression or dysthymia

1078

3839

1.58

39.67

1.1

1.48

1.98

u/ml

0.88

450

1579

Voice disturbances

370

1774

2.12

39.21

1.2

1.1

1.01

1.69

u/ml

1.00

154

664

Examination and observation for other reasons

954

3631

1.61

38.35

1.1

1.17

1.94

u/ml

2.09

429

1386

Migraine

984

5376

1.58

37.92

1.1

1.35

2.05

u/ml

1.47

419

2188

Migraine, single triptan purchase ok & required. ICD-code if available is included

1393

6460

1.47

37.92

1.1

1.37

1.87

u/ml

0.92

528

2684

Triptan medication for migraine, single purchase ok

1393

6460

1.47

37.92

1.1

1.37

1.87

u/ml

0.92

528

2684

Dermatographic urticaria

170

593

2.99

36.65

1.2

1.1

1.93

1.57

u/ml

0.16

101

224

Chronic laryngitis and laryngotracheitis

168

590

2.90

35.28

1.1

0.81

1.19

u/ml

0.41

181

Episodal and paroxysmal disorders

1852

6873

1.39

35.00

1.1

1.22

2.06

u/ml

3.33

817

2889

Neurotic, stress-related and somatoform disorders

1479

7426

1.43

34.45

1.1

1.63

1.78

u/ml

0.20

663

2992

Idiopathic urticaria

165

5.07

34.38

1.2

2.47

3.10

u/ml

0.14

Symptoms and signs involving speech and voice

405

2105

1.95

34.24

1.2

1.1

1.12

1.63

u/ml

0.72

169

805

Anxiety disorders

1484

7446

1.42

34.10

1.1

1.64

1.77

u/ml

0.18

667

2998

COPD

271

998

2.25

32.87

1.1

1.46

0.85

u/ml

0.66

124

321

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

758

2325

1.65

32.19

1.1

1.26

2.23

u/ml

1.98

324

952

Bronchiectasis

160

4.72

32.02

1.1

0.41

0.68

u/ml

0.44

Irritable bowel syndrome

445

2461

1.84

31.14

1.1

1.01

1.36

u/ml

0.67

186

941

Pain (limb, back, neck, head abdominally)

1224

4211

1.47

31.00

1.1

1.53

1.95

u/ml

0.70

552

1833

Other chronic obstructive pulmonary disease

252

939

2.25

30.40

1.1

1.38

0.90

u/ml

0.45

117

297

Sleep disorders (combined)

1355

6301

1.42

30.34

1.1

1.04

1.67

u/ml

2.62

578

2507

Asthma and opportunity respiratory infection

114

5.42

30.26

1.1

0.43

0.63

u/ml

0.25

Anxiety disorders, excluding more controls

1347

6346

1.42

30.05

1.1

1.64

1.77

u/ml

0.17

610

2532

Pain in throat and chest

1198

5101

1.44

29.32

1.1

1.29

1.93

u/ml

1.68

536

1960

All anxiety disorders

1148

6483

1.44

28.55

1.1

1.74

1.87

u/ml

0.14

520

2632

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

607

5742

0.62

28.40

1.1

2.04

1.58

u/ml

0.43

233

2295

Malignant neoplasm, wide definition for exclusion

607

5741

0.62

28.38

1.1

2.04

1.58

u/ml

0.43

233

2295

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

608

5746

0.62

28.33

1.1

2.04

1.59

u/ml

0.42

233

2299

Special screening examination for infectious and parasitic diseases

566

2542

1.69

28.29

1.1

0.98

1.77

u/ml

1.21

260

901

Acute bronchitis

536

3141

1.69

28.29

1.2

1.1

2.15

1.72

u/ml

0.33

250

1326

Low back pain

1078

5770

1.45

27.90

1.1

2.13

1.63

u/ml

0.63

448

2296

Malignant neoplasm

570

5461

0.61

27.77

1.1

1.85

1.57

u/ml

0.22

221

2182

Dorsalgia

1566

6225

1.37

27.72

1.1

1.68

1.64

u/ml

0.05

663

2527

Other dorsopathies, not elsewhere classified

1624

6331

1.36

27.41

1.1

1.64

1.72

u/ml

0.12

690

2594

Abnormalities of heart beat

432

2439

1.77

27.26

1.1

1.11

1.80

u/ml

1.27

171

914

Tonsillectomy and adenotomy

1239

6205

1.41

26.36

1.1

1.74

1.89

u/ml

0.19

542

2691

Anxiety (asthma-related co-morbidities)

1114

6219

1.43

26.30

1.1

1.67

1.92

u/ml

0.32

498

2496

Temporomandibular joint disorders, including avohilmo

769

5137

1.51

25.41

1.2

1.1

1.41

1.66

u/ml

0.29

338

2041

Any event in cancer register

693

6211

0.66

24.89

1.1

1.73

1.54

u/ml

0.18

269

2473

Conjunctivitis (acute, non atopic)

443

2625

1.71

24.21

1.1

1.77

2.02

u/ml

0.22

217

1113

Atopic conjunctivitis

112

395

2.96

23.87

1.2

1.1

3.82

2.28

u/ml

0.40

174

Parasetamol

1403

5293

1.36

23.61

1.1

1.67

1.93

u/ml

0.37

587

2167

Other headache syndromes

613

3983

1.55

23.18

1.1

0.87

1.87

u/ml

3.72

259

1512

Neurological diseases

1571

5962

1.33

23.18

1.1

1.38

2.12

u/ml

2.14

700

2542

Eosinophilic disease (BM)

7.72

23.13

1.3

1.0

0.42

1.83

u/ml

0.44

Depression

1448

7490

1.34

23.12

1.1

1.44

1.77

u/ml

0.64

649

2990

Provisional assignment of new diseases of uncertain etiology

700

4684

1.51

23.08

1.1

1.66

1.67

u/ml

0.01

285

1970

Codes for special purposes

700

4687

1.51

23.01

1.1

1.66

1.68

u/ml

0.02

285

1972

Soft tissue disorders

1693

6725

1.31

22.68

1.1

1.59

1.91

u/ml

0.59

729

2859

Acetic acid derivatives and related substances

404

1200

1.77

22.49

1.1

1.91

2.25

u/ml

0.20

162

564

Exposure to unspecified factor

1401

8220

1.33

21.81

1.1

1.39

1.86

u/ml

1.05

690

3370

Persons encountering health services for examination and investigation

1024

3657

1.41

21.50

1.1

1.83

1.93

u/ml

0.09

458

1397

Mood [affective] disorders

1502

7533

1.32

21.49

1.1

1.38

1.77

u/ml

0.82

669

3013

Dental caries 2, only avohilmo

1257

7410

1.35

21.35

1.1

2.11

1.69

u/ml

0.55

558

3082

Dorsopathies

1656

6500

1.31

21.25

1.1

1.68

1.78

u/ml

0.13

707

2709

Diseases of the musculoskeletal system and connective tissue

1141

4173

1.38

21.02

1.1

1.83

2.05

u/ml

0.27

521

1824

Mood disorders

1500

7536

1.31

20.99

1.1

1.38

1.77

u/ml

0.81

668

3016

Coxibs

399

1235

1.74

20.94

1.1

1.57

2.30

u/ml

0.80

159

574

Myalgia

343

1982

1.75

20.89

1.1

1.15

1.55

u/ml

0.38

151

774

Triptan medication for migraine, min. 3 purchases

1018

5842

1.39

20.74

1.1

0.98

1.77

u/ml

3.04

370

2333

Other disorders of lacrimal gland

390

2348

1.68

20.35

1.2

1.1

1.25

1.53

u/ml

0.34

162

878

Dental caries 2 and operation codes

1240

7427

1.34

19.92

1.1

1.90

1.69

u/ml

0.24

548

3079

Dental caries 2

1258

7468

1.33

19.88

1.1

1.89

1.71

u/ml

0.22

559

3098

Other soft tissue disorders, not elsewhere classified

1373

6454

1.32

19.79

1.1

1.50

1.91

u/ml

0.83

595

2716

Lower back pain or/and sciatica

1386

7362

1.31

19.44

1.1

1.85

1.61

u/ml

0.33

567

2933

Other diseases of hard tissues of teeth

926

4988

1.39

19.38

1.1

1.12

1.84

u/ml

2.23

392

2069

Functional dyspepsia

325

1889

1.74

19.38

1.1

0.95

1.51

u/ml

0.90

125

710

Gastrointestinal diseases

1216

4559

1.35

19.02

1.1

1.88

1.84

u/ml

0.04

548

1966

Other specific joint derangements/joint disorders

1222

6193

1.33

18.82

1.1

1.23

1.93

u/ml

2.89

508

2568

Allergic contact dermatitis due to drugs in contact with skin

114

4.41

18.80

1.1

0.92

1.63

u/ml

0.50

Other anxiety disorders

845

5391

1.40

18.75

1.1

1.63

1.88

u/ml

0.25

398

2182

Diseases of middle ear and mastoid

1011

6130

1.36

18.55

1.2

1.1

1.84

1.81

u/ml

0.03

461

2636

Disorders of lacrimal system

463

2976

1.57

18.49

1.2

1.1

1.32

1.63

u/ml

0.36

189

1108

Covid-19 suspected case

401

2507

1.62

18.25

1.1

1.27

1.71

u/ml

0.48

150

1028

Propionic acid derivatives

494

1581

1.58

18.15

1.1

2.31

2.79

u/ml

0.30

215

810

Abdominal and pelvic pain

1520

5939

1.29

18.06

1.1

1.73

1.90

u/ml

0.24

642

2552

Selective serotonin reuptake inhibitors

1451

5914

1.30

17.91

1.1

1.81

1.77

u/ml

0.03

610

2400

Abnormal findings on diagnostic imaging of lung

337

1965

1.68

17.85

1.1

1.23

1.18

u/ml

0.05

144

746

Diseases of oesophagus, stomach and duodenum

1406

6620

1.30

17.68

1.1

1.64

u/ml

0.00

592

2687

Soft tissue disorders related to use, overuse and pressure

277

1581

1.77

17.64

1.1

1.62

1.40

u/ml

0.13

110

586

Neurological diseases, wide definition

747

2626

1.44

17.52

1.2

1.1

1.71

2.35

u/ml

0.70

338

1213

Speech therapy

283

1630

1.75

17.48

1.2

1.1

0.72

1.59

u/ml

2.18

109

645

Temporomandibular joint disorders

261

1476

1.79

17.27

1.1

0.70

1.49

u/ml

1.75

100

557

Bronchitis, not specified as acute or chronic

389

2.59

17.00

1.2

1.1

1.70

1.06

u/ml

0.34

129

Diabetes, insulin treatment (Kela reimbursement)

740

6270

0.72

16.64

1.1

1.14

1.58

u/ml

1.14

289

2578

Other antidepressants

1417

5780

1.28

16.25

1.1

1.33

1.73

u/ml

0.81

597

2310

Opioids

1512

6262

1.27

16.18

1.1

1.38

1.60

u/ml

0.40

657

2454

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

726

6113

0.72

15.89

1.1

1.15

1.59

u/ml

1.10

286

2518

COPD (mode)

155

591

2.09

15.87

1.1

1.62

1.18

u/ml

0.21

174

Pain and other conditions associated with female genital organs and menstrual cycle

406

2529

1.56

15.65

1.1

1.65

1.84

u/ml

0.15

152

1006

Codeine

1392

6013

1.28

15.49

1.1

1.40

1.56

u/ml

0.27

591

2335

Dentofacial anomalies [including malocclusion]

475

3164

1.50

15.44

1.2

1.1

1.65

1.89

u/ml

0.19

201

1331

Oxicams

251

798

1.80

15.44

1.1

0.56

2.11

u/ml

3.38

363

Fenamates

199

707

1.92

15.36

1.1

0.76

2.00

u/ml

1.51

306

Other joint disorders

1515

6414

1.26

15.32

1.1

1.22

1.98

u/ml

2.80

648

2690

Symptoms and signs involving the digestive system and abdomen

1495

5940

1.27

15.22

1.1

1.69

1.91

u/ml

0.31

638

2553

Acute pharyngitis

303

1848

1.66

14.95

1.2

1.1

2.04

2.20

u/ml

0.09

140

861

Early onset COPD

191

1026

1.88

14.94

1.1

1.42

1.52

u/ml

0.05

406

Lichen simplex chronicus and prurigo

298

2.71

14.83

1.1

1.76

1.31

u/ml

0.20

110

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1869

0.44

14.74

1.1

1.35

1.27

u/ml

0.04

723

Codeine or tramadol medication

1533

6797

1.25

14.67

1.1

1.34

1.55

u/ml

0.42

639

2638

Mood disorders, excluding more controls

1320

6332

1.27

14.65

1.1

1.47

1.76

u/ml

0.45

589

2498

Eosinophilia

4.80

14.41

1.3

1.1

0.42

2.12

u/ml

1.12

Depression medications

769

2827

1.38

14.30

1.1

2.10

1.90

u/ml

0.16

331

1198

Exfoliative dermatitis

6.73

14.26

1.1

9.19

1.41

u/ml

1.08

Diabetes mellitus

902

7074

0.76

14.25

1.1

1.31

1.68

u/ml

0.92

371

2898

Acute bronchiolitis

217

1113

1.82

14.23

1.3

1.2

3.08

2.53

u/ml

0.25

149

618

General symptoms and signs

1663

6748

1.24

14.13

1.1

1.59

1.81

u/ml

0.34

713

2794

Migraine with aura

427

2872

1.50

14.07

1.1

1.06

1.66

u/ml

1.21

182

1116

Diabetes, varying definitions

893

7007

0.76

14.04

1.1

1.32

1.67

u/ml

0.84

368

2876

Anti-inflammatory and antirheumatic products, non-steroids

471

1584

1.51

13.99

1.1

2.33

2.78

u/ml

0.26

204

813

Cystitis

1164

5559

1.29

13.95

1.1

1.72

1.68

u/ml

0.04

462

2253

Later onset COPD, excluding more controls

155

3.08

13.91

1.1

1.18

0.71

u/ml

0.51

Pain in thoracic spine

203

1139

1.81

13.91

1.2

1.1

1.01

1.38

u/ml

0.51

427

Simple and mucopurulent chronic bronchitis

115

3.72

13.49

1.1

1.2

0.59

0.94

u/ml

0.34

Diabetes medication

881

7003

0.76

13.48

1.1

1.25

1.62

u/ml

0.98

364

2857

Haemorrhage from respiratory passages

260

1456

1.67

13.44

1.2

1.1

1.82

1.93

u/ml

0.04

119

562

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1559

7207

1.24

13.42

1.1

1.71

1.81

u/ml

0.13

740

2938

Allergic urticaria

155

817

1.94

13.11

1.2

1.1

1.14

2.08

u/ml

1.16

355

Diseases of the ear and mastoid process

1743

7241

1.22

13.05

1.2

1.1

1.79

1.69

u/ml

0.13

758

2976

Renal tubulo-interstitial diseases

616

6442

0.73

12.99

1.1

1.30

1.75

u/ml

0.54

265

2621

Other chronic obstructive pulmonary disease, including avohilmo

337

1810

1.56

12.94

1.1

2.05

1.30

u/ml

0.50

161

696

Schizophrenia or delusion

190

3272

0.58

12.92

1.1

1.60

1.45

u/ml

0.06

1336

Schizophrenia, schizotypal and delusional disorders

191

3280

0.58

12.85

1.1

1.60

1.45

u/ml

0.06

1339

Migraine without aura

397

2693

1.49

12.66

1.1

0.78

1.85

u/ml

3.98

172

1081

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

534

3529

1.41

12.63

1.1

1.24

1.53

u/ml

0.38

227

1375

Symptoms and signs involving the skin and subcutaneous tissue

823

6259

1.32

12.58

1.1

1.52

1.67

u/ml

0.20

372

2492

Exposure to other specified factors

1035

7637

1.28

12.55

1.1

1.86

1.72

u/ml

0.16

497

3159

Other enthesopathies

339

2230

1.53

12.41

1.2

1.1

1.63

1.52

u/ml

0.06

141

814

Schizophrenia

1572

0.41

12.33

1.1

3.56

1.51

u/ml

0.30

660

Suppurative and unspecified otitis media

716

4770

1.34

12.30

1.2

1.1

2.05

1.74

u/ml

0.26

336

2124

Persons encountering health services for specific procedures and health care

1504

7610

1.23

12.29

1.1

1.51

1.80

u/ml

0.42

746

3085

Non-allergic asthma

103

478

2.19

12.28

1.1

0.45

1.16

u/ml

2.17

172

Pruritus

135

695

1.97

12.18

1.2

1.1

0.73

1.08

u/ml

0.33

236

Migraine with aura and triptan purchases

294

1892

1.58

12.07

1.1

0.94

1.42

u/ml

0.93

119

765

Paracetamol of NSAID medication

352

1160

1.54

11.74

1.1

2.39

3.11

u/ml

0.39

155

630

Vocal cord dysfunction

194

1051

1.73

11.57

1.2

1.1

1.68

1.43

u/ml

0.10

399

Intestinal infectious diseases

1280

8094

1.24

11.45

1.2

1.1

1.47

1.82

u/ml

0.78

566

3388

ILD, hospital admissions 1, main diag only

394

2.26

11.44

1.1

1.56

2.18

u/ml

0.26

160

Somatoform disorder

228

1399

1.65

11.39

1.2

1.1

0.56

1.33

u/ml

2.94

538

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

233

2433

0.62

11.38

1.1

1.40

1.13

u/ml

0.17

841

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

233

2433

0.62

11.38

1.1

1.40

1.13

u/ml

0.17

841

Allergic colitis

103

503

2.17

11.26

1.3

1.2

5.16

2.63

u/ml

0.71

290

Other bacterial diseases

679

6186

0.76

11.25

1.1

2.40

1.60

u/ml

0.92

327

2544

Emphysema

101

3.60

11.17

1.2

1.1

2.45

0.85

u/ml

0.98

Accidents

1284

5210

1.24

11.02

1.1

1.79

1.75

u/ml

0.04

564

2037

ILD, hospital admissions

440

2.16

10.97

1.1

1.53

2.43

u/ml

0.41

180

Other interstitial pulmonary diseases

441

2.15

10.90

1.1

1.53

2.44

u/ml

0.41

179

Chronic conjunctivitis

204

2.78

10.86

1.1

2.83

2.91

u/ml

0.01

Mouth breathing

467

3352

1.40

10.85

1.1

1.10

1.92

u/ml

1.80

203

1464

Chronic gastritis

182

1065

1.72

10.80

1.1

0.46

1.35

u/ml

2.50

397

Interstitial lung disease endpoints

443

2.14

10.79

1.1

1.52

2.43

u/ml

0.41

180

Interstitial lung disease

443

2.14

10.79

1.1

1.53

2.43

u/ml

0.41

180

Diaphragmatic hernia

271

1753

1.55

10.75

1.1

0.90

1.10

u/ml

0.31

118

638

Trochanteric bursitis

128

677

1.91

10.69

1.1

0.78

1.23

u/ml

0.41

241

Other diseases of urinary system

1363

6287

1.22

10.67

1.1

1.58

1.77

u/ml

0.30

546

2595

TMD related operations

243

1544

1.59

10.57

1.2

1.1

0.56

1.50

u/ml

3.44

106

591

Pain in limb

1028

5949

1.25

10.53

1.1

1.45

1.90

u/ml

0.80

444

2463

COPD, hospital admissions

251

1349

1.58

10.51

1.1

1.38

1.30

u/ml

0.05

117

520

Follow-up examination after treatment for conditions other than malignant neoplasms

585

2842

1.36

10.48

1.1

0.73

1.91

u/ml

5.03

226

1034

Benign neoplasm: Colon

325

2151

1.49

10.45

1.1

0.89

1.20

u/ml

0.32

127

801

Other and unspecified tonsillitis

631

4046

1.33

10.44

1.1

1.38

1.98

u/ml

0.95

269

1738

Migraine without aura and triptan purchases

306

2055

1.51

10.38

1.1

0.86

1.63

u/ml

1.96

121

837

COPD, early/later onset

252

1357

1.57

10.36

1.1

1.38

1.30

u/ml

0.06

117

523

Other and unspecified nonorganic psychotic disorders

132

2344

0.56

10.24

1.1

1.79

1.48

u/ml

0.09

990

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

100

355

2.09

10.23

1.1

1.45

1.77

u/ml

0.13

147

Kela-code for severe mental illness

241

3703

0.65

10.22

1.1

2.21

1.44

u/ml

0.33

111

1500

Acute suppurative otitis media

573

4015

1.35

10.17

1.2

1.1

1.84

1.85

u/ml

0.01

271

1809

Dental caries 2 and operation codes, only avohilmo

1057

5279

1.25

10.12

1.1

2.08

1.64

u/ml

0.52

466

2227

Malignant neoplasm of breast

230

2583

0.64

10.10

1.1

1.47

1.03

u/ml

0.33

880

Schizophrenia or delusion, excluding more controls

190

3040

0.62

10.04

1.1

1.60

1.55

u/ml

0.02

1216

Dysphagia

200

1226

1.64

10.02

1.1

0.72

1.37

u/ml

1.01

478

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

118

624

1.92

9.96

1.2

1.1

1.79

1.37

u/ml

0.21

250

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

284

1896

1.52

9.92

1.2

1.1

0.80

1.64

u/ml

1.74

122

706

Other respiratory diseases principally affecting the interstitium

109

560

1.96

9.92

1.1

1.40

2.19

u/ml

0.43

236

Rotator cuff syndrome

554

3063

1.35

9.89

1.1

1.20

1.53

u/ml

0.48

221

1119

Nummular dermatitis

363

2.21

9.75

1.1

1.28

1.58

u/ml

0.15

133

Type 2 diabetes

780

5889

0.78

9.69

1.1

1.34

1.41

u/ml

0.11

314

2288

Inflammatory diseases of female pelvic organs

876

5253

1.26

9.58

1.2

1.1

1.35

1.60

u/ml

0.28

351

1985

Prurigo nodularis

3.76

9.49

1.0

1.1

1.31

1.78

u/ml

0.15

Injuries to the wrist and hand

1342

8094

1.21

9.46

1.1

1.41

1.80

u/ml

1.05

597

3340

Disturbances of skin sensation

370

2622

1.42

9.43

1.2

1.1

0.94

1.40

u/ml

0.95

171

1012

Disorders of skin appendages

669

5182

1.30

9.43

1.1

1.75

1.81

u/ml

0.05

304

2138

External causes of morbidity and mortality

1087

4419

1.24

9.31

1.1

1.77

1.75

u/ml

0.02

481

1732

Heartburn

128

710

1.83

9.30

1.1

0.79

1.11

u/ml

0.35

276

Arthropathies

1524

6508

1.20

9.30

1.1

1.31

1.97

u/ml

2.07

656

2764

Injury, poisoning and certain other consequences of external causes

916

3657

1.26

9.26

1.1

1.81

1.70

u/ml

0.11

393

1455

Other/unspecified dorsalgia

417

3008

1.39

9.24

1.1

1.67

1.60

u/ml

0.05

196

1156

Persons encountering health services in other circumstances, wide

1646

7228

1.19

9.12

1.1

1.59

1.81

u/ml

0.37

768

2944

Other diseases of oesophagus

373

2.14

9.11

1.2

1.1

5.82

1.95

u/ml

0.72

151

ILD, hospital admission 2, with pulmonary infections

241

2.43

9.03

1.2

1.1

1.95

1.94

u/ml

0.00

Other (not insulin) diabetes medications

704

5402

0.78

8.89

1.1

1.30

1.39

u/ml

0.13

289

2076

Cervicobrachial syndrome

244

1614

1.52

8.88

1.2

1.1

1.14

1.54

u/ml

0.35

568

Enthesopathies of lower limb, excluding foot

252

1679

1.51

8.87

1.1

0.93

1.54

u/ml

1.09

107

621

Organic, including symptomatic, mental disorders

1217

0.51

8.84

1.1

0.44

1.42

u/ml

3.10

469

Injuries to the ankle and foot

1044

7806

1.22

8.82

1.2

1.1

1.78

1.84

u/ml

0.06

503

3253

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

112

1561

0.56

8.73

1.1

4.47

1.25

u/ml

0.72

623

Disorders of synovium and tendon

629

4395

1.29

8.69

1.1

1.41

1.58

u/ml

0.20

234

1729

Parodontitis or/and operation codes

532

4155

0.76

8.67

1.1

2.02

1.36

u/ml

0.68

225

1657

Other nutritional deficiencies

847

6667

1.25

8.65

1.1

1.32

1.72

u/ml

0.77

385

2635

Other external causes of accidental injury

1253

5210

1.21

8.60

1.2

1.1

1.81

1.75

u/ml

0.06

569

2037

Preparation and fitting of bite rail to mouth

197

1255

1.59

8.59

1.1

0.56

1.52

u/ml

2.73

481

Cervicocranial syndrome

122

686

1.80

8.51

1.2

1.1

1.39

1.25

u/ml

0.06

256

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

885

0.36

8.36

1.1

0.19

1.13

u/ml

—

349

Shoulder lesions

789

3848

1.26

8.31

1.1

1.02

1.55

u/ml

1.25

310

1442

Cervicalgia

205

1327

1.56

8.28

1.1

1.37

1.45

u/ml

0.04

482

Malignant neoplasm of breast, HER2-negative

225

2472

0.67

8.25

1.1

1.45

1.06

u/ml

0.27

840

Other intervertebral disc disorders

954

4757

1.23

8.21

1.1

1.30

1.41

u/ml

0.14

388

1832

Disorders of eyelid, lacrimal system and orbit

902

5752

1.23

8.21

1.1

1.58

1.74

u/ml

0.20

380

2291

Hard cardiovascular diseases

375

3296

0.73

8.20

1.1

2.58

1.34

u/ml

0.75

142

1282

Other menopausal disorders

295

1169

1.46

8.16

1.1

1.08

1.31

u/ml

0.18

414

Disorders of the thyroid gland

1192

6502

1.20

8.11

1.1

1.55

1.64

u/ml

0.12

438

2647

Benign neoplasm: Colon, unspecified

141

837

1.69

8.08

1.1

1.28

1.46

u/ml

0.08

338

Mental and behavioural disorders due to alcohol, excluding acute intoxication

244

3554

0.68

8.05

1.2

1.1

2.07

1.44

u/ml

0.36

116

1433

Subjective visual disturbances

266

1830

1.46

8.04

1.1

1.08

1.59

u/ml

0.92

127

731

Biguanides

674

5242

0.79

8.00

1.1

1.23

1.39

u/ml

0.27

270

2003

Unspecified threat to breathing

3.42

7.99

1.3

1.2

0.32

0.93

u/ml

0.85

Alcohol use disorder, Swedish definition

332

4257

0.72

7.96

1.1

1.84

1.47

u/ml

0.25

150

1702

Sciatica+with lumbago

541

3960

1.30

7.93

1.1

2.11

1.43

u/ml

0.56

219

1499

Type 2 diabetes, strict (exclude DM1)

709

5305

0.80

7.89

1.1

1.35

1.43

u/ml

0.10

289

2041

Dermatitis due to substances taken internally

369

2.07

7.89

1.1

1.86

1.40

u/ml

0.16

136

Hypertrophy of breast in women and men

248

1693

1.48

7.84

1.1

1.66

1.34

u/ml

0.18

610

Other and unspecified rosacea

537

1.87

7.82

1.1

1.14

1.44

u/ml

0.18

189

Other noninfective gastroenteritis and colitis

310

2204

1.42

7.81

1.2

1.1

3.28

2.07

u/ml

0.71

157

1005

Transport accidents

643

4499

1.27

7.81

1.1

2.22

1.78

u/ml

0.42

286

1734

Oter anti-inflammatory and antirheumatic agents, non-steroids

165

556

1.65

7.80

1.2

1.1

1.89

2.60

u/ml

0.24

237

Type 2 diabetes, definitions combined

709

5293

0.80

7.77

1.1

1.35

1.43

u/ml

0.11

290

2038

Cerebrovascular diseases

298

3001

0.71

7.77

1.1

1.49

1.31

u/ml

0.11

115

1167

Oedema, not elsewhere classified

272

1881

1.45

7.75

1.1

1.12

1.47

u/ml

0.39

120

735

STROKE

310

3002

0.71

7.74

1.1

1.24

1.36

u/ml

0.09

126

1136

Alcohol use disorder, ICD-based

225

3305

0.68

7.74

1.2

1.1

2.22

1.47

u/ml

0.41

107

1335

Type 2 diabetes, definitions combined, including avohilmo

731

5380

0.80

7.58

1.1

1.30

1.41

u/ml

0.19

305

2072

Stroke, including SAH

204

2260

0.67

7.55

1.1

1.29

1.24

u/ml

0.02

881

Factors influencing health status and contact with health services

429

1594

1.36

7.55

1.1

2.01

2.16

u/ml

0.10

193

598

Inflammatory diseases of prostate (prostatitis)

528

1.85

7.55

1.1

1.08

1.67

u/ml

0.52

236

Vasomotor rhinitis (mode)

424

1.96

7.51

1.1

0.29

1.50

u/ml

1.98

168

Benign neoplasm: Colon, unspecified

141

856

1.65

7.32

1.1

1.28

1.07

u/ml

0.10

334

Alcohol dependence

107

1830

0.58

7.32

1.2

1.1

3.31

1.56

u/ml

0.47

754

416

4906

0.76

7.25

1.1

2.10

1.52

u/ml

0.48

190

1991

Acute laryngitis and tracheitis

256

1762

1.45

7.22

1.2

1.1

2.09

2.25

u/ml

0.09

118

824

Pulmonary eosinophilia, not elsewhere classified

4.85

7.22

1.2

1.1

0.18

1.97

u/ml

—

Genitourinary diseases

992

4114

1.21

7.19

1.1

1.74

2.07

u/ml

0.39

449

1910

Restless leg syndrome

119

700

1.72

7.17

1.2

1.1

1.39

u/ml

0.00

271

Substance abuse

409

5145

0.76

7.16

1.2

1.1

1.91

1.51

u/ml

0.31

194

2080

Infective dermatitis

110

633

1.75

7.16

1.1

1.66

1.14

u/ml

0.25

211

Diseases of oral cavity, salivary glands and jaws

1183

5106

1.19

7.14

1.1

1.55

1.83

u/ml

0.38

498

2129

Sequelae of other external causes

296

2.13

7.09

1.1

2.14

1.87

u/ml

0.06

125

Other and unspecified vaccines and biological substances

3.95

7.09

1.2

0.87

0.93

u/ml

0.03

Peritonsillar abscess

239

1657

1.45

7.00

1.1

1.03

1.59

u/ml

0.62

105

570

Mental and behavioural disorders due to psychoactive substance use

430

5284

0.76

6.96

1.1

2.01

1.55

u/ml

0.38

202

2128

Polyarthropathies

549

4636

0.79

6.90

1.1

1.03

1.72

u/ml

1.65

218

1859

Lumbar disc prolapse

681

4358

1.25

6.89

1.1

1.49

1.38

u/ml

0.11

286

1661

Other general symptoms and signs

104

593

1.77

6.84

1.1

1.2

0.48

2.49

u/ml

3.25

318

Occupational exposure to risk-factors

167

2.51

6.82

1.1

1.83

1.28

u/ml

0.27

Unspecified mental disorder

318

4298

0.74

6.78

1.2

1.1

1.83

1.44

u/ml

0.19

143

1742

Acute and transient psychotic disorders

1075

0.48

6.77

1.1

1.47

1.40

u/ml

0.03

424

Other and unspecified drugs and medicaments

541

1.80

6.77

1.2

1.1

2.00

1.46

u/ml

0.23

218

Any operation in hilmo

100

279

1.85

6.75

1.1

1.38

1.88

u/ml

0.26

114

Lichen simplex chronicus

162

2.52

6.72

1.2

1.1

0.86

1.45

u/ml

0.55

Any gastric operation

1397

6015

1.17

6.68

1.1

2.00

1.84

u/ml

0.21

609

2559

GASTRO-related operations

1397

6015

1.17

6.68

1.1

2.00

1.84

u/ml

0.21

609

2559

Internal derangement of knee

427

3266

1.31

6.67

1.1

1.57

u/ml

0.00

169

1250

Dental operations, only avohilmo

742

3079

1.24

6.63

1.1

1.23

1.61

u/ml

0.64

302

1236

387

4659

0.76

6.60

1.1

2.17

1.50

u/ml

0.54

177

1886

Unspecified chronic bronchitis

3.28

6.56

1.3

1.1

5.02

1.36

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

936

7124

1.20

6.53

1.2

1.1

1.42

1.85

u/ml

0.96

431

2999

Other inflammation of eyelid

137

860

1.61

6.46

1.1

2.35

1.70

u/ml

0.25

344

Continuous positive airway pressure

202

1185

1.48

6.44

1.2

1.1

2.16

1.72

u/ml

0.17

542

Other and unspecified polyneuropathies, also in other diseases

117

707

1.66

6.39

1.2

1.1

1.66

1.68

u/ml

0.01

276

Disorders of muscles

113

679

1.68

6.35

1.2

1.1

1.97

1.73

u/ml

0.08

259

Hypertrophy of breast

222

1550

1.45

6.35

1.1

1.91

1.22

u/ml

0.37

547

Other disorders of white blood cells

290

2.06

6.30

1.2

1.1

0.39

2.68

u/ml

2.61

131

Gingivitis and periodontal diseases

1138

4986

1.18

6.29

1.1

1.54

1.81

u/ml

0.36

501

2033

Drug-induced adrenocortical insufficiency

104

2.88

6.24

1.2

1.1

0.30

2.25

u/ml

0.95

Rosacea

128

799

1.62

6.21

1.1

1.58

1.19

u/ml

0.27

289

Obesity

780

6404

1.21

6.19

1.1

1.17

1.70

u/ml

1.29

351

2517

Irregular menses

751

5024

1.22

6.18

1.1

1.36

1.55

u/ml

0.23

297

1919

Benign neoplasm: Liver/bile ducts

151

2.51

6.18

1.1

0.74

2.19

u/ml

0.79

Correction of physiology of bite - very demanding therapy visit

240

2.18

6.16

1.2

1.1

0.60

1.37

u/ml

1.00

Obesity and other hyperalimentation

782

6423

1.21

6.14

1.1

1.16

1.70

u/ml

1.35

353

2522

COPD, hospital admissions 1, only main diagnosis

165

925

1.52

6.13

1.1

1.66

1.54

u/ml

0.05

366

COPD related to multimorbidity

174

975

1.51

6.12

1.1

0.94

1.46

u/ml

0.67

380

Hypothyroidism, other/unspecified

1096

6157

1.18

6.12

1.1

1.87

1.57

u/ml

0.39

410

2484

Unspecified acute lower respiratory infection

173

1160

1.50

6.09

1.2

1.1

1.76

1.69

u/ml

0.04

479

Emergency coronary revascularization (for ACS)

117

1348

0.62

6.07

1.1

3.61

1.20

u/ml

0.66

536

Other degenerative diseases of the nervous system

1087

0.57

6.07

1.1

0.83

1.23

u/ml

0.30

393

Other disorders of patella

235

1672

1.42

6.06

1.1

1.18

1.51

u/ml

0.38

617

Otalgia

116

713

1.65

6.04

1.3

1.2

2.92

2.07

u/ml

0.22

335

Benign neoplasm: Liver/bile ducts

153

2.48

6.02

1.1

0.74

1.50

u/ml

0.76

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

398

3072

1.30

6.02

1.2

1.1

2.01

1.95

u/ml

0.03

192

1283

Heart failure, not strict

372

3340

0.77

5.93

1.1

2.48

1.62

u/ml

0.49

144

1345

Disorders of breast

585

4386

1.24

5.90

1.1

1.66

1.34

u/ml

0.30

230

1611

Chondrocostal junction syndrome [Tietze]

211

2.22

5.90

1.2

1.1

2.69

1.79

u/ml

0.24

Other extrapyramidal and movement disorders in other diseases

182

1241

1.48

5.89

1.2

1.1

1.43

1.39

u/ml

0.02

490

Dislocation, sprain and strain of joints and ligaments of knee

817

6347

1.20

5.88

1.1

1.08

1.70

u/ml

1.66

355

2521

Other gastritis (incl. Duodenitis)

163

1087

1.51

5.87

1.2

1.1

1.12

1.34

u/ml

0.23

408

Benign neoplasm of colon, rectum, anus and anal canal

376

2601

1.31

5.85

1.1

0.95

1.19

u/ml

0.26

147

971

Insulin medication

392

4314

0.77

5.83

1.1

1.01

1.69

u/ml

2.17

159

1839

Generalized anxiety disorder

268

1966

1.38

5.81

1.2

1.1

1.69

u/ml

0.00

122

796

General examination and investigation of persons without complaint and reported diagnosis

826

3657

1.21

5.81

1.1

1.94

1.93

u/ml

0.00

348

1397

Spondylolisthesis/Spondylolysis

158

1051

1.51

5.78

1.1

0.85

1.29

u/ml

0.50

380

Cervical disc disorders

296

2202

1.35

5.78

1.1

1.26

1.54

u/ml

0.19

118

786

Benign neoplasm: Liver

138

2.53

5.77

1.1

0.76

1.62

u/ml

0.79

Dental operations

687

2883

1.23

5.70

1.1

1.33

1.65

u/ml

0.47

282

1161

Benign neoplasm: Liver

139

2.51

5.69

1.1

0.76

2.39

u/ml

0.80

Substance abuse, excluding more controls

409

4561

0.78

5.64

1.2

1.1

1.91

1.58

u/ml

0.25

194

1785

Mental and behavioural disorders due to alcohol

343

4343

0.77

5.63

1.2

1.1

2.27

1.52

u/ml

0.55

162

1763

Stroke, excluding SAH

190

2017

0.70

5.62

1.1

1.38

1.28

u/ml

0.05

790

Other disorders of eye and adnexa

177

1215

1.47

5.60

1.1

0.86

1.56

u/ml

1.57

511

Dislocation, sprain and strain of joints and ligaments at neck level

236

1708

1.40

5.58

1.2

1.1

1.61

1.66

u/ml

0.04

108

691

Embedded and impacted teeth

553

3807

1.24

5.57

1.1

1.63

2.12

u/ml

0.59

246

1688

Visual disturbances

492

3936

1.26

5.57

1.1

0.82

1.84

u/ml

4.84

234

1628

Coronary revascularization (ANGIO or CABG)

111

1230

0.63

5.56

1.1

3.89

1.18

u/ml

0.70

494

Other enthesopathy of foot (+metatarsalgia)

112

697

1.62

5.55

1.1

0.83

1.32

u/ml

0.42

271

Hypothyroidism, strict autoimmune

941

5284

1.18

5.54

1.1

1.80

1.58

u/ml

0.25

346

2118

Ocular pain

111

691

1.63

5.52

1.2

1.1

0.81

1.45

u/ml

0.93

279

Other disorders of eyelid

259

1838

1.37

5.48

1.1

1.16

1.48

u/ml

0.37

675

Benign neoplasm of other and ill-defined parts of digestive system

126

809

1.57

5.45

1.2

1.1

2.05

1.50

u/ml

0.22

304

Hypothyreosis and Thyroxine purchase for inclusion criteria

1116

6342

1.16

5.44

1.1

1.85

1.55

u/ml

0.40

415

2544

Recurring oral aphthae, including avohilmo

160

1084

1.49

5.42

1.2

1.1

1.63

1.62

u/ml

0.01

482

Ischaemic Stroke, excluding all haemorrhages

167

1832

0.69

5.42

1.1

1.56

1.24

u/ml

0.14

716

Hyperkinetic disorders, excluding more controls

252

1807

1.38

5.39

1.2

1.1

2.42

1.95

u/ml

0.24

137

870

Disorders of thyroid, IBD co-morbidities

257

1372

1.37

5.38

1.1

2.26

1.97

u/ml

0.13

555

Striking against or struck by other objects

449

3571

1.26

5.37

1.1

3.18

1.85

u/ml

0.96

211

1618

Olecranon bursitis

246

2.05

5.36

1.1

4.69

2.27

u/ml

0.39

100

Diseases of external ear

343

2643

1.30

5.30

1.2

1.1

3.17

1.80

u/ml

1.03

179

1130

Other and unspecified disorders of vitreous body

242

1763

1.37

5.26

1.1

0.70

1.42

u/ml

1.71

627

Ganglion

252

1861

1.36

5.24

1.1

1.56

1.40

u/ml

0.09

693

Anomalies of dental arch relationship, including avohilmo

354

2464

1.30

5.23

1.2

1.1

2.17

2.20

u/ml

0.02

169

1145

Spinal osteochondrosis

3.32

5.23

1.2

1.1

0.30

3.03

u/ml

0.65

Dementia, including avohilmo

701

0.53

5.19

1.2

1.1

0.34

1.36

u/ml

2.40

269

Seborrhoeic dermatitis

506

1.69

5.03

1.2

1.1

3.71

1.27

u/ml

0.53

187

Oesophagitis

239

2.03

5.01

1.1

0.74

1.67

u/ml

0.85

102

1058

5721

1.16

5.01

1.1

2.49

1.75

u/ml

0.85

512

2240

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1058

5721

1.16

5.01

1.1

2.49

1.75

u/ml

0.85

512

2240

Other reaction to severe stress, and adjustment disorders

547

4485

1.23

5.00

1.2

1.1

1.88

1.59

u/ml

0.28

263

1757

Herpesviral [herpes simplex] infections

136

908

1.51

4.99

1.2

1.1

3.14

1.41

u/ml

0.84

357

Tinnitus

199

1426

1.40

4.99

1.2

1.1

0.90

1.27

u/ml

0.53

551

Malaise and fatigue

468

3140

1.25

4.94

1.2

1.1

2.90

1.77

u/ml

0.78

205

1299

Rheumatism, unspecified

123

805

1.54

4.93

1.2

1.1

0.94

1.13

u/ml

0.15

286

Mental retardation, wide definition

635

0.43

4.92

1.3

1.2

0.37

2.85

u/ml

4.83

375

Atypical facial pain

304

1.90

4.91

1.1

0.32

1.60

u/ml

1.45

128

Metatarsalgia

102

641

1.61

4.91

1.1

0.74

1.41

u/ml

0.54

248

Cerebrovascular diseases (FINNGEN)

204

2007

0.72

4.88

1.1

1.75

1.22

u/ml

0.27

758

Female infertility, cervigal, vaginal, other or unspecified origin

433

2312

1.26

4.86

1.1

0.82

1.53

u/ml

2.07

154

879

COPD, hospital admission 2, with asthma infections

149

864

1.48

4.85

1.1

0.77

1.61

u/ml

1.27

346

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

666

0.45

4.85

1.1

1.39

u/ml

—

266

Dementia

650

0.53

4.85

1.2

1.1

0.38

1.44

u/ml

2.19

246

3.71

4.83

1.0

1.1

0.52

1.64

u/ml

—

Blepharochalasis

156

1076

1.46

4.83

1.1

1.16

1.44

u/ml

0.21

378

Any dementia, excluding more controls

532

0.48

4.82

1.2

1.1

0.27

1.89

u/ml

2.61

199

ILD-related respiratory insufficiency

3.10

4.80

1.1

1.2

1.01

1.06

u/ml

—

Universal erythroderma, KELA reimbursement

3.23

4.80

1.1

1.16

1.06

u/ml

0.07

Female infertility

487

2431

1.24

4.80

1.1

0.92

1.60

u/ml

1.82

179

935

Fibromyalgia

112

724

1.56

4.80

1.1

0.55

1.59

u/ml

1.43

254

Visual disturbances and blindness

510

4170

1.23

4.78

1.1

0.85

1.81

u/ml

4.56

245

1736

TMD related pain

315

1.88

4.78

1.1

0.76

1.42

u/ml

0.63

124

Separation of retinal layers (serosa)

203

2.10

4.78

1.2

1.1

0.72

1.82

u/ml

0.85

Polyneuropathies and other disorders of the peripheral nervous system

138

933

1.49

4.75

1.1

1.66

1.63

u/ml

0.01

382

Disorders of sclera, cornea, iris and ciliary body

579

4803

1.21

4.70

1.1

1.98

1.53

u/ml

0.44

257

1922

Care involving use of rehabilitation procedures

669

5335

1.19

4.70

1.1

0.75

1.76

u/ml

6.33

313

2166

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

153

1774

0.70

4.68

1.1

1.74

1.15

u/ml

0.29

599

Any dementia

543

0.49

4.67

1.2

1.1

0.31

1.66

u/ml

2.40

199

Mental retardation

620

0.44

4.66

1.3

1.2

0.37

2.89

u/ml

4.85

369

Hypothyroidism and >3 levothyroxin purchases

542

2555

1.23

4.65

1.1

1.78

1.82

u/ml

0.04

212

1081

Hypothyroidism, levothyroxine purchases

542

2555

1.23

4.65

1.1

1.78

1.82

u/ml

0.04

212

1081

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

914

7200

0.86

4.65

1.2

1.1

1.59

1.74

u/ml

0.16

414

2985

Adrenocortical insufficiency

240

1.99

4.64

1.2

1.1

0.53

2.70

u/ml

2.12

111

Panic disorder

253

1912

1.33

4.61

1.1

2.08

1.54

u/ml

0.29

121

750

Certain infectious and parasitic diseases

1448

6418

1.13

4.61

1.1

1.50

1.84

u/ml

0.67

622

2643

Hypothyroidism (congenital or acquired)

548

2587

1.22

4.59

1.1

1.80

1.82

u/ml

0.02

218

1100

Nontoxic goitre/thyroid nodule

219

1618

1.36

4.59

1.1

0.75

1.13

u/ml

0.50

578

Urticaria due to cold and heat

2.98

4.58

1.2

1.1

1.95

3.72

u/ml

0.42

Selective deficiency of immunoglobulin G [IgG] subclasses

3.74

4.55

1.2

0.93

2.88

u/ml

—

Hypermobility syndrome

632

1.59

4.55

1.2

1.1

2.68

1.77

u/ml

0.23

251

Other diseases of lip and oral mucosa

136

927

1.48

4.53

1.2

1.1

2.24

1.90

u/ml

0.12

344

Diseases of male genital organs

563

2342

1.22

4.52

1.1

1.65

1.99

u/ml

0.31

262

1155

Autoimmune diseases excluding thyroid diseases

1144

7242

0.87

4.51

1.1

1.50

1.80

u/ml

0.43

479

3101

Benign neoplasm of other and ill-defined parts of digestive system

126

847

1.50

4.49

1.2

1.1

2.05

1.19

u/ml

0.39

317

Endometriosis of pelvic peritoneum

229

1690

1.35

4.47

1.1

0.52

1.36

u/ml

2.71

641

Noninflammatory disorders of female genital tract

716

3037

1.19

4.46

1.1

1.41

2.02

u/ml

0.94

279

1259

Excessive attrition of teeth

573

2572

1.21

4.46

1.1

1.52

1.79

u/ml

0.33

245

1078

Adenomyosis (Endometriosis of uterus)

126

849

1.49

4.46

1.2

1.1

0.42

0.88

u/ml

1.66

307

Benign neoplasm: Transverse colon

314

1.83

4.44

1.1

0.25

1.54

u/ml

2.20

123

Parodontitis or operation codes

661

5759

0.84

4.41

1.1

1.77

1.39

u/ml

0.41

275

2221

Parodontitis

660

5753

0.84

4.39

1.1

1.78

1.39

u/ml

0.42

274

2219

Acute tubulo-interstitial nephritis

444

4820

0.81

4.38

1.1

1.28

1.71

u/ml

0.41

191

1958

Nonsuppurative otitis media

442

3108

1.24

4.37

1.1

2.79

2.15

u/ml

0.39

228

1440

Other maternal disorders predominantly related to pregnancy

845

4563

1.17

4.37

1.2

1.1

2.05

1.35

u/ml

0.92

290

1747

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

720

4995

1.18

4.37

1.1

1.34

1.49

u/ml

0.18

247

1892

Benign neoplasm: Choroid

224

1.98

4.37

1.1

0.14

1.82

u/ml

1.93

Crossbite

173

1155

1.41

4.36

1.2

2.24

3.03

u/ml

0.49

107

641

Other disorders of urethra and urinary system

771

4939

1.17

4.31

1.1

1.88

1.61

u/ml

0.23

283

1918

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

458

3415

1.23

4.31

1.1

2.28

2.19

u/ml

0.06

227

1627

Keratitis

370

2963

1.25

4.28

1.1

2.75

1.57

u/ml

0.93

168

1175

Chronic periodontitis, including avohilmo

658

5742

0.85

4.26

1.1

1.79

1.39

u/ml

0.43

272

2218

COPD-related respiratory insufficiency

261

1.89

4.25

1.2

1.1

3.63

2.36

u/ml

0.20

101

Other disorders of breast

147

1032

1.44

4.24

1.2

1.1

1.89

1.31

u/ml

0.25

383

Autoimmune diseases excluding thyroid diseases, strict definition

1125

7124

0.88

4.23

1.1

1.52

1.77

u/ml

0.34

470

3054

Mental retardation, excluding more controls

587

0.46

4.23

1.3

1.2

0.37

2.44

u/ml

3.63

346

Cardiovascular diseases

1259

6063

1.14

4.23

1.1

1.71

1.78

u/ml

0.07

538

2653

Radiculopathy

114

761

1.51

4.22

1.2

1.1

0.97

1.37

u/ml

0.28

267

Unspecified privation

113

755

1.51

4.20

1.2

1.1

0.93

1.50

u/ml

0.77

295

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

225

2034

0.75

4.19

1.1

1.36

1.09

u/ml

0.21

762

Acute appendicitis, no complications

715

6097

1.17

4.17

1.1

1.48

1.56

u/ml

0.09

280

2413

Otitis externa

250

1915

1.31

4.16

1.1

3.59

1.78

u/ml

1.13

129

808

Noninfective enteritis and colitis

553

4622

1.20

4.16

1.2

1.1

2.69

1.79

u/ml

0.74

238

2016

Peripheral artery disease

1139

0.65

4.15

1.1

0.91

1.53

u/ml

0.92

442

All influenza

263

2028

1.30

4.15

1.2

1.1

1.08

1.71

u/ml

1.17

126

920

Mental and behavioural disorders due to opioids

426

0.37

4.14

1.0

1.1

0.47

1.66

u/ml

—

179

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

832

0.55

4.13

1.2

1.1

4.67

1.66

u/ml

0.34

356

Pain, not elsewhere classified

308

2427

1.28

4.11

1.2

1.1

1.57

1.74

u/ml

0.13

133

978

Inflammatory disease of uterus

207

1549

1.35

4.09

1.2

1.1

1.90

1.33

u/ml

0.27

547

Panniculitis affecting regions of neck and back

216

1.97

4.09

1.2

1.1

5.90

1.65

u/ml

0.36

Excessive, frequent and irregular menstruation

610

2850

1.20

4.08

1.2

1.1

1.30

1.84

u/ml

0.80

231

1160

Substance use, excluding alcohol

144

2018

0.71

4.08

1.1

1.96

1.48

u/ml

0.15

833

Other diseases of peritoneum

223

1.95

4.08

1.1

0.65

1.59

u/ml

0.80

Spondylosis

391

2711

1.24

4.07

1.1

1.14

1.52

u/ml

0.42

133

975

Deforming dorsopathies

295

2318

1.28

4.03

1.1

1.87

1.86

u/ml

0.01

126

953

Fever of other and unknown origin

613

4808

1.19

4.03

1.1

0.93

1.87

u/ml

2.85

286

2015

Other/unspecified enthesopathies, not elsewhere classified

453

1.65

4.02

1.4

1.1

2.68

1.93

u/ml

0.21

169

Correction of physiology of bite - demanding therapy visit

651

1.54

4.01

1.2

1.1

0.52

1.39

u/ml

1.87

261

Disorders of ocular muscles, binocular movement, accommodation and refraction

642

5416

1.18

4.01

1.1

0.87

2.01

u/ml

6.44

287

2347

Extrapyramidal and movement disorders

245

1881

1.31

3.99

1.1

1.12

1.33

u/ml

0.22

736

Other specified disorders of external ear

124

2.29

3.98

1.1

4.71

1.91

u/ml

0.33

Benign neoplasm: Choroid

232

1.92

3.98

1.1

0.14

1.56

u/ml

1.67

Infections of the skin and subcutaneous tissue

700

5974

1.17

3.98

1.1

2.49

1.73

u/ml

0.74

343

2526

Transplanted organ and tissue status

758

0.54

3.96

1.3

1.2

0.32

2.19

u/ml

3.40

361

Renal failure

134

1732

0.71

3.95

1.2

1.1

3.23

1.36

u/ml

0.45

741

Major coronary heart disease event

268

2294

0.78

3.95

1.2

1.1

3.04

1.30

u/ml

0.80

905

All influenza (not pneumonia)

184

1360

1.36

3.94

1.2

1.1

0.97

1.70

u/ml

1.21

619

Condition for Implicit Sepsis (Organ dysfunction codes)

663

5637

0.85

3.93

1.1

1.48

1.65

u/ml

0.22

291

2316

Benign neoplasm: Transverse colon

327

1.75

3.93

1.1

0.25

1.75

u/ml

1.86

129

Pleural plaque

131

2.22

3.92

1.2

1.1

0.68

1.52

u/ml

—

Epiphora

2.54

3.91

1.1

0.74

1.41

u/ml

—

Unspecific neurodegenerative disorder

499

0.52

3.91

1.2

1.1

0.46

1.39

u/ml

1.52

187

Other disorders of adrenal gland

374

1.71

3.90

1.2

1.1

0.65

2.89

u/ml

2.29

172

Erysipelas

266

3099

0.78

3.90

1.1

2.18

1.31

u/ml

0.74

138

1205

Lateral epicondylitis

134

942

1.43

3.87

1.2

1.1

0.50

1.57

u/ml

2.51

336

Exclusions for E4_PCOS_CONSORTIUM

822

5927

0.87

3.84

1.1

1.85

1.72

u/ml

0.10

300

2435

Obesity, other/unspecified

402

3292

1.23

3.83

1.1

0.90

1.44

u/ml

0.88

180

1272

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

671

0.52

3.80

1.2

1.1

1.93

1.67

u/ml

0.07

267

Insulin, combination of fast acting with intermediate-acting or long-acting

392

4406

0.82

3.79

1.1

1.01

1.71

u/ml

2.28

159

1876

Candidiasis

140

996

1.42

3.79

1.2

1.1

1.13

1.33

u/ml

0.13

396

Obsessive-compulsive disorder

129

907

1.44

3.79

1.1

2.67

1.65

u/ml

0.64

403

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

662

3672

1.18

3.79

1.2

1.1

1.38

1.51

u/ml

0.13

276

1416

Other neurological diseases

398

3898

0.82

3.77

1.1

1.07

1.51

u/ml

0.60

169

1544

Type 2 diabetes, wide definition

481

3758

0.83

3.76

1.1

1.22

1.44

u/ml

0.29

186

1419

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

326

1.75

3.74

1.2

1.1

3.20

1.74

u/ml

0.27

146

Other disorders of bone

240

1858

1.30

3.74

1.2

1.1

1.61

1.76

u/ml

0.09

110

765

ILD, hospital admissions 3, with pneumonia sepsis

202

1.94

3.72

1.2

1.1

2.43

1.27

u/ml

0.26

Impetigo

560

1.56

3.71

1.2

4.28

2.72

u/ml

0.33

288

Other acute skin changes due to ultraviolet radiation

148

2.12

3.70

1.1

1.03

2.07

u/ml

0.47

Mycoses

247

1921

1.29

3.70

1.1

2.30

1.66

u/ml

0.36

106

800

Degenerative diseases of the nervous system

464

0.50

3.70

1.2

1.1

0.29

1.73

u/ml

2.08

169

Contact with other specified venomous animals

3.38

3.68

1.2

1.1

0.72

2.27

u/ml

—

Benign neoplasm: Sigmoid colon

639

1.51

3.66

1.1

2.15

1.66

u/ml

0.12

251

Postmenopausal atrophic vaginitis

180

798

1.36

3.66

1.1

0.70

1.28

u/ml

0.75

290

Sub-endpoint used in defining T1D endpoints

230

2909

0.77

3.65

1.1

1.12

1.91

u/ml

1.41

1312

Single spontaneous delivery

374

2440

0.81

3.64

1.1

1.92

1.36

u/ml

0.53

162

995

Schizoaffective disorder

737

0.55

3.64

1.1

4.05

1.27

u/ml

0.33

289

Other systemic involvement of connective tissue (FG)

225

1721

1.30

3.64

1.2

1.1

2.10

1.25

u/ml

0.54

632

Other and unspecified acute skin changes due to ultraviolet radiation

2.77

3.60

1.1

2.14

3.30

u/ml

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

256

1.83

3.59

1.2

1.1

1.18

1.59

u/ml

0.16

Septicaemia

188

2383

0.76

3.58

1.1

3.31

1.60

u/ml

0.74

1035

Metabolic disorders

785

5600

0.87

3.58

1.1

1.27

1.61

u/ml

0.51

329

2268

Certain disorders involving the immune mechanism

189

1425

1.33

3.58

1.1

1.76

1.59

u/ml

0.07

592

Other systemic involvement of connective tissue

227

1755

1.30

3.57

1.2

1.1

2.06

1.31

u/ml

0.47

665

Cholecystectomy

616

4660

1.17

3.56

1.1

1.24

1.36

u/ml

0.17

231

1732

Impacted teeth

396

3041

1.22

3.56

1.1

1.38

2.10

u/ml

1.04

183

1360

Other complications of surgical and medical care, not elsewhere classified

101

685

1.49

3.56

1.2

1.1

0.74

1.75

u/ml

1.44

258

Other respiratory disorders and diseases

110

758

1.46

3.54

1.1

0.94

1.89

u/ml

0.69

333

Other diseases of the respiratory system

110

758

1.46

3.54

1.1

0.94

1.89

u/ml

0.69

333

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

763

0.65

3.53

1.0

1.1

0.56

1.37

u/ml

1.80

323

Other shoulder lesions

103

703

1.48

3.52

1.1

0.70

1.24

u/ml

0.87

265

Coronary artery bypass grafting

550

0.55

3.52

1.1

6.04

1.34

u/ml

0.66

211

Dialysis, with operation codes

755

0.57

3.50

1.3

1.1

0.78

1.95

u/ml

1.52

349

Contracture of joint

2.95

3.49

1.1

0.45

3.80

u/ml

—

Ovarian cyst

522

2542

1.19

3.49

1.2

1.1

0.84

1.69

u/ml

2.63

207

982

Alzheimer disease, including avohilmo

378

0.48

3.48

1.2

1.1

0.42

1.00

u/ml

—

137

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

371

1.66

3.48

1.1

1.70

1.78

u/ml

0.02

142

Other contact dermatitis

559

1.53

3.48

1.1

1.49

1.02

u/ml

0.24

190

Atherosclerosis, excluding cerebral and coronary sclerosis

923

0.65

3.47

1.1

1.10

1.36

u/ml

0.26

355

Appendicitis, broad definition

888

7150

1.14

3.47

1.1

1.44

1.58

u/ml

0.21

353

2823

Other and unspecified nerve root and plexus disorders, also in other diseases

179

1347

1.34

3.45

1.1

0.49

1.36

u/ml

3.05

520

Bruxism

160

2.05

3.45

1.1

0.39

1.57

u/ml

—

Other obstetric conditions, not elsewhere classified

666

3730

1.17

3.44

1.1

1.37

1.51

u/ml

0.14

277

1427

Disturbance of activity and attention

246

1913

1.28

3.44

1.2

1.1

2.36

2.27

u/ml

0.04

136

959

Other/unspecified enthesopathies of lower limb, excluding foot

529

1.55

3.43

1.1

0.88

1.24

u/ml

0.30

192

Other and unspecified mental retardation

341

0.37

3.42

1.2

1.3

0.23

2.92

u/ml

—

240

Flat foot [pes planus] (acquired)

594

1.51

3.40

1.1

0.95

1.68

u/ml

0.61

221

Nephropathy related operations

735

0.57

3.39

1.3

1.1

0.79

1.97

u/ml

1.45

343

Viral pneumonia

128

917

1.41

3.38

1.2

1.1

1.50

1.85

u/ml

0.20

389

Other and unspecified follicular disorders

261

1.79

3.37

1.1

2.12

2.15

u/ml

0.01

111

Other diseases of stomach and duodenum

247

1.80

3.32

1.1

0.81

1.71

u/ml

0.85

106

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1277

0.68

3.32

1.1

0.89

u/ml

0.00

449

Diseases of appendix

890

7166

1.13

3.31

1.1

1.44

1.60

u/ml

0.26

354

2831

Other arthrosis

436

2604

1.20

3.30

1.1

0.81

1.53

u/ml

1.48

178

946

Deep bite

215

1462

1.30

3.30

1.2

3.55

2.63

u/ml

0.33

109

761

Thyroiditis, ILD-related definition

144

1058

1.37

3.29

1.1

1.60

1.85

u/ml

0.11

413

Benign neoplasm: Other and unspecified parts of mouth

142

2.07

3.28

1.0

1.1

12.41

1.88

u/ml

—

Glucagon-like peptide-1 (GLP-1) analogues

198

2108

0.77

3.27

1.1

1.39

1.56

u/ml

0.10

813

Type 1 diabetes, wide definition

204

2618

0.77

3.27

1.1

0.90

1.92

u/ml

2.65

1190

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.63

3.24

1.2

1.1

0.45

4.21

u/ml

—

Other bursopathies

634

1.47

3.21

1.1

2.24

1.66

u/ml

0.24

239

Acute appendicitis

841

7006

1.14

3.20

1.1

1.44

1.58

u/ml

0.20

335

2766

Major anomalies of jaw size

229

1.82

3.20

1.2

1.1

0.73

1.73

u/ml

0.82

101

Congenital malformations, deformations and chromosomal abnormalities

863

7315

1.13

3.20

1.1

1.82

1.85

u/ml

0.03

392

3107

Inhalation and ingestion of food causing obstruction of respiratory tract

2.81

3.19

1.5

1.2

2.94

4.50

u/ml

—

Meniscus derangement

526

3066

1.18

3.17

1.1

1.36

1.50

u/ml

0.18

219

1144

Postpartum care and examination

209

1705

0.78

3.16

1.2

1.1

1.33

1.42

u/ml

0.07

688

Thyroiditis

548

1.51

3.16

1.1

1.77

1.27

u/ml

0.14

213

Coronary angioplasty

1005

0.69

3.16

1.2

1.1

2.48

1.24

u/ml

0.36

399

Endometriosis

467

2341

1.19

3.16

1.1

0.63

1.66

u/ml

3.97

171

891

N06DA Anticholinesterases

396

0.49

3.15

1.3

1.1

0.64

0.88

u/ml

—

140

Use of anticholinesterases

396

0.49

3.15

1.3

1.1

0.64

0.88

u/ml

—

140

Persons encountering health services in other circumstances

462

3910

1.18

3.15

1.1

1.95

1.83

u/ml

0.08

193

1616

Injury of muscle and tendon at shoulder and upper arm level

230

1814

1.27

3.14

1.2

1.1

1.06

1.76

u/ml

0.88

101

697

Other/unspecified soft tissue disorders related to use, overuse and pressure

187

1.90

3.13

1.1

0.40

2.47

u/ml

1.27

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

566

4871

1.16

3.11

1.2

1.1

2.27

1.91

u/ml

0.30

269

2043

Tracheo-bronchomalasia

3.39

3.11

1.2

1.1

1.15

1.26

u/ml

—

Postviral fatigue syndrome

2.35

3.11

1.2

1.1

0.19

2.25

u/ml

—

Benign neoplasm of eye and adnexa

485

1.54

3.11

1.1

0.86

1.53

u/ml

0.70

196

Benign neoplasm of eye and adnexa

485

1.54

3.11

1.1

0.86

1.37

u/ml

0.48

191

Disorders of other endocrine glands

507

4262

1.17

3.10

1.2

1.1

1.73

1.89

u/ml

0.12

222

1858

Type 1 diabetes, strict (exclude DM2)

120

1639

0.72

3.10

1.1

1.2

1.19

2.37

u/ml

1.46

806

Polyarthrosis

111

755

1.41

3.09

1.1

0.98

1.51

u/ml

0.45

261

Hyperkinetic disorders

260

2065

1.26

3.08

1.2

1.1

2.36

2.26

u/ml

0.05

145

1038

Malignant neoplasm of digestive organs

1231

0.69

3.08

1.1

3.80

1.36

u/ml

0.44

484

Other septicaemia

160

2066

0.76

3.08

1.1

3.16

1.74

u/ml

0.51

914

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

261

1.73

3.06

1.0

1.1

3.76

1.08

u/ml

0.46

Sulfonylureas

798

0.65

3.05

1.1

1.44

1.29

u/ml

0.08

312

Falls/tendency to fall

1589

7261

1.10

3.04

1.1

1.79

1.78

u/ml

0.00

729

2965

Suppurative otitis media, unspecified

248

1.77

3.03

1.0

1.2

2.38

1.99

u/ml

0.10

118

Other skin changes

125

910

1.38

3.03

1.1

3.71

1.64

u/ml

0.79

364

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

491

4152

1.18

3.02

1.1

1.12

1.83

u/ml

1.87

233

1805

Dental caries 1 and operation codes

1003

4588

1.12

3.01

1.1

1.97

1.59

u/ml

0.38

431

1877

Umbilical hernia

232

1845

1.26

2.99

1.1

1.15

1.72

u/ml

0.49

107

732

Complications predominantly related to the puerperium

358

2983

1.21

2.98

1.1

2.87

1.11

u/ml

1.13

145

1099

Impingement syndrome of shoulder

176

1353

1.31

2.96

1.1

0.62

1.30

u/ml

1.41

494

Vulvovaginal ulceration/inflammation in other diseases

664

1.45

2.96

1.2

1.1

1.89

1.75

u/ml

0.04

241

Benign neoplasm: Colon

324

2041

1.22

2.96

1.1

0.90

1.08

u/ml

0.17

126

771

Complications of medical and surgical care

688

5726

1.14

2.96

1.1

1.39

1.57

u/ml

0.22

311

2222

L04AD Calcineurin inhibitors

974

0.65

2.96

1.2

2.79

2.00

u/ml

0.14

467

Pulmonary embolism

167

1275

1.31

2.95

1.1

0.81

1.31

u/ml

0.82

480

Idiopathic pulmonary fibrosis

155

1.95

2.94

1.1

0.65

2.46

u/ml

1.13

Ehlers-Danlos syndrome

102

2.23

2.93

1.2

1.1

1.71

1.32

u/ml

0.10

Subacute thyroiditis

228

1.78

2.93

1.1

0.28

1.02

u/ml

1.67

Tramadol

832

4735

1.13

2.93

1.2

1.1

1.51

1.42

u/ml

0.09

359

1806

Other and unspecified local infections of skin and subcutaneous tissue

648

1.45

2.92

1.1

3.88

1.91

u/ml

0.53

273

Injuries to the neck

285

2327

1.23

2.92

1.2

1.1

1.54

1.79

u/ml

0.21

128

964

Benign neoplasm of mouth and pharynx

582

1.47

2.92

1.1

4.71

1.65

u/ml

0.60

228

Pericarditis

149

1.97

2.91

1.2

1.1

6.45

2.75

u/ml

0.30

Pulmonary heart disease

167

1278

1.31

2.90

1.1

0.81

1.31

u/ml

0.81

483

Carpal tunnel syndrome

541

4214

1.16

2.90

1.2

1.1

0.79

1.40

u/ml

2.51

197

1573

Synovial cyst of popliteal space [Baker]

296

1.67

2.90

1.1

1.26

1.95

u/ml

0.30

117

Melanocytic naevi

322

2666

1.21

2.87

1.1

1.80

1.71

u/ml

0.05

132

1062

Mental and behavioural disorders due to use of other stimulants, including caffeine

345

0.43

2.87

1.2

1.1

0.23

1.87

u/ml

—

145

Implicit Sepsis

494

4468

0.86

2.87

1.1

1.26

1.70

u/ml

0.82

220

1833

Cholecystitis

543

1.48

2.86

1.2

1.1

0.88

1.71

u/ml

0.82

211

Type 1 diabetes

232

2880

0.80

2.86

1.1

1.11

1.92

u/ml

1.48

1314

Injuries to the knee and lower leg

1509

7897

1.10

2.86

1.1

1.37

1.83

u/ml

1.12

653

3255

Sequelae of external causes of morbidity and mortality

192

1502

1.28

2.85

1.1

1.17

1.46

u/ml

0.20

612

Abnormal findings in secretions and smears from cervix uteri vagina vulva

671

4624

1.14

2.85

1.1

1.28

1.44

u/ml

0.19

235

1721

Type 1 diabetes, wide definition, subgroup 1

199

2512

0.79

2.85

1.1

0.92

1.91

u/ml

2.47

1133

Muscle strain

223

1.77

2.84

1.2

1.1

0.81

1.69

u/ml

0.61

Other diseases of intestines

1436

7619

1.10

2.83

1.1

1.43

1.80

u/ml

0.75

585

3246

Hypothyroidism, strict autoimmune, 3 medication purchases required

976

5965

1.12

2.83

1.1

1.69

1.53

u/ml

0.19

352

2361

Concussion

652

4944

1.14

2.83

1.2

1.1

1.65

2.10

u/ml

0.63

289

2101

Benign neoplasm: Sigmoid colon

677

1.42

2.82

1.1

2.15

1.20

u/ml

0.27

271

Obesity due to excess calories

538

4659

1.16

2.82

1.1

1.54

1.67

u/ml

0.14

238

1848

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.60

2.81

1.4

1.1

0.30

1.69

u/ml

—

Benign neoplasm: Other and unspecified parts of mouth

151

1.94

2.81

1.0

1.1

12.41

2.02

u/ml

—

Disorders of parathyroid gland

112

801

1.39

2.81

1.1

1.95

1.15

u/ml

0.24

304

Benign neoplasm: Duodenum

2.42

2.81

1.4

1.1

1.32

1.80

u/ml

—

Peroneal tendinitis

2.21

2.80

1.1

1.25

3.02

u/ml

0.56

Uterine polyps

571

1.46

2.80

1.1

0.65

0.99

u/ml

0.53

215

Other and unspecified trigeminal disorders

2.30

2.80

1.1

1.36

2.39

u/ml

—

Disorders of refraction and accommodation

379

3183

1.19

2.80

1.2

1.1

1.03

2.08

u/ml

3.00

158

1435

Type 1 diabetes, definitions combined

123

1644

0.74

2.79

1.1

1.2

1.19

2.38

u/ml

1.49

809

Other specified/unspecified soft tissue disorders

209

1.78

2.79

1.1

1.13

1.81

u/ml

0.25

Diseases of salivary glands

177

1375

1.29

2.79

1.1

0.71

1.89

u/ml

2.74

515

Other superficial mycoses

138

1.99

2.78

1.2

1.1

0.49

2.22

u/ml

—

Benign neoplasm: Small intestine

117

2.07

2.78

1.3

1.1

1.73

1.27

u/ml

0.26

Iron deficiency

248

1.73

2.78

1.1

1.2

2.02

2.08

u/ml

0.01

Insulin, intermediate and long-acting

344

4022

0.84

2.76

1.1

1.02

1.76

u/ml

2.18

139

1712

Other spirochaetal diseases

209

1660

1.26

2.76

1.1

2.28

1.42

u/ml

0.37

658

Myotonic disorders

2.79

2.75

1.4

1.1

0.17

2.36

u/ml

—

Fissure and fistula of anal and rectal regions

221

1767

1.26

2.75

1.1

0.79

1.50

u/ml

1.38

702

Nontoxic multinodular goitre

129

961

1.35

2.74

1.1

0.90

0.94

u/ml

0.03

345

Short Achilles tendon (acquired)

146

1.94

2.72

1.3

1.1

1.14

3.39

u/ml

0.77

Sicca syndrome [Sjögren]

493

1.49

2.71

1.2

1.1

1.48

1.42

u/ml

0.03

177

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

419

0.50

2.70

1.2

1.1

6.53

1.93

u/ml

0.38

186

Dyshidrosis [pompholyx]

119

2.06

2.70

1.1

0.39

1.77

u/ml

—

Superficial injury of hip and thigh

113

827

1.37

2.69

1.2

1.1

2.22

1.53

u/ml

0.30

341

Dizziness and giddiness

699

5010

1.13

2.68

1.1

1.32

1.42

u/ml

0.11

285

1961

Type 1 diabetes, strict definition

109

1472

0.73

2.68

1.1

1.2

0.87

2.26

u/ml

2.74

738

Other deformities of toe(s)

161

1.88

2.68

1.1

0.48

2.42

u/ml

—

Rash and other nonspecific skin eruption

694

1.41

2.67

1.2

1.1

1.74

1.89

u/ml

0.07

296

Benign neoplasm: Duodenum

2.36

2.66

1.4

1.1

1.32

1.79

u/ml

—

Other disorders of teeth and supporting structures

173

1350

1.29

2.65

1.2

1.1

2.29

1.66

u/ml

0.24

529

Other local infections of skin and subcutaneous tissue

687

1.41

2.64

1.1

3.72

1.84

u/ml

0.53

285

Acne

211

1691

1.26

2.63

1.2

1.1

1.13

2.14

u/ml

1.65

113

758

Drug-induced cataract

120

2.03

2.63

1.3

1.1

4.08

1.93

u/ml

0.22

Inflammation of lacrimal passages (acute and unspecified)

2.29

2.63

1.3

1.1

0.32

0.98

u/ml

—

Benign neoplasm: Small intestine

120

2.02

2.61

1.3

1.1

1.73

1.34

u/ml

0.21

Other noninflammatory disorders of vulva and perineum

105

765

1.38

2.61

1.1

0.37

1.21

u/ml

1.62

285

Other and unspecified injuries of ankle and foot

442

1.51

2.60

1.2

1.1

0.59

2.41

u/ml

2.51

201

Chondropathies

182

1435

1.28

2.59

1.2

1.1

1.86

1.54

u/ml

0.17

586

Dysplasia of cervi uteri

339

2200

1.20

2.59

1.1

1.36

1.53

u/ml

0.14

126

827

Alzheimer disease, excluding more controls

224

0.45

2.58

1.2

1.1

0.27

1.53

u/ml

—

Explicit Sepsis

237

2786

0.81

2.58

1.1

3.14

1.65

u/ml

0.72

111

1206

Otitis media, unspecified

225

1675

1.25

2.58

1.3

1.1

2.45

2.48

u/ml

0.01

132

850

Other diseases of jaws

450

1.50

2.58

1.1

1.86

2.01

u/ml

0.05

168

Insulin, fast-acting (human)

115

1538

0.74

2.58

1.1

0.70

1.67

u/ml

2.04

651

Other specified/unspecified bacterial intestinal infections

330

1.59

2.58

1.1

1.15

1.66

u/ml

0.30

138

Melanocytic naevi of lip

2.80

2.57

1.2

1.0

0.13

1.39

u/ml

—

Diseases of arteries, arterioles and capillaries

288

2590

0.83

2.57

1.1

1.17

1.44

u/ml

0.36

114

1008

Other puerperal infections

141

1079

1.32

2.56

1.1

5.51

0.92

u/ml

1.38

416

Oral leukoplakia and related diseases, including avohilmo

402

1.53

2.56

1.1

1.26

1.77

u/ml

0.28

164

Abnormal involuntary movements

119

887

1.35

2.56

1.1

2.01

1.48

u/ml

0.35

353

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

302

0.43

2.55

1.2

1.1

7.61

1.62

u/ml

—

148

Type 1 diabetes, strict definition, subgroup 1

103

1391

0.73

2.55

1.1

0.90

2.23

u/ml

2.46

691

Other viral hepatitis

638

0.61

2.54

1.3

1.1

1.56

1.80

u/ml

0.10

253

Bleeding

559

4645

0.87

2.54

1.2

1.1

1.86

1.65

u/ml

0.15

241

1911

Other factor of the environment

2.32

2.54

1.1

2.93

1.15

u/ml

0.36

Gluteal tendinitis

201

1.76

2.54

1.1

0.14

1.01

u/ml

2.29

Immunodeficiencies

388

1.54

2.53

1.1

0.61

2.98

u/ml

2.96

181

Statin medication

719

4540

0.89

2.52

1.1

1.37

1.46

u/ml

0.09

282

1802

Nonalcoholic fatty liver disease

643

1.41

2.52

1.1

1.23

1.63

u/ml

0.34

253

Polyuria

145

1114

1.31

2.52

1.1

1.43

1.52

u/ml

0.06

427

Polyp of the female genital tract

329

1600

1.20

2.51

1.1

1.63

1.32

u/ml

0.16

124

581

Fitting and adjustment of other devices

173

1264

1.28

2.50

1.2

1.1

0.69

1.56

u/ml

1.88

474

Major coronary heart disease event excluding revascularizations

236

1997

0.81

2.50

1.1

3.25

1.27

u/ml

0.81

768

Use of disulfiram, acamprosate or naltrexone

672

0.62

2.49

1.3

1.1

0.64

1.66

u/ml

1.30

269

Disorder of lipoprotein metabolism, unspecified

445

1.49

2.49

1.0

1.1

0.60

1.88

u/ml

1.50

181

malignant neoplasm of male genital organs

795

0.72

2.49

1.1

0.44

1.58

u/ml

3.29

333

Other disorders of penis

687

1.39

2.48

1.2

1.30

2.83

u/ml

1.51

378

Antihypertensive medication - note that there are other indications

1175

5856

1.10

2.48

1.1

1.57

1.80

u/ml

0.35

487

2546

Melanocytic naevi of lip

2.73

2.48

1.2

1.1

0.13

1.48

u/ml

—

Hyperlipidaemia, other/unspecified

192

1448

1.26

2.47

1.1

0.68

1.28

u/ml

1.25

581

Lyme disease

202

1622

1.25

2.47

1.1

2.28

1.44

u/ml

0.36

638

Persistent mood disorders

197

1579

1.25

2.45

1.2

1.1

1.19

1.40

u/ml

0.11

617

Haemorrhage in early pregnancy

375

3121

1.18

2.45

1.1

1.52

1.23

u/ml

0.24

128

1170

Any mental disorder

1429

6573

1.09

2.45

1.1

1.60

1.80

u/ml

0.27

627

2682

Immunodeficiency with predominantly antibody defects

219

1.72

2.44

1.2

1.1

0.79

2.41

u/ml

1.46

107

Acute renal failure

743

0.64

2.44

1.1

0.43

2.11

u/ml

3.63

320

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

614

0.64

2.43

1.1

0.41

1.31

u/ml

1.90

246

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

174

1.80

2.43

1.1

1.54

1.94

u/ml

0.12

Menorrhagia

419

1983

1.17

2.43

1.1

2.33

1.39

u/ml

0.72

161

748

Hernia of abdominal wall

353

2998

1.18

2.42

1.1

1.50

1.53

u/ml

0.02

151

1177

Other immunodeficiencies

2.12

2.41

1.2

0.48

4.56

u/ml

1.85

Erosion of teeth, including avohilmo

268

2147

1.21

2.41

1.2

1.1

0.75

1.75

u/ml

1.86

118

888

Other benign neoplasms of uterus

138

1.90

2.41

1.2

1.1

4.99

1.57

u/ml

—

Other otitis externa (chronic)

441

1.49

2.41

1.1

6.60

1.91

u/ml

0.75

195

Parodontitis and operation codes

638

5593

0.88

2.41

1.1

1.82

1.35

u/ml

0.54

265

2162

Perforation of tympanic membrane

101

742

1.37

2.41

1.1

0.68

1.73

u/ml

1.37

315

Benign neoplasm: Ascending colon

416

1.50

2.41

1.1

3.15

1.58

u/ml

0.30

157

Fasciculation

2.26

2.41

1.0

1.1

0.31

1.86

u/ml

—

Secondary uncertain malignant neoplasm

467

0.55

2.40

1.2

1.1

2.92

1.81

u/ml

—

185

Alzheimer disease

315

0.53

2.40

1.2

1.1

0.36

0.93

u/ml

—

108

Superficial injury of lower leg

283

2361

1.20

2.40

1.2

1.1

2.10

2.17

u/ml

0.03

123

994

Sexual dysfunction

2.10

2.40

1.0

1.1

0.22

2.59

u/ml

—

Disorders of vitreous body

284

2318

1.20

2.39

1.1

0.71

1.26

u/ml

1.50

112

836

Complications associated with artificial fertilization

221

1.71

2.39

1.1

2.33

1.00

u/ml

0.42

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

175

1.79

2.39

1.1

1.54

1.95

u/ml

0.12

Other acquired deformities of musculoskeletal system and connective tissue

274

1.62

2.39

1.2

1.1

2.41

1.87

u/ml

0.18

114

Covid-19 confirmed case

285

2380

1.20

2.38

1.2

1.1

1.82

1.77

u/ml

0.03

129

998

Familial hypercholesterolemia

507

1.44

2.38

1.1

0.64

1.97

u/ml

1.88

212

Sacrococcygeal disorders, not elsewhere classified

213

1.71

2.38

1.1

0.50

1.46

u/ml

0.71

Other disorders of cornea

533

1.43

2.37

1.1

4.35

1.45

u/ml

0.58

205

Whooping cough

2.40

2.37

1.2

1.1

2.33

2.76

u/ml

—

Disorders of vitreous body and globe

293

2392

1.20

2.37

1.1

0.70

1.23

u/ml

1.53

116

862

Mucosal proctocolitis

1253

0.73

2.37

1.1

0.38

1.55

u/ml

3.49

523

Neuralgia and neuritis, unspecified

291

1.59

2.34

1.1

0.85

1.87

u/ml

0.61

113

Endocrine, nutritional and metabolic diseases

1343

6279

1.09

2.33

1.1

1.65

1.95

u/ml

0.51

567

2700

Benign neoplasm: Scapula and long bones of upper limb

2.43

2.32

1.1

0.35

1.69

u/ml

—

Benign neoplasm of mouth and pharynx

611

1.40

2.32

1.1

4.71

1.62

u/ml

0.61

229

Benign neoplasms

1340

6879

1.09

2.31

1.1

1.75

1.72

u/ml

0.03

538

2875

Retained placenta and membranes, without haemorrhage

135

1043

1.30

2.30

1.1

2.05

0.80

u/ml

0.80

363

Viral hepatitis

694

0.64

2.30

1.2

1.1

1.51

1.69

u/ml

0.08

275

Demyelinating diseases of the central nervous system

873

0.68

2.29

1.1

1.11

1.30

u/ml

0.09

345

Appendectomy

795

6897

1.11

2.28

1.1

1.39

1.62

u/ml

0.36

323

2714

Oligomenorrhoea

382

1.51

2.28

1.1

0.86

1.52

u/ml

0.46

149

Congenital malformations of trachea and bronchus

2.34

2.28

1.3

4.83

3.52

u/ml

—

Special screening examination for neoplasms

141

1.86

2.28

1.1

0.17

1.59

u/ml

—

Pulmonary heart disease, diseases of pulmonary circulation

179

1432

1.25

2.27

1.1

0.78

1.49

u/ml

1.42

566

Haemangioma, any site

597

1.40

2.27

1.2

1.1

1.44

1.80

u/ml

0.16

255

Nonorganic sleeping disorders, excluding more controls

236

1948

1.22

2.27

1.1

1.33

1.46

u/ml

0.09

782

Type1 diabetes, definitions combined, early onset

1292

0.74

2.27

1.1

1.2

1.23

2.50

u/ml

1.33

672

Malignant neoplasm of respiratory system and intrathoracic organs

469

0.59

2.26

1.1

0.56

1.68

u/ml

1.43

184

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

281

2357

1.20

2.26

1.2

1.1

1.20

1.61

u/ml

0.64

118

985

Haemangioma and lymphangioma, any site

674

1.37

2.26

1.2

1.1

1.32

1.98

u/ml

0.34

293

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

626

0.71

2.25

1.0

1.1

0.60

1.37

u/ml

1.32

262

Injury of muscle and tendon at hip and thigh level

632

1.39

2.25

1.2

1.1

1.59

1.62

u/ml

0.01

250

Budesonide

134

1038

1.30

2.24

1.1

1.59

1.68

u/ml

0.03

381

Keratoconus

172

1.77

2.23

1.1

8.64

2.27

u/ml

0.62

Mental and behavioural disorders due to cannabinoids

389

0.53

2.23

1.2

1.1

0.57

1.36

u/ml

1.06

168

Adhesive capsulitis of shoulder

112

847

1.33

2.22

1.2

1.1

0.77

1.64

u/ml

1.31

308

Suicide or other Intentional self-harm

221

2678

0.82

2.22

1.1

0.74

1.62

u/ml

2.69

1087

Bacterial Sepsis

192

2103

0.81

2.22

1.1

1.48

1.80

u/ml

0.21

887

Hallux rigidus

582

1.40

2.22

1.1

0.39

1.57

u/ml

1.66

220

Benign neoplasm of middle ear and respiratory system

343

1.52

2.22

1.1

1.41

1.53

u/ml

0.06

143

Dental caries 1, only avohilmo

893

4127

1.11

2.22

1.1

1.72

1.53

u/ml

0.19

392

1677

Examination and encounter for administrative purposes

172

1.76

2.21

1.2

1.1

1.31

1.45

u/ml

0.04

Fracture of femur

826

0.69

2.21

1.0

1.1

2.17

1.83

u/ml

0.08

344

Diagnoses used for exclusion with ILD

170

1358

1.26

2.21

1.1

1.92

1.56

u/ml

0.14

540

Leiomyoma of uterus

454

2935

0.87

2.21

1.1

1.55

1.21

u/ml

0.25

149

1048

Redundant prepuce, phimosis and paraphimosis

202

1638

1.23

2.21

1.1

1.57

2.07

u/ml

0.23

796

Other hammer toe(s) (acquired)

593

1.38

2.20

1.1

0.94

1.31

u/ml

0.25

215

Other retinal artery occlusion

2.64

2.19

1.0

1.2

0.82

1.47

u/ml

—

Syncope and collapse

368

2802

1.17

2.19

1.1

1.98

1.71

u/ml

0.19

153

1145

False labour

557

3090

1.14

2.18

1.1

1.63

1.37

u/ml

0.21

212

1223

Delivery

405

2477

0.86

2.18

1.1

2.27

1.44

u/ml

0.63

176

1015

Valvular heart disease excluding rheumatic fever

234

2063

0.83

2.18

1.1

2.33

1.37

u/ml

0.45

888

Atrial septal defect

557

0.61

2.17

1.1

1.2

7.27

2.70

u/ml

0.43

342

Exposure to other and unspecified inanimate mechanical forces

620

1.38

2.17

1.1

1.17

2.23

u/ml

0.93

272

Leiomyosarcoma

4.37

2.16

1.3

1.0

—

3.51

—

Intracranial injury

609

5242

1.12

2.16

1.2

1.1

1.40

1.75

u/ml

0.50

273

2231

Haemangioma and lymphangioma, any site

680

1.36

2.15

1.2

1.1

1.32

2.02

u/ml

0.37

294

Benign neoplasm: Ascending colon

427

1.46

2.15

1.1

3.15

1.08

u/ml

0.43

168

Scleritis and episcleritis

428

1.46

2.15

1.1

0.56

1.50

u/ml

1.28

169

Haemangioma, any site

604

1.38

2.14

1.2

1.1

1.44

1.90

u/ml

0.21

257

Melanocytic naevi

322

2749

1.18

2.14

1.1

1.80

1.60

u/ml

0.11

132

1087

Persistent delusional disorders

449

0.58

2.14

1.2

1.1

0.28

1.68

u/ml

2.65

178

Seborrhoeic keratosis

114

870

1.31

2.13

1.1

1.07

1.46

u/ml

0.22

329

Viral infections characterized by skin and mucous membrane lesions

448

3917

1.15

2.13

1.2

1.1

1.72

1.99

u/ml

0.22

214

1695

Persons encountering health services in circumstances related to reproduction

841

5161

1.11

2.13

1.1

2.06

1.95

u/ml

0.09

378

2292

Androgenic alopecia

2.51

2.13

1.1

1.2

0.41

2.17

u/ml

—

MS-disease / Multiple Sclerosis

740

0.67

2.12

1.1

1.35

1.25

u/ml

0.03

301

Trigger finger

112

854

1.32

2.12

1.1

0.92

1.51

u/ml

0.61

308

Retinal breaks without detachment

733

1.34

2.11

1.1

0.92

1.63

u/ml

0.54

282

Mild mental retardation

303

0.49

2.10

1.3

1.2

0.60

3.06

u/ml

—

159

Dental caries 3 and operation codes

1065

4997

1.10

2.09

1.1

1.97

1.65

u/ml

0.32

457

2047

Other sleep disorders

101

761

1.33

2.09

1.3

1.1

1.33

1.70

u/ml

0.24

292

Faecal incontinence

340

1.51

2.09

1.1

0.63

1.03

u/ml

0.37

133

Disturbances of smell and taste

206

1.66

2.08

1.1

0.40

1.62

u/ml

1.01

Contraceptive management

578

3611

1.13

2.08

1.1

1.33

1.68

u/ml

0.38

219

1466

Malignant neoplasm of breast, HER-positive

151

1864

0.80

2.08

1.1

1.77

1.07

u/ml

0.35

630

Other and/or unspecified nontoxic goitre

414

1.46

2.08

1.1

0.79

1.30

u/ml

0.45

152

Other disorders of veins

318

2716

1.17

2.08

1.1

1.26

1.16

u/ml

0.08

122

973

Open wound of hip and thigh

277

1.57

2.08

1.1

2.62

2.39

u/ml

0.04

122

Impacted maxillary canine

155

1.81

2.07

1.1

1.2

3.97

2.77

u/ml

0.16

Complications of procedures, not elsewhere classified

814

6376

1.10

2.07

1.1

1.17

1.61

u/ml

0.91

352

2479

Other erythematous conditions

176

1.72

2.07

1.1

5.95

1.98

u/ml

0.51

Superficial injury of thorax

132

1033

1.28

2.07

1.1

2.29

1.63

u/ml

0.23

418

Dementia in Alzheimer disease

166

0.41

2.06

1.5

1.1

—

0.87

—

Other diseases of anus and rectum

207

1703

1.22

2.05

1.1

1.07

1.30

u/ml

0.26

669

Patellar tendinitis

147

1.80

2.05

1.2

1.1

0.54

2.33

u/ml

0.97

Post-traumatic stress disorder

144

1143

1.27

2.04

1.2

1.1

2.24

1.61

u/ml

0.33

474

Abscess of external ear

2.14

2.04

1.1

1.2

5.82

2.85

u/ml

0.26

Inflammatory disorders of breast

653

1.36

2.04

1.2

1.1

1.76

1.38

u/ml

0.12

251

Nerve, nerve root and plexus disorders

1113

6424

1.09

2.04

1.1

1.05

1.52

u/ml

1.16

418

2538

Primary_lymphoid and hematopoietic malignant neoplasms

1164

0.74

2.03

1.2

1.1

3.16

1.54

u/ml

0.40

504

Chronic viral hepatitis

552

0.63

2.03

1.2

1.1

1.69

1.80

u/ml

0.04

221

Use of biperiden

287

0.48

2.03

1.1

0.66

2.06

u/ml

—

122

Other diseases of intestine

483

1.41

2.02

1.1

4.43

1.76

u/ml

0.48

197

Carcinoma in situ of breast, other/unspecified

2.67

2.02

1.2

1.1

0.13

3.18

u/ml

—

Other viral diseases

436

3816

1.14

2.02

1.2

1.1

1.07

2.04

u/ml

2.24

203

1725

L04AA Selective immunosuppressants

149

1859

0.80

2.02

1.1

0.68

1.71

u/ml

2.23

778

Malignant neoplasm of breast, HER-negative

1013

0.73

2.02

1.1

0.75

0.94

u/ml

0.17

353

Residual foreign body in soft tissue

360

1.48

2.01

1.1

2.14

2.11

u/ml

0.01

147

Ill-defined and unknown causes of mortality

146

0.34

2.01

1.0

1.1

—

2.72

—

Hyperparathyroidism

654

1.35

2.00

1.1

0.39

1.20

u/ml

2.02

256

Unspecified/other endometriosis

141

1119

1.27

2.00

1.1

0.75

1.17

u/ml

0.42

417

Benign neoplasm: Skin of ear and external auricular canal

133

1.82

2.00

1.1

1.89

1.72

u/ml

—

Alcoholic liver disease

377

0.55

2.00

1.1

1.32

2.04

u/ml

—

161

Benign lipomatous neoplasm

216

1793

1.21

1.99

1.1

1.50

1.40

u/ml

0.03

683

Galactorrhea

2.03

1.98

1.1

1.2

0.22

1.44

u/ml

—

Other disorders of conjunctiva

578

1.37

1.98

1.1

1.43

1.48

u/ml

0.02

212

Nausea and vomiting

267

2223

1.18

1.98

1.2

1.1

0.93

2.10

u/ml

1.96

127

1011

Testicular dysfunction

225

1.62

1.98

1.2

1.1

4.16

1.95

u/ml

0.32

Endometriosis ASRM stages 1,2

231

1933

1.20

1.98

1.1

0.52

1.16

u/ml

2.16

702

Deep bite that required surgery

2.02

1.98

1.1

0.51

1.93

u/ml

—

Systemic connective tissue disorders

277

2353

1.18

1.97

1.1

1.73

1.39

u/ml

0.22

117

894

Viral pneumonia (known virus, not influenza)

134

1.81

1.97

1.3

1.2

0.49

3.27

u/ml

1.87

Mixed conductive and sensorineural hearing loss

511

1.40

1.97

1.1

3.68

1.79

u/ml

0.24

209

Lichen planus

596

1.36

1.97

1.1

3.70

1.44

u/ml

0.54

232

Severe mental retardation

0.00

1.96

0.0

1.2

—

3.53

—

Premenstrual syndrome

120

1.88

1.96

1.0

1.1

0.58

0.81

u/ml

—

Benign paroxysmal vertigo

188

1542

1.22

1.96

1.1

0.76

1.45

u/ml

1.72

579

Dislocation, sprain and strain of joints and ligaments of thorax

210

1.64

1.96

1.1

1.00

1.79

u/ml

0.48

Procedures for purposes other than remedying health state

149

1.77

1.96

1.2

1.1

0.22

1.32

u/ml

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

512

0.62

1.96

1.0

1.1

8.68

1.55

u/ml

—

226

Maternal care for other known or suspected fetal problems

366

2701

0.87

1.95

1.1

2.26

1.44

u/ml

0.62

127

1082

Pre-eclampsia or poor fetal growth

342

3933

0.86

1.95

1.1

2.36

1.32

u/ml

0.76

113

1467

195

1.66

1.95

1.1

1.00

1.69

u/ml

0.38

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

242

1.59

1.95

1.1

0.51

2.51

u/ml

1.64

Dental caries 1

872

4056

1.10

1.94

1.1

1.79

1.54

u/ml

0.25

382

1642

Status epilepticus

187

0.42

1.93

1.1

—

2.48

—

Mental and behavioural disorders due to sedatives or hypnotics

594

0.65

1.93

1.1

0.39

1.72

u/ml

2.01

245

Struck by thrown, projected or falling objec

405

1.45

1.93

1.2

1.1

0.74

1.97

u/ml

1.61

178

Carcinoma in situ of breast, other/unspecified

2.60

1.93

1.2

0.13

2.10

u/ml

—

Other demyelinating diseases of the central nervous system

371

0.56

1.92

1.1

0.16

1.74

u/ml

—

140

Thyroiditis, unspecified

1.95

1.92

1.2

1.1

1.03

1.81

u/ml

—

Cellulitis

211

1756

1.21

1.92

1.1

2.35

1.89

u/ml

0.17

760

Benign intracranial hypertension

114

1.89

1.91

1.2

1.1

1.89

1.76

u/ml

—

Dental caries, including avohilmo

871

4055

1.10

1.91

1.1

1.80

1.54

u/ml

0.26

381

1642

Anosmia

112

1.87

1.90

1.1

0.63

1.10

u/ml

—

Sequelae of injuries of upper limb

721

1.33

1.90

1.1

2.16

1.52

u/ml

0.24

287

Benign neoplasm of middle ear and respiratory system

356

1.47

1.90

1.1

1.41

1.35

u/ml

0.03

144

Other and unspecified erythematous conditions

158

1.73

1.90

1.1

6.53

2.18

u/ml

—

Reimbursement for rheumatic diseases

444

5010

0.88

1.89

1.1

1.24

1.53

u/ml

0.28

171

2019

Other abnormal products of conception

542

3219

1.13

1.89

1.1

1.32

1.54

u/ml

0.23

193

1198

Later onset COPD

336

1.43

1.89

1.1

1.18

1.58

u/ml

0.24

129

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

485

0.65

1.88

1.1

0.50

1.24

u/ml

1.39

190

Familial hypercholesterolemia, with ischemic heart disease

204

1.62

1.88

1.1

0.91

2.00

u/ml

—

Non-selective monoamine reuptake inhibitors

282

2337

1.17

1.88

1.1

0.81

1.57

u/ml

1.67

135

829

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

161

1972

0.81

1.87

1.1

0.75

1.60

u/ml

1.80

812

Oxycodone

134

1621

0.80

1.87

1.1

2.29

1.33

u/ml

0.60

600

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

191

1584

0.83

1.86

1.1

1.34

1.06

u/ml

0.19

610

L02BG Aromatase inhibitors

117

1485

0.79

1.86

1.1

1.32

0.96

u/ml

0.16

522

Calculus of kidney and ureter

201

1671

1.21

1.85

1.2

1.1

0.64

1.42

u/ml

2.16

667

Injury of muscle and tendon at ankle and foot level

175

1.68

1.84

1.1

1.71

2.18

u/ml

0.11

Heart failure, strict

182

1589

0.82

1.84

1.1

2.06

1.40

u/ml

0.22

656

Kidney transplant status

404

0.59

1.84

1.5

1.2

0.14

2.30

u/ml

—

209

Spirochaetal infections, other/unspecified

459

1.40

1.84

1.2

1.1

2.67

1.71

u/ml

0.18

193

Benign neoplasm: Skin of ear and external auricular canal

137

1.76

1.84

1.1

1.89

1.47

u/ml

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

270

1.54

1.83

1.1

1.67

2.11

u/ml

0.17

133

141

1064

1.25

1.81

1.1

1.31

1.32

u/ml

0.00

409

Fibroblastic disorders

130

1035

1.26

1.80

1.2

1.1

0.58

1.57

u/ml

1.58

376

Benign mammary dysplasia

103

797

1.30

1.80

1.2

1.1

0.64

1.06

u/ml

0.85

286

Atrial fibrillation and flutter

215

1673

0.84

1.80

1.1

2.73

1.21

u/ml

0.56

648

Coeliac disease

137

1099

1.25

1.80

1.1

2.98

1.92

u/ml

0.38

471

Finngen Rheumatological endpoints

1123

6916

0.92

1.80

1.1

1.57

1.64

u/ml

0.07

468

2800

Enlarged lymph nodes

155

1260

1.24

1.80

1.2

1.1

1.57

1.53

u/ml

0.02

526

Other inflammation of vagina/vulva

395

1.43

1.80

1.1

0.26

1.41

u/ml

1.94

144

Psychiatric diseases

1408

6570

1.07

1.80

1.1

1.62

1.79

u/ml

0.23

618

2681

Noninfectious colitis NAS

138

1109

1.25

1.79

1.2

1.1

3.19

1.77

u/ml

0.53

477

Non-rheumatic valve diseases

229

1978

0.84

1.78

1.1

2.32

1.35

u/ml

0.44

833

Malignant neoplasm of bronchus and lung

376

0.60

1.78

1.1

0.72

1.47

u/ml

—

143

Heart failure,strict

177

1547

0.82

1.78

1.1

2.13

1.29

u/ml

0.27

642

Congenital absence, atresia and stenosis of large intestine

0.00

1.78

0.0

1.3

—

1.72

—

Benign neoplasm: Scapula and long bones of upper limb

2.13

1.78

1.1

0.35

1.57

u/ml

—

LeFortI or BSSRO operation

421

1.42

1.78

1.1

0.39

1.53

u/ml

1.71

164

Use of pramipexole

126

1002

1.26

1.77

1.1

0.66

1.51

u/ml

1.55

378

Other noninflammatory disorders of vagina

565

1.35

1.77

1.1

0.51

1.42

u/ml

1.15

200

Other/unspecified synovitis and tenosynovitis

101

782

1.30

1.77

1.0

1.1

0.54

1.49

u/ml

1.73

301

Insulin, fast-acting or short human

275

3193

0.86

1.76

1.1

0.96

1.83

u/ml

2.38

111

1406

Acute nasopharyngitis (common cold)

124

980

1.26

1.76

1.1

2.30

2.04

u/ml

0.08

449

Myocardial infarction

175

1521

0.82

1.76

1.1

3.80

1.08

u/ml

0.87

591

Congenital malformations of the urinary system

627

0.68

1.75

1.1

1.2

0.40

2.36

u/ml

3.37

323

Disorders of choroid and retina

487

3974

0.89

1.75

1.1

0.92

1.56

u/ml

1.96

190

1537

Presence of cardiac and vascular implants and grafts

140

1311

0.81

1.75

1.1

2.84

1.33

u/ml

0.48

532

Viral pneumonia (unknown virus, not influenza)

498

1.38

1.75

1.2

1.1

2.08

1.72

u/ml

0.13

201

Bilateral sagittal split ramus osteotomy operation

339

1.46

1.75

1.1

0.43

1.75

u/ml

1.60

136

Autoimmune thyroiditis

155

1.70

1.75

1.1

4.27

1.73

u/ml

0.30

Sequelae of cerebrovascular disease

1048

0.77

1.75

1.1

1.03

1.50

u/ml

0.51

407

Helminthiases

110

1.84

1.74

1.3

1.2

0.28

2.44

u/ml

—

Cholera

147

1.71

1.74

1.1

0.16

1.03

u/ml

—

Retinal detachments and breaks

183

1518

1.21

1.74

1.1

1.05

1.34

u/ml

0.30

574

Open wound of wrist and hand

492

4354

1.12

1.74

1.1

1.34

1.73

u/ml

0.58

208

1807

Atrial fibrillation and flutter with reimbursement

125

1004

0.80

1.73

1.1

3.80

1.21

u/ml

0.68

402

Other disorders of the musculoskeletal system and connective tissue

767

1.30

1.73

1.2

1.1

1.26

1.63

u/ml

0.27

288

Malignant neoplasm of skin

212

1895

0.84

1.73

1.1

1.25

1.14

u/ml

0.07

708

Other congenital malformations of skin

415

1.41

1.73

1.1

1.2

1.70

2.03

u/ml

0.10

206

Alzheimer’s disease, wide definition, excluding more controls

194

0.52

1.72

1.1

0.30

0.76

u/ml

—

Coronary atherosclerosis

296

2208

0.86

1.72

1.1

2.90

1.27

u/ml

0.87

120

866

Benign neoplasm: Stomach

381

1.42

1.71

1.1

1.08

1.90

u/ml

0.45

150

Other functional intestinal disorders

418

3525

1.13

1.71

1.1

2.10

1.91

u/ml

0.12

187

1542

Urethritis and urethral syndrome

118

1.80

1.71

1.2

1.1

5.78

1.79

u/ml

—

Speech and linguistic disorders, excluding more controls

173

1350

1.22

1.71

1.2

2.68

2.30

u/ml

0.14

102

720

Chronic mastoiditis

1.93

1.70

1.1

0.21

1.35

u/ml

—

Endometriosis of ovary

184

1528

1.21

1.70

1.1

0.50

1.41

u/ml

3.11

566

Maternal care for other conditions predominantly related to pregnancy

334

2881

1.15

1.70

1.2

1.1

1.96

1.28

u/ml

0.57

121

1082

Primary_lymphoid and hematopoietic malignant neoplasms

1131

0.77

1.70

1.2

1.1

3.16

1.78

u/ml

0.33

493

Insulin, fast-acting

275

3182

0.86

1.70

1.1

0.96

1.83

u/ml

2.36

111

1407

Other specified disorders of muscle

156

1.68

1.70

1.1

1.71

1.67

u/ml

0.01

Symptoms and signs involving the nervous and musculoskeletal systems

549

4942

1.11

1.69

1.2

1.1

1.38

1.70

u/ml

0.36

260

2053

Testicular hypofunction

203

1.59

1.69

1.2

1.1

4.23

1.90

u/ml

0.30

Pilonidal cyst

1014

0.75

1.68

1.2

1.1

0.69

1.60

u/ml

1.73

421

Benign neoplasms

1216

6401

1.08

1.68

1.1

1.82

1.73

u/ml

0.09

499

2694

Poor fetal growth

151

1836

0.82

1.68

1.1

3.04

1.09

u/ml

0.84

700

Intermittent heterotropia

864

0.73

1.68

1.1

1.2

0.38

2.73

u/ml

5.49

463

Fracture at wrist and hand level

373

3285

1.14

1.68

1.2

1.1

1.97

1.87

u/ml

0.05

182

1422

Sequelae of injuries, of poisoning and of other consequences of external causes

227

1929

1.18

1.68

1.1

1.88

1.58

u/ml

0.20

110

791

Other infective otitis externa

375

1.42

1.67

1.1

0.74

1.96

u/ml

1.30

157

Pain associated with micturition

101

789

1.29

1.67

1.1

1.55

1.79

u/ml

0.09

323

Haemorrhoids and perianal venous thrombosis

170

1406

1.21

1.67

1.1

0.78

1.05

u/ml

0.40

538

Contusion of toe(s) with damage to nail

1.97

1.67

1.2

1.1

0.15

1.39

u/ml

—

DVT of lower extremities and pulmonary embolism

236

2005

1.18

1.67

1.1

0.85

1.34

u/ml

1.02

760

Deformity of finger(s)

2.86

1.66

1.0

1.2

—

2.32

—

Other bursitis of knee

2.06

1.66

1.1

1.0

0.39

3.08

u/ml

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

478

4276

1.12

1.66

1.1

1.20

1.36

u/ml

0.18

215

1636

Other benign neoplasms of uterus

157

1.66

1.2

1.1

4.99

1.20

u/ml

—

Amblyopia ex anopsia

487

1.37

1.65

1.1

1.2

0.55

2.45

u/ml

3.42

256

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

355

0.59

1.65

1.1

4.38

1.81

u/ml

—

141

Other and specified injuries of hip and thigh

1.95

1.65

1.1

3.02

3.03

u/ml

—

Poisoning by drugs, medicaments and biological substances

239

2788

0.85

1.65

1.2

1.1

1.11

1.64

u/ml

0.66

112

1145

Localized swelling, mass and lump of skin and subcutaneous tissue

272

2348

1.16

1.65

1.1

1.27

1.78

u/ml

0.55

121

973

Congenital malformations of the musculoskeletal system, not elsewhere classified

166

1.66

1.65

1.2

1.53

3.20

u/ml

0.50

Puerperal sepsis

118

942

1.26

1.64

1.1

3.36

0.85

u/ml

0.62

341

Fall on same level involving ice and snow

544

4907

1.11

1.64

1.1

1.52

1.68

u/ml

0.16

237

1983

Other arrhythmias

650

4522

1.10

1.64

1.1

1.14

1.45

u/ml

0.65

259

1768

Injury of muscle and tendon at lower leg level

123

987

1.25

1.64

1.2

1.1

1.61

2.03

u/ml

0.16

411

Disorders of eyelid in diseases classified elsewhere

197

1.59

1.63

1.2

1.1

2.11

2.31

u/ml

0.05

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

904

0.75

1.63

1.1

0.49

0.87

u/ml

0.70

323

Diseases of pulp and periapical tissues

326

2853

1.15

1.63

1.1

1.46

1.94

u/ml

0.33

142

1102

Biological medication for rheuma

141

1721

0.82

1.63

1.1

0.45

1.93

u/ml

5.11

715

Biomechanical lesions, not elsewhere classified

221

1.55

1.63

1.3

1.1

0.42

2.43

u/ml

1.48

Other and unspecified visual disturbances

591

1.33

1.63

1.2

1.1

0.83

1.61

u/ml

0.88

232

Other symptoms and signs involving the circulatory and respiratory systems

352

1.43

1.62

1.2

1.1

1.97

2.41

u/ml

0.16

140

Glaucoma suspect

190

1594

1.19

1.62

1.1

1.90

1.35

u/ml

0.17

598

Palindromic rheumatism

2.36

1.61

1.2

1.1

1.58

1.66

u/ml

—

Toxic effect of contact with venomous animals

295

1.47

1.61

1.1

1.10

2.71

u/ml

0.93

133

Ulcerative colitis (strict definition, require KELA)

139

1697

0.82

1.61

1.1

1.17

1.66

u/ml

0.36

717

Certain conditions originating in the perinatal period

218

1645

1.18

1.61

1.2

2.58

2.62

u/ml

0.01

123

876

Superficial injury of shoulder and upper arm

110

874

1.26

1.60

1.1

2.94

1.57

u/ml

0.41

358

Monoplegia

2.03

1.60

1.1

0.28

2.93

u/ml

—

Lesion of ulnar nerve

111

883

1.26

1.60

1.1

1.07

1.60

u/ml

0.51

332

Bicipital tendinitis

222

1.54

1.60

1.2

1.1

0.27

2.43

u/ml

1.84

Benign neoplasm: Skin of eyelid, including canthus

706

1.29

1.60

1.1

2.90

1.59

u/ml

0.25

267

Female infertility, tubal origin

464

1.37

1.60

1.1

1.45

0.98

u/ml

0.22

170

Ulcerative colitis (strict definition, all Crohn cases excluded)

116

1440

0.80

1.58

1.1

1.37

1.67

u/ml

0.15

602

Focal epilepsy

149

1802

0.82

1.58

1.2

1.1

1.27

2.08

u/ml

0.82

823

Acute alcohol intoxication

164

1967

0.83

1.58

1.2

1.1

2.39

1.70

u/ml

0.37

820

Colonic or urogenital fistula

225

1922

1.17

1.58

1.1

0.88

1.59

u/ml

1.33

769

Otitis externa, unspecified

121

975

1.25

1.57

1.2

1.1

3.80

1.75

u/ml

0.81

415

Hypertensive diseases

797

4907

0.92

1.57

1.1

2.28

1.46

u/ml

0.89

334

1967

Respiratory insufficiency

121

1.74

1.57

1.2

1.1

0.35

1.13

u/ml

—

Postdysenteric arthropathy

2.15

1.57

1.2

1.1

0.17

1.35

u/ml

—

Dialysis

273

0.54

1.57

1.7

1.1

0.21

2.03

u/ml

—

147

Acute lymphadenitis

613

1.32

1.56

1.1

0.49

2.11

u/ml

3.00

261

Superficial injury of wrist and hand

263

2277

1.16

1.56

1.2

1.1

1.06

1.98

u/ml

1.39

122

1003

Sarcoidosis

104

824

1.27

1.56

1.1

1.87

1.46

u/ml

0.12

306

Carcinoma in situ of breast, intraductal

422

0.64

1.56

1.1

0.49

1.17

u/ml

0.99

154

Disease of hard tissues of teeth, NOS

2.07

1.56

1.4

1.2

0.33

1.61

u/ml

—

Other abnormal auditory perceptions

2.01

1.56

1.2

2.75

1.63

u/ml

—

Malignant neoplasm of bladder

1.85

1.56

1.2

1.1

0.99

1.26

u/ml

—

175

1.60

1.55

1.2

1.1

8.25

1.20

u/ml

0.65

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

138

1.71

1.55

1.1

1.2

0.37

2.42

u/ml

1.44

Polyarthritis, unspecified

216

1.54

1.55

1.1

0.95

3.15

u/ml

1.23

Abnormal findings on diagnostic imaging of other body structures

675

1.29

1.54

1.2

1.1

0.42

1.56

u/ml

2.26

257

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

922

7131

0.93

1.54

1.2

1.1

1.51

1.73

u/ml

0.27

417

2934

Impacted cerumen

501

1.34

1.54

1.2

2.42

2.49

u/ml

0.01

246

Oral leukoplakia

2.29

1.54

1.3

1.1

—

1.65

—

Fall on and from stairs and steps

215

1835

1.17

1.53

1.1

2.20

1.48

u/ml

0.37

751

Intestinal malabsorption

315

1.44

1.53

1.1

4.22

1.87

u/ml

0.30

138

Cystic kidney disease

232

0.51

1.53

1.1

0.33

2.72

u/ml

—

117

Acute generalized exanthematous pustulosis

307

1.44

1.53

1.1

0.69

1.83

u/ml

1.20

132

Other disorders of optic disc

1.89

1.52

1.4

1.2

4.54

2.47

u/ml

—

Open wound of abdomen, lower back and pelvis

258

1.49

1.52

1.2

1.1

2.42

2.92

u/ml

0.08

111

Autonomic disorders

123

1.73

1.52

1.1

0.67

1.26

u/ml

—

Inflammatory disease of cervix uteri

349

1.41

1.52

1.2

1.1

0.22

1.46

u/ml

1.75

116

Benign neoplasm: Tongue

108

1.77

1.51

1.2

1.1

0.34

1.90

u/ml

—

Postmenopausal bleeding

162

736

1.21

1.51

1.1

0.56

1.36

u/ml

1.57

268

TMD muscular pain linked with fibromyalgia

2.04

1.51

1.2

1.1

0.41

1.83

u/ml

—

Extracorporeal dialysis

295

0.57

1.50

1.5

1.1

1.29

2.24

u/ml

—

138

Care involving dialysis

418

0.64

1.50

1.4

1.2

1.00

2.21

u/ml

0.95

193

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

152

1824

0.83

1.50

1.1

2.21

1.64

u/ml

0.19

773

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

136

1649

0.82

1.50

1.1

1.17

1.68

u/ml

0.37

699

Other diseases of gallbladder

162

1.61

1.49

1.5

1.1

7.43

2.93

u/ml

—

Osteopathies and chondropathies

469

4004

1.11

1.49

1.1

1.43

1.72

u/ml

0.33

205

1620

All-cause Heart Failure

181

1546

0.84

1.49

1.1

2.06

1.43

u/ml

0.21

642

Pterygium

1.96

1.49

1.1

0.08

1.11

u/ml

—

Tobacco use

376

1.39

1.49

1.1

7.97

1.77

u/ml

0.55

143

Bullous disorders

218

1.52

1.49

1.1

0.68

2.33

u/ml

1.59

Generalized epilepsy, strict definition

268

1.48

1.2

1.52

1.95

u/ml

0.14

133

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

560

0.69

1.48

1.1

1.18

1.26

u/ml

0.06

221

Glucosamine medication

209

1421

1.18

1.48

1.1

0.96

1.24

u/ml

0.37

526

Hypertension

798

4897

0.92

1.48

1.1

2.27

1.47

u/ml

0.88

335

1958

Acute gastritis

334

1.41

1.47

1.1

0.72

1.70

u/ml

0.85

135

Use of donepezil

246

0.55

1.47

1.2

1.1

0.51

0.91

u/ml

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

125

1525

0.82

1.47

1.2

1.1

1.38

2.08

u/ml

0.54

695

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

445

1.36

1.47

1.2

1.1

2.43

1.60

u/ml

0.23

177

Ptosis of eyelid

402

1.37

1.47

1.1

0.31

2.13

u/ml

2.68

168

Unspecified fall

475

4252

1.11

1.46

1.2

1.1

2.78

1.84

u/ml

0.81

225

1881

Pedestrian injured in collision with pedal cycle

187

1.56

1.46

1.1

0.93

1.92

u/ml

0.65

Other female pelvic inflammatory diseases

149

1238

1.21

1.46

1.1

2.90

1.35

u/ml

0.41

422

Benign neoplasm: Stomach

394

1.38

1.46

1.1

1.08

1.66

u/ml

0.30

154

Persons encountering health services for specific procedures, not carried out

611

1.30

1.46

1.2

1.1

0.94

1.59

u/ml

0.69

242

Insomnia

190

1615

1.18

1.45

1.1

0.96

1.58

u/ml

0.95

645

Acute epiglottitis

1.94

1.45

1.3

1.1

0.56

3.43

u/ml

—

Myocarditis

344

1.40

1.44

1.1

0.90

1.26

u/ml

0.31

146

Pregnancy, childbirth and the puerperium

315

1873

0.88

1.44

1.1

1.95

1.85

u/ml

0.06

135

764

Melanocytic naevi of other and unspecified parts of face

447

1.35

1.44

1.2

1.1

0.65

1.48

u/ml

0.82

174

Benign neoplasm: Tongue

110

1.74

1.43

1.2

1.1

0.34

2.08

u/ml

—

Crohn disease (strict definition, all UC cases excluded)

491

1.33

1.43

1.1

3.08

1.89

u/ml

0.17

206

Stenosis and insufficiency of lacrimal passages

499

1.33

1.43

1.2

1.1

2.02

1.88

u/ml

0.03

217

Lichen planus, including avohilmo

114

924

1.24

1.42

1.1

2.86

1.51

u/ml

0.42

342

Other neurotic disorders

237

1.49

1.42

1.3

1.1

0.36

1.58

u/ml

1.35

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

180

1465

0.85

1.42

1.1

0.83

1.07

u/ml

0.39

564

Other follicular disorders

623

1.29

1.41

1.1

1.14

1.43

u/ml

0.19

248

Alzheimer’s disease, wide definition

264

0.60

1.41

1.2

1.1

0.36

0.92

u/ml

—

Other orthopaedic follow-up care

312

1.42

1.41

1.1

0.84

1.76

u/ml

0.69

121

Chondromalacia

181

1.56

1.41

1.3

1.1

0.49

2.10

u/ml

—

Bacterial infection, other or unspecified

284

2914

0.88

1.41

1.1

1.41

1.60

u/ml

0.12

123

1210

Implicit bacterial Sepsis

149

1633

0.84

1.40

1.1

1.00

1.35

u/ml

0.52

659

Benign neoplasm: Caecum

304

1.42

1.40

1.0

1.1

0.77

1.55

u/ml

0.69

112

Lichen ruber planus, wide definition including periferal and oral lichen planus

135

1117

1.21

1.39

1.1

2.49

1.41

u/ml

0.39

412

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

2.03

1.39

1.2

1.1

0.40

1.70

u/ml

—

Colorectal neuroendocrine tumor and carcinoma

2.03

1.39

1.2

1.1

0.40

1.98

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

824

5729

0.93

1.39

1.1

1.59

1.50

u/ml

0.09

311

2231

Ischemic heart diseases

433

3013

0.90

1.39

1.1

2.35

1.34

u/ml

0.64

157

1152

Carcinoma in situ of other and unspecified digestive organs

2.09

1.39

1.3

1.1

0.52

0.79

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

802

5639

0.92

1.38

1.1

1.29

1.47

u/ml

0.24

307

2173

Algoneurodystrophy

272

1.45

1.38

1.2

1.1

0.78

2.20

u/ml

0.97

116

Secondary and unspecified malignant neoplasm of lymph nodes

349

0.63

1.38

1.2

1.1

2.92

1.89

u/ml

—

146

Early lumbar disc prolapse, operated

140

1165

1.21

1.38

1.1

3.47

1.49

u/ml

0.72

443

Medicines for HER+ breast cancer

186

2120

0.85

1.38

1.1

1.43

1.11

u/ml

0.20

731

Alopecia areata

223

1.50

1.37

1.0

1.1

3.21

2.35

u/ml

0.12

100

Other and unspecified acne

143

1.64

1.37

1.1

0.60

1.49

u/ml

0.98

Exposure to other and unspecified man-made environmental factors

112

1.72

1.37

1.1

0.69

1.40

u/ml

—

Non-follicular lymphoma, hilmo, excluding all cancers

348

0.63

1.37

1.0

1.1

14.30

1.86

u/ml

—

148

Tic and related disorders

216

1.51

1.37

1.1

1.2

3.81

2.56

u/ml

0.25

125

Acute alcohol intoxication, ICD10

144

1719

0.84

1.37

1.2

1.1

2.63

1.91

u/ml

0.33

731

Benign neoplasm: Parotid gland

348

1.39

1.37

1.2

1.1

0.33

1.75

u/ml

1.97

143

Carcinoma in situ of breast, intraductal

408

0.66

1.36

1.1

0.49

1.20

u/ml

0.99

146

Colorectal adenocarcinoma

550

0.71

1.36

1.1

1.18

1.64

u/ml

0.34

216

Cardiac murmurs and other cardiac sounds

120

973

1.23

1.36

1.2

1.1

2.92

2.93

u/ml

0.00

463

Ovarian hyperstimulation (induction)

224

1.50

1.36

1.1

2.59

1.85

u/ml

0.17

Burns and corrosions confined to eye and internal organs

199

1.52

1.36

1.1

1.61

1.81

u/ml

0.07

Single delivery by caesarean section

281

1848

0.88

1.36

1.2

1.1

2.92

1.22

u/ml

0.87

761

Achilles tendinitis

600

1.29

1.36

1.1

0.93

1.24

u/ml

0.32

217

Tumor necrosis factor alpha inhibitors

132

1586

0.83

1.36

1.1

0.45

1.66

u/ml

4.58

659

Transient ischemic attack

188

1821

0.85

1.35

1.1

1.54

1.19

u/ml

0.20

689

Disorders of lipoprotein metabolism and other lipidaemias

530

3659

0.91

1.35

1.1

1.08

1.45

u/ml

0.60

216

1406

Other symptoms and signs involving the digestive system and abdomen

136

1130

1.21

1.35

1.2

1.1

0.87

1.73

u/ml

1.25

449

Other nonscarring hair loss

1.95

1.35

1.1

6.69

1.81

u/ml

—

Benign neoplasm of bone and articular cartilage

663

1.27

1.35

1.1

0.57

1.42

u/ml

1.30

273

Malignant neoplasm of prostate

679

0.79

1.35

1.1

0.45

1.61

u/ml

2.71

282

Habitual aborter

266

1.45

1.34

1.1

0.71

0.88

u/ml

0.11

Dental caries 3

950

4521

1.08

1.34

1.1

1.91

1.61

u/ml

0.29

419

1834

Hydronephrosis

594

0.72

1.34

1.1

6.16

1.66

u/ml

0.47

242

Dental caries 3, only avohilmo

961

4578

1.07

1.34

1.1

1.90

1.59

u/ml

0.31

423

1866

L04AC Interleukin inhibitors

417

0.67

1.33

1.1

0.67

1.98

u/ml

1.62

167

Other specified and unspecified disorders of eye and adnexa

208

1.50

1.33

1.1

1.42

1.58

u/ml

0.07

Dislocation, sprain and strain of joint and ligaments of hip

136

1.63

1.33

1.1

0.26

1.54

u/ml

0.81

Spinal instabilities

168

1.56

1.32

1.0

1.1

0.17

1.95

u/ml

—

Lesion of radial nerve

176

1.54

1.32

1.1

7.19

2.41

u/ml

0.32

Tic disorders

210

1.51

1.31

1.1

1.2

4.00

1.84

u/ml

0.47

122

Scleritis

1.87

1.31

1.1

0.57

1.98

u/ml

—

Hyperplasia of prostate

170

819

1.19

1.31

1.1

1.71

1.57

u/ml

0.05

338

Unspecified event, undetermined intent

193

1.52

1.30

1.2

1.1

0.92

2.18

u/ml

0.70

Long labour

366

2866

1.12

1.30

1.1

1.54

1.35

u/ml

0.17

146

1059

Presbyopia

386

1.35

1.30

1.1

0.51

1.65

u/ml

1.27

144

Foreign body in alimentary tract

369

1.36

1.30

1.1

1.2

0.33

2.61

u/ml

3.24

171

Other and unspecified corneal deformities and disorders

185

1.53

1.30

1.0

1.1

0.36

2.02

u/ml

1.61

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

306

0.62

1.29

1.0

1.1

1.56

1.41

u/ml

—

117

Urolithiasis

204

1763

1.16

1.29

1.2

1.1

0.64

1.58

u/ml

2.53

708

Delivery, wide proxy

360

2140

0.89

1.29

1.1

2.57

1.54

u/ml

0.71

153

887

Caught, crushed, jammed or pinched in or between objects

439

1.33

1.29

1.2

1.1

1.03

2.39

u/ml

1.16

186

Other papulosquamous disorders

2.03

1.28

1.5

1.1

0.38

1.65

u/ml

—

Other/unspecified rheumatoid arthritis

531

0.71

1.28

1.2

1.1

0.26

1.46

u/ml

—

205

Injuries to the thorax

334

2983

1.12

1.28

1.1

2.00

1.56

u/ml

0.31

141

1204

Anorexia (incl.atypical)

814

0.77

1.28

1.2

1.1

1.71

1.94

u/ml

0.11

359

Colorectal cancer, excluding all cancers (controls excluding all cancers)

952

0.79

1.28

1.1

2.93

1.23

u/ml

0.35

363

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

527

0.71

1.28

1.1

1.2

2.59

2.73

u/ml

0.04

296

Other and unspecified diseases of blood and blood-forming organs

1.73

1.28

1.2

1.1

0.93

1.62

u/ml

—

Small fibre neuropathy

1.73

1.27

1.3

1.1

0.99

1.27

u/ml

—

Other diseases of blood and blood-forming organs

319

1.39

1.27

1.2

1.1

0.60

1.63

u/ml

1.03

128

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

326

3645

0.89

1.27

1.1

0.98

1.53

u/ml

1.22

137

1471

Poisoning by medicine

222

2542

0.87

1.27

1.2

1.1

0.80

1.71

u/ml

2.66

106

1047

Cardiomyopathy (excluding other)

553

0.72

1.27

1.3

1.1

0.75

1.56

u/ml

1.31

239

Congenital malformations of the respiratory system

195

1.51

1.26

1.2

3.32

2.73

u/ml

0.09

116

Varicose veins of other sites

388

1.35

1.26

1.1

1.73

1.65

u/ml

0.02

159

Family history of malignant neoplasm

970

0.79

1.26

1.1

0.57

1.11

u/ml

1.14

344

Invasive ventilation

459

0.69

1.26

1.3

1.2

0.20

2.27

u/ml

4.79

250

Contact with machinery

598

1.28

1.26

1.1

1.19

1.90

u/ml

0.63

249

Behavioural syndromes associated with physiological disturbances and physical factors

457

4155

1.10

1.26

1.1

1.10

1.83

u/ml

1.64

205

1764

Infections with a predominantly sexual mode of transmission

446

4050

1.10

1.26

1.1

1.60

1.46

u/ml

0.12

181

1596

Nonorganic sleeping disorders

236

2068

1.15

1.25

1.1

1.33

1.62

u/ml

0.22

858

Myocardial infarction, strict

162

1388

0.85

1.25

1.1

2.74

1.13

u/ml

0.59

546

Agranulocytosis

688

0.75

1.25

1.2

1.1

3.47

1.79

u/ml

0.29

289

Additional codes for the location of defect, injury or illness

372

1.35

1.24

1.1

3.86

1.22

u/ml

0.37

163

Lesion of plantar nerve

295

1.40

1.24

1.1

0.11

1.97

u/ml

2.03

109

Other disorders of prostate

1.87

1.24

1.1

0.38

3.29

u/ml

—

Sleep disorders

259

2286

1.14

1.23

1.2

1.1

1.28

1.75

u/ml

0.45

106

948

Second line medication for Crohn's disease

504

5502

0.91

1.23

1.1

1.72

1.65

u/ml

0.04

212

2299

Pure hypercholesterolaemia

412

3053

0.90

1.23

1.1

1.17

1.45

u/ml

0.33

180

1178

Melanocytic naevi of other and unspecified parts of face

460

1.31

1.23

1.2

1.1

0.65

1.47

u/ml

0.83

183

Unspecified kidney failure

265

0.60

1.22

1.3

1.1

0.28

2.12

u/ml

—

115

Collagenous colitis

539

1.29

1.22

1.1

0.43

1.51

u/ml

2.04

214

Carcinoma in situ of other and unspecified digestive organs

1.98

1.22

1.3

1.1

0.52

0.91

u/ml

—

Burn and corrosion confined to eye and adnexa

172

1.53

1.21

1.1

1.82

1.95

u/ml

0.04

658

0.75

1.21

1.2

2.98

3.01

u/ml

0.00

418

Other and unspecified coagulation defects

409

1.33

1.21

1.2

1.1

1.10

1.55

u/ml

0.22

171

Sacroiliitis, not elsewhere classified

479

1.30

1.21

1.1

0.91

1.85

u/ml

0.78

187

Nontraumatic intracranial haemmorrhage

707

0.76

1.20

1.1

0.27

1.71

u/ml

4.01

290

Other diseases of liver

142

1201

1.19

1.20

1.1

1.09

1.35

u/ml

0.31

470

Other bursitis of hip

1.85

1.20

1.0

1.1

2.76

1.42

u/ml

—

Heart failure and coronary heart disease

562

0.77

1.19

1.2

1.1

5.51

1.15

u/ml

0.50

217

Papulosquamous disorders

314

2810

1.12

1.19

1.1

1.89

1.56

u/ml

0.17

130

1113

Other specified/unspecified dorsopathies

189

1.49

1.19

1.1

5.18

1.82

u/ml

0.29

Benign neoplasm: Spinal meninges

2.33

1.19

1.2

1.1

—

1.22

—

Benign neoplasm of other and unspecified female genital organs

239

1.43

1.18

1.2

1.1

3.97

0.92

u/ml

0.71

Non-follicular lymphoma

335

0.65

1.18

1.0

1.1

14.30

1.96

u/ml

—

145

Unknown and unspecified causes of morbidity

480

1.30

1.18

1.1

1.35

1.20

u/ml

0.08

187

Benign neoplasm: Skin of eyelid, including canthus

738

1.24

1.18

1.1

2.90

1.26

u/ml

0.33

278

Mandibular retrognathia AND surgery (BSSRO)

248

1.43

1.18

1.1

0.46

1.78

u/ml

1.34

Other and unspecified iridocyclitis

273

1.40

1.18

1.1

0.63

2.59

u/ml

1.90

118

Polyarteritis nodosa and related conditions

1.79

1.18

1.4

1.1

0.23

0.73

u/ml

—

Complications following infusion, transfusion and therapeutic injection

1.79

1.18

1.4

1.2

0.91

3.39

u/ml

—

Episcleritis

376

1.34

1.18

1.2

1.1

0.66

1.64

u/ml

1.15

152

Varicose veins

357

2991

0.90

1.17

1.1

2.18

1.20

u/ml

0.65

105

1075

Dermatitis herpetiformis

1.79

1.17

1.0

1.1

0.65

1.58

u/ml

—

Monoamine oxidase A inhibitors

685

1.24

1.17

1.1

1.05

1.46

u/ml

0.43

245

Astigmatism

722

1.24

1.16

1.1

1.2

1.29

2.94

u/ml

1.50

375

Chronic myeloproliferative disease

0.00

1.16

0.0

1.2

—

2.02

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

273

0.62

1.16

1.0

1.1

1.56

1.80

u/ml

—

Focal epilepsy, strict definition

136

1602

0.85

1.16

1.2

1.1

1.40

2.09

u/ml

0.58

740

Abnormalities of forces of labour

134

1133

1.19

1.16

1.1

3.32

0.85

u/ml

0.65

387

Benign lipomatous neoplasm

216

1893

1.14

1.16

1.1

1.50

1.21

u/ml

0.11

720

Chronic kidney disease

1119

0.82

1.15

1.2

1.1

4.79

1.53

u/ml

0.52

493

Myopia

178

1541

1.16

1.15

1.1

1.04

1.53

u/ml

0.65

650

Mixed specific developmental disorders

575

0.75

1.15

1.1

1.3

4.99

2.27

u/ml

0.42

363

Ulcer of vagina/vulva

191

1.48

1.15

1.2

1.1

0.70

2.10

u/ml

0.86

Other predominantly sexually transmitted diseases, not elsewhere classified

252

2234

1.13

1.15

1.2

1.1

1.30

1.38

u/ml

0.05

113

887

Heterophoria

106

878

1.21

1.15

1.2

0.95

2.41

u/ml

1.80

410

Eustachian salpingitis and obstruction

114

951

1.21

1.15

1.1

5.84

1.72

u/ml

0.80

402

Other and unspecified injuries of forearm

1.93

1.13

1.4

1.1

12.10

0.86

u/ml

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

192

1518

0.87

1.13

1.1

0.79

1.08

u/ml

0.53

582

Acute otitis externa, noninfective

1.77

1.13

1.2

1.1

3.20

1.37

u/ml

—

169

1460

1.16

1.13

1.1

0.58

1.31

u/ml

1.71

541

Juvenile osteochondrosis

379

1.33

1.13

1.1

0.33

2.33

u/ml

2.72

163

Postpartum haemorrhage due to anatomy

165

1423

1.17

1.13

1.2

1.1

2.69

1.31

u/ml

0.53

514

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

175

1.50

1.13

1.2

1.1

0.59

2.66

u/ml

1.19

Spinal stenosis

253

1755

1.13

1.1

0.73

1.25

u/ml

1.41

632

Fall involving playground equipment

177

1.52

1.13

1.5

1.3

4.11

4.33

u/ml

0.02

119

Seropositive rheumatoid arthritis, strict definition

889

0.80

1.13

1.1

0.81

1.17

u/ml

0.28

331

Other congenital malformations

139

1182

1.18

1.13

1.1

1.2

3.32

1.96

u/ml

0.51

591

Other benign neoplasms of skin

256

2273

1.13

1.1

2.62

1.29

u/ml

0.67

866

Benign neoplasm: salivary glands, exclude unknown (D119)

396

1.32

1.13

1.2

1.1

0.32

1.69

u/ml

2.29

164

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

509

3512

0.92

1.12

1.1

1.59

1.28

u/ml

0.30

193

1349

Juvenile arthritis (FINNGEN)

708

0.77

1.12

1.1

0.46

2.15

u/ml

3.68

341

Asymmetry of jaw

160

1.52

1.11

1.1

3.04

1.92

u/ml

0.23

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

341

0.67

1.10

1.3

1.1

0.82

1.27

u/ml

—

133

Rheumatic fever incl heart disease

1.68

1.10

1.1

0.84

1.14

u/ml

—

Congenital malformations of breast

210

1.45

1.10

1.2

1.1

0.74

1.74

u/ml

0.72

Personal history of risk-factors, not elsewhere classified

112

1.63

1.10

1.3

1.1

0.34

1.96

u/ml

1.11

Carcinoma in situ of skin of other and unspecified parts of face

1.67

1.10

1.1

1.14

1.03

u/ml

—

Hypopituitarism

739

0.78

1.09

1.1

1.2

5.38

2.38

u/ml

0.46

382

Drug-induced neutropenia

340

0.67

1.09

1.1

6.88

1.66

u/ml

0.49

140

Benign neoplasm: Long bones of lower limb

252

1.40

1.09

1.1

1.16

2.12

u/ml

0.43

115

Benign neoplasm: Long bones of lower limb

252

1.40

1.09

1.1

1.16

2.19

u/ml

0.47

115

Other disorders starting during childhood or adolecense, excluding more controls

125

1021

1.19

1.09

1.2

0.64

2.37

u/ml

4.86

564

Ischaemic heart disease, wide definition

422

2893

0.91

1.09

1.1

2.35

1.40

u/ml

0.58

155

1103

Endometriosis of rectovaginal septum and vagina

549

1.26

1.09

1.2

1.1

0.27

0.87

u/ml

2.58

192

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

292

0.65

1.09

1.0

1.1

1.56

1.46

u/ml

—

112

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

605

0.76

1.09

1.1

0.95

1.90

u/ml

1.03

265

Rheumatoid arthritis

190

1974

0.87

1.08

1.1

0.79

1.31

u/ml

0.81

699

Open bite that required surgery (Lefort1 or BSSRO)

1.68

1.08

1.1

0.34

1.29

u/ml

—

Rheumatoid arthritis, including avohilmo

215

2436

0.88

1.08

1.1

0.72

1.32

u/ml

1.31

910

Use of teriflunomide

1.68

1.08

1.1

3.52

1.40

u/ml

—

Crohn's disease of small intestine

658

1.24

1.07

1.1

2.31

1.41

u/ml

0.17

268

Melanocytic naevi, other sites/unspecified

586

1.25

1.07

1.1

1.16

1.30

u/ml

0.08

228

Congenital malformations and deformations of the musculoskeletal system

160

1377

1.16

1.07

1.1

1.2

1.75

2.51

u/ml

0.56

721

Diseases of tongue

330

1.34

1.07

1.0

1.1

0.53

2.08

u/ml

1.35

122

Acute pancreatitis (for exclusion)

1080

0.82

1.07

1.1

1.68

1.73

u/ml

0.02

420

Other bursal cyst

1.94

1.06

1.0

1.1

4.77

1.83

u/ml

—

Misadventures to patients during surgical and medical care

105

876

1.20

1.06

1.1

1.47

1.54

u/ml

0.02

330

Other abnormal uterine and vaginal bleeding

192

1196

1.15

1.06

1.2

1.1

1.40

1.27

u/ml

0.07

437

Generalized skin eruption due to drugs and medicaments

279

1.37

1.06

1.2

1.1

0.75

1.93

u/ml

1.10

119

Other secondary gonarthrosis

211

1.43

1.06

1.0

1.1

0.36

1.89

u/ml

1.41

750

0.79

1.06

1.2

2.69

3.00

u/ml

0.05

472

Contusion of toe(s) without damage to nail

237

1.41

1.06

1.2

1.1

0.37

1.23

u/ml

1.99

Gastric ulcer

542

1.26

1.05

1.1

1.16

1.57

u/ml

0.31

217

Benign neoplasm of major salivary glands

436

1.29

1.05

1.2

1.1

0.29

1.64

u/ml

2.54

179

Benign neoplasm: Parotid gland

366

1.32

1.05

1.2

1.1

0.33

1.64

u/ml

1.85

148

Lymphoid leukaemia

265

0.64

1.05

1.4

1.2

1.23

2.33

u/ml

—

140

Leiomyoma of uterus

541

3329

0.92

1.05

1.1

1.38

1.18

u/ml

0.16

178

1191

Hypertensive Renal Disease

1.80

1.04

1.0

1.1

1.47

2.56

u/ml

—

Anogenital herpesviral [herpes simplex] infection

715

1.22

1.04

1.2

1.1

1.69

1.53

u/ml

0.06

294

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.65

1.04

1.1

0.45

2.63

u/ml

0.96

Tic and related disorders

230

1.42

1.04

1.1

1.2

3.81

1.56

u/ml

0.53

133

Supplementary factors related to causes of morbidity and mortality classified elsewhere

315

2847

1.11

1.04

1.2

1.1

1.65

1.99

u/ml

0.41

160

1216

Campylobacter enteritis

154

1.51

1.04

1.1

0.23

2.55

u/ml

—

Benign neoplasm of other and unspecified sites

154

1.50

1.04

1.1

1.06

2.14

u/ml

—

Cardiomyopathies, Primary/intrinsic

521

0.75

1.04

1.3

1.1

0.75

1.55

u/ml

1.26

234

Chronic iridocyclitis

347

0.69

1.03

1.0

1.1

4.86

2.11

u/ml

—

151

Delayed milestone in childhood

558

0.76

1.03

1.3

1.2

3.35

2.93

u/ml

0.09

383

Benign neoplasm: Other/unspecified site

1.85

1.03

1.1

1.20

1.17

u/ml

—

Inguinal hernia

459

3366

0.92

1.03

1.1

1.65

1.75

u/ml

0.07

179

1461

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

503

4628

1.08

1.03

1.1

1.17

1.35

u/ml

0.22

225

1766

Myocardial infarction, unclassifiable

424

0.74

1.03

1.1

8.23

1.75

u/ml

0.37

171

Conotruncal defects

297

0.66

1.03

1.2

1.3

17.84

2.08

u/ml

1.25

192

Tooth agenesis EXCLUDE clefts and syndromes

663

1.23

1.03

1.3

1.2

0.73

2.95

u/ml

3.57

330

Schizotypal disorder

202

0.59

1.02

1.3

1.1

0.38

2.27

u/ml

—

Hordeolum and other deep inflammation of eyelid

465

1.28

1.02

1.2

1.1

3.30

1.88

u/ml

0.49

208

Benign neoplasm: Caecum

324

1.33

1.02

1.0

1.1

0.77

1.37

u/ml

0.48

115

Measles

1.67

1.02

1.1

0.25

2.60

u/ml

—

Stomatitis and related lesions

690

1.22

1.01

1.1

1.70

2.30

u/ml

0.29

285

5-aminosalicylic acid

217

1924

1.13

1.01

1.1

1.74

1.47

u/ml

0.11

758

Other disorders of breast and lactation associated with childbirth

231

1.40

1.01

1.1

1.09

1.13

u/ml

0.02

Contact with other hot fluids

291

1.35

1.00

1.1

1.2

0.59

2.61

u/ml

2.17

137

Other and unspecified nail disorders

1.63

1.00

1.1

0.51

4.01

u/ml

—

Erythema nodosum

172

1.46

1.00

1.2

1.1

0.54

1.58

u/ml

1.09

Amputation

274

0.66

1.00

1.1

1.17

1.70

u/ml

—

105

Marasmic kwashiorkor

0.00

1.00

0.0

1.1

—

3.31

—

Prepatellar bursitis

231

1.39

1.00

1.2

1.1

0.28

2.01

u/ml

—

Nontoxic single thyroid nodule

440

1.28

0.99

1.1

0.38

1.09

u/ml

1.27

165

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.99

0.0

1.1

—

3.40

—

Benign neoplasm: Other/unspecified site

1.82

0.99

1.1

1.0

1.20

1.12

u/ml

—

Benign neoplasm of other and unspecified sites

156

1.48

0.99

1.1

1.06

2.24

u/ml

—

Hypoparathyroidism

156

1.48

0.99

1.2

1.1

7.81

1.91

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

187

1646

1.14

0.99

1.1

2.00

1.24

u/ml

0.39

606

Barrett oesophagus

156

1.48

0.98

1.2

1.1

0.43

2.03

u/ml

—

Bitten or struck by other mammals

135

1162

1.17

0.98

1.2

1.1

1.05

1.80

u/ml

1.05

469

SLE, strict definition

224

0.62

0.98

1.2

1.1

1.47

1.71

u/ml

—

SLE, ICD10

224

0.62

0.98

1.2

1.1

1.47

1.71

u/ml

—

Other bursitis of elbow

0.00

0.98

0.0

1.2

—

0.21

—

Pre-eclampsia

197

2225

0.88

0.98

1.1

2.72

1.09

u/ml

0.72

833

Follicular adenocarcinoma of thyroid gland

0.00

0.98

0.0

1.2

—

1.07

—

Pervasive developmental disorders excl. Autism + Asperger

315

0.68

0.98

1.0

1.3

2.52

2.41

u/ml

0.02

212

Vascular dementia (undefined)

0.00

0.98

0.0

1.1

—

0.70

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

712

1.21

0.97

1.1

0.33

1.60

u/ml

3.46

302

Secondary malignant neoplasm of other and unspecified sites

0.00

0.97

0.0

1.2

—

2.07

—

Adult respiratory distress syndrome

0.00

0.97

0.0

1.2

—

3.34

—

Bulimia nervosa (incl. atypical)

505

1.26

0.97

1.2

1.1

0.46

1.63

u/ml

1.52

202

Malignant neoplasm of rectum

272

0.66

0.97

1.2

1.1

1.44

1.84

u/ml

—

103

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

605

0.78

0.97

1.1

0.48

1.44

u/ml

1.73

239

Other specified and unspecified retinal disorders

124

1.54

0.97

1.1

0.16

2.29

u/ml

—

Melanoma in situ

100

1.61

0.97

1.1

0.28

1.58

u/ml

—

Wide developmental disorders

646

0.78

0.96

1.1

1.2

3.39

2.04

u/ml

0.43

363

Circumscribed brain atrophy

0.00

0.96

0.0

1.2

—

1.17

—

Spermatocele

241

1.37

0.96

1.3

1.1

2.40

2.56

u/ml

0.04

105

Female genital prolapse

244

1257

1.12

0.96

1.1

1.23

1.40

u/ml

0.13

449

Heart failure and antihypertensive medication

124

957

0.85

0.96

1.1

2.40

1.32

u/ml

0.28

387

Crohn disease (strict definition, require KELA)

668

1.22

0.96

1.1

0.29

1.63

u/ml

3.53

286

Injuries to the abdomen, lower back, lumbar spine and pelvis

336

3041

1.10

0.96

1.1

1.93

1.73

u/ml

0.10

148

1262

Cardiac arrest

234

0.66

0.96

1.0

1.1

0.20

2.39

u/ml

—

Speech and linguistic disorders

184

1558

1.14

0.96

1.2

2.79

2.35

u/ml

0.17

109

841

Adenocarcinoma and papilloma adenocarcinoma of rectum

259

0.65

0.96

1.0

1.1

1.56

1.88

u/ml

—

Hyperhidrosis

259

1.36

0.96

1.2

1.1

1.46

1.90

u/ml

0.12

Other disorders of Eustachian tube

174

1.45

0.95

1.3

1.1

8.86

2.01

u/ml

0.45

Gout, idiopatic and unspecified

726

0.80

0.95

1.2

1.1

2.26

1.46

u/ml

0.25

287

Alzheimer’s disease (Late onset)

212

0.65

0.95

1.3

1.1

0.43

0.89

u/ml

—

Ulcer of lower limb, not elsewhere classified

456

0.74

0.95

1.1

3.15

1.89

u/ml

0.30

185

Diseases of arteries, arterioles and capillaries (FINNGEN)

137

1108

0.86

0.95

1.1

0.75

1.20

u/ml

0.88

447

Symptoms and signs involving emotional state

277

1.35

0.94

1.2

1.1

0.92

2.41

u/ml

1.00

117

Postpartum hemorraghe, parous women as controls

367

2943

1.09

0.94

1.1

1.81

1.45

u/ml

0.21

135

1079

Other and unspecified mononeuropathies, also in other diseases

125

1.53

0.94

1.2

1.1

0.30

2.52

u/ml

—

Benign neoplasm of other and unspecified female genital organs

251

1.36

0.94

1.2

1.1

3.97

1.40

u/ml

0.55

104

Sequelae of injuries of lower limb

706

1.21

0.94

1.1

2.27

1.23

u/ml

0.45

272

Injuries to the hip and thigh

325

2709

1.10

0.93

1.1

2.18

1.60

u/ml

0.46

146

1119

Diabetic nephropathy, excluding more controls

521

0.78

0.93

1.0

1.1

0.41

1.09

u/ml

1.76

205

Glomerular diseases

102

1203

0.85

0.93

1.2

1.1

1.97

1.77

u/ml

0.06

528

Melanocytic naevi of lower limb, including hip

330

1.31

0.93

1.0

1.1

5.13

1.74

u/ml

0.39

130

Burn and corrosion of trunk

209

1.40

0.93

1.2

1.1

0.60

2.40

u/ml

1.41

103

Glomerular disorders in diseases classified elsewhere

656

0.79

0.93

1.2

1.1

2.81

1.42

u/ml

0.24

269

Acute pancreatitis

1062

0.84

0.93

1.1

1.68

1.58

u/ml

0.05

414

Acne vulgaris

152

1328

1.15

0.93

1.2

1.1

1.06

2.08

u/ml

1.44

585

Benign neoplasm of bone and articular cartilage

698

1.21

0.93

1.1

0.57

1.43

u/ml

1.34

277

Other diseases of pleura

216

1706

1.12

0.93

1.1

1.29

1.39

u/ml

0.06

688

Benign neoplasm: Spinal meninges

2.16

0.92

1.2

—

1.38

—

Emotional disorders starting during childhood or adolecense, excluding more controls

113

947

1.18

0.91

1.1

1.2

2.52

2.29

u/ml

0.07

497

Chronic suppurative otitis media, including avohilmo

681

1.21

0.91

1.2

1.1

0.92

2.06

u/ml

0.94

330

Inguinal of femoral hernia, unilateral

1.64

0.91

1.4

1.1

0.13

1.66

u/ml

—

Femoral hernia, unilateral

1.64

0.91

1.4

1.1

0.13

1.66

u/ml

—

Inguinal hernia, unilateral

1.64

0.91

1.4

1.1

0.13

1.66

u/ml

—

Diverticular disease of intestine

468

2876

1.08

0.91

1.1

1.00

1.41

u/ml

0.49

165

1060

Disorders of vestibular function (Vertigo)

301

2719

1.10

0.91

1.1

1.44

1.32

u/ml

0.07

114

996

Other, unspecified and serous retinal detachments

110

1.55

0.91

1.2

1.1

3.26

2.05

u/ml

—

Disorders of orbit

288

1.33

0.90

1.0

1.1

0.97

1.79

u/ml

0.53

127

L04AX Other immunosuppressants

490

5266

0.93

0.89

1.1

1.74

1.64

u/ml

0.06

207

2195

Benign neoplasm: Conjunctiva

160

1.45

0.89

1.1

2.38

0.87

u/ml

—

Deficiency of other B group vitamins

1.70

0.89

1.2

1.1

0.32

3.40

u/ml

—

Placental disorders

103

1.58

0.89

1.1

0.36

0.64

u/ml

—

Contact with heat and hot substances

484

1.25

0.89

1.1

1.2

1.98

1.95

u/ml

0.01

230

Endocarditis

127

1.50

0.88

1.1

5.33

2.26

u/ml

—

Guttate psoriasis

1.66

0.88

1.2

1.1

0.34

1.67

u/ml

—

Abnormal findings on diagnostic imaging of central nervous system

324

1.30

0.88

1.1

5.86

1.94

u/ml

0.33

138

Use of hypnotics and sedatives

1052

6396

0.95

0.88

1.1

1.44

1.51

u/ml

0.08

414

2557

Other congenital malformations of ear

212

1.39

0.88

1.1

1.2

2.16

2.20

u/ml

0.01

101

Crohn disease (strict definition, require KELA, min 2 HDR)

657

1.21

0.88

1.1

0.29

1.66

u/ml

3.55

281

Tongue abnormality

289

1.32

0.88

1.0

1.1

0.53

2.06

u/ml

1.38

115

Benign neoplasm: Larynx

111

1.54

0.88

1.1

0.45

1.87

u/ml

—

Recurring oral aphthae

351

1.29

0.88

1.1

1.48

2.27

u/ml

0.28

166

Other specified/unspecified disorders of bone/cartilage

144

1.47

0.87

1.1

0.68

2.11

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

342

1.29

0.87

1.1

0.36

1.84

u/ml

2.06

142

Cramp and spasm

316

1.30

0.87

1.2

1.1

1.44

2.10

u/ml

0.24

135

Ulcer of oesophagus

203

1.38

0.87

1.3

1.1

2.29

1.91

u/ml

0.14

Influenza and pneumonia

1290

8108

1.05

0.87

1.2

1.1

2.24

1.72

u/ml

0.69

624

3336

Hypertrophic scar

531

1.23

0.86

1.1

1.76

1.72

u/ml

0.01

221

Crohn's disease of large intestine

486

1.24

0.86

1.1

2.70

1.66

u/ml

0.17

202

Other congenital malformations of circulatory system

153

1.45

0.86

1.1

0.12

2.58

u/ml

—

Crowding of teeth, including avohilmo

210

1553

1.12

0.86

1.2

3.39

2.70

u/ml

0.30

129

807

Other and unspecified injuries of lower leg

677

1.20

0.86

1.1

0.66

2.09

u/ml

2.74

286

Vertical strabismus

221

1.37

0.86

1.1

1.2

0.20

3.14

u/ml

2.41

100

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

108

926

1.17

0.86

1.2

1.1

2.03

1.47

u/ml

0.29

333

Gout, FINNGEN

890

0.83

0.85

1.1

2.36

1.30

u/ml

0.42

360

Alcohol-induced chronic pancreatitis

310

0.71

0.85

1.0

1.1

1.72

2.42

u/ml

—

126

Vitreous haemorrhage

447

0.76

0.85

1.0

1.1

0.90

1.77

u/ml

0.81

180

Follicular cysts of skin and subcutaneous tissue

148

1299

1.14

0.85

1.1

1.35

1.51

u/ml

0.08

521

Cysts of oral region, not elsewhere classified

256

1.33

0.85

1.1

0.35

2.66

u/ml

2.11

100

Benzodiazepine use

995

7439

0.95

0.85

1.1

0.95

1.63

u/ml

2.42

399

2975

ILD medications: immunosuppressive drugs

605

5446

1.07

0.84

1.1

1.89

1.83

u/ml

0.04

256

2142

Melanoma in situ

104

1.54

0.84

1.1

0.28

1.09

u/ml

—

Diseases of peritoneum

505

1.23

0.84

1.2

1.1

1.02

1.86

u/ml

0.64

209

Other keratitis

107

918

1.17

0.84

1.1

0.88

1.48

u/ml

0.74

371

Other juvenile arthritis

612

0.79

0.84

1.1

1.2

0.39

2.38

u/ml

4.04

297

Excessive vomiting in pregnancy

110

947

1.17

0.84

1.1

2.05

1.12

u/ml

0.24

348

Abnormal blood-pressure reading, without diagnosis

248

1.34

0.84

1.2

1.1

0.29

3.27

u/ml

1.92

111

Congenital malformations of eye, ear, face and neck

104

892

1.17

0.83

1.1

1.2

0.86

2.53

u/ml

2.02

438

Other congenital malformations of tongue, mouth and pharynx

336

1.30

0.83

1.2

1.3

1.84

1.81

u/ml

0.01

208

Congenital malformations of anterior segment of eye

1.72

0.83

1.0

1.2

0.55

5.12

u/ml

—

364

1.28

0.83

1.1

1.2

0.91

2.26

u/ml

1.09

183

Pre-eclampsia or eclampsia

209

2323

0.90

0.83

1.1

2.58

1.10

u/ml

0.72

863

Congenital malformations of cardiac septa

981

0.84

0.83

1.1

1.2

5.28

2.55

u/ml

0.56

570

Gout, unspecified

568

0.79

0.83

1.2

1.1

2.23

1.72

u/ml

0.12

225

Pedal cyclist injured in noncollision transport accidents

1026

0.85

0.83

1.1

1.16

1.65

u/ml

0.31

432

Coxarthrosis, primary

263

2073

1.10

0.83

1.1

1.00

1.24

u/ml

0.27

792

Chronic periodontitis, complicated

422

0.76

0.82

1.2

1.1

0.50

2.24

u/ml

2.12

169

Other and unspecified mood [affective] disorders

104

893

1.17

0.82

1.1

0.37

1.59

u/ml

4.20

371

Diseases of the digestive system

339

3112

1.09

0.82

1.1

3.34

1.69

u/ml

1.12

146

1333

Hirsprung

0.00

0.82

0.0

1.2

—

2.81

—

Maxillary retrognathism

241

1.34

0.82

1.2

3.32

2.54

u/ml

0.10

116

Benign neoplasm: Vulva

1.56

0.82

1.3

1.1

5.34

1.99

u/ml

—

Toxic effect of carbon monoxide

1.59

0.81

1.1

4.51

2.91

u/ml

—

Haemolytic anaemias

206

1.37

0.81

1.5

1.1

6.65

1.34

u/ml

0.38

102

Respiratory tuberculosis, not confirmed

1.65

0.81

1.2

1.1

0.47

0.80

u/ml

—

Cluster headache, strict, including avohilmo

427

1.25

0.81

1.1

3.21

1.62

u/ml

0.37

170

IgA nephropathy (IgA glomerulonephritis)

130

1.47

0.81

1.1

7.83

2.14

u/ml

—

Delayed puberty

156

1.44

0.81

1.1

1.2

12.91

1.73

u/ml

—

Benign neoplasm of ovary

116

1005

1.16

0.81

1.2

1.1

2.22

1.00

u/ml

0.30

358

Malignant melanoma of skin

432

0.76

0.81

1.0

1.1

1.16

1.67

u/ml

0.30

174

SLE (Finngen)

248

0.68

0.81

1.2

1.1

1.47

1.14

u/ml

—

103

Hypertrophic disorders of skin

563

1.21

0.81

1.1

1.71

1.62

u/ml

0.03

237

Valvular operations

621

0.80

0.81

1.1

2.56

1.91

u/ml

0.15

293

Other congenital malformations of the digestive system

624

1.20

0.80

1.2

3.34

2.78

u/ml

0.10

366

Other leukaemias of specified cell type

0.00

0.80

0.0

1.2

—

2.24

—

Melanocytic naevi, other sites/unspecified

609

1.20

0.80

1.1

1.16

1.36

u/ml

0.13

239

Benign neoplasm: Conjunctiva

164

1.41

0.80

1.1

2.38

0.73

u/ml

—

Other specified/unspecified hearing loss

338

1.28

0.80

1.1

0.74

1.68

u/ml

1.00

138

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

565

0.79

0.80

1.0

1.1

1.22

1.41

u/ml

0.12

218

Other retinal disorders

337

2938

0.92

0.80

1.1

0.88

1.47

u/ml

1.74

124

1193

Open wound of ankle and foot

849

1.17

0.80

1.2

1.1

0.80

1.82

u/ml

1.65

364

Thyrotoxicosis

205

1845

1.11

0.80

1.1

2.24

1.36

u/ml

0.46

697

Other leukaemias of specified cell type

0.00

0.80

0.0

1.2

—

2.04

—

Nonischemic cardiomyopathy

259

0.69

0.80

1.4

1.1

0.44

2.01

u/ml

—

112

Myositis

114

1.50

0.79

1.2

1.1

1.27

2.78

u/ml

—

Precocious puberty

100

0.49

0.79

1.2

0.99

2.05

u/ml

—

Benign neoplasm: Larynx

114

1.50

0.79

1.1

0.45

1.96

u/ml

—

Benign neoplasm: Endocrine pancreas

0.00

0.79

0.0

1.1

—

1.08

—

Chronic suppurative otitis media

546

1.21

0.79

1.2

1.1

1.09

2.47

u/ml

0.88

254

Other and unspecified vasculitis limited to skin

106

1.52

0.79

1.3

1.1

0.51

2.71

u/ml

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

603

1.19

0.79

1.1

1.14

1.58

u/ml

0.29

245

Polymyalgia rheumatica

305

0.72

0.79

1.0

1.1

0.27

1.40

u/ml

—

113

Benign neoplasm: Vulva

1.54

0.79

1.3

1.1

5.34

1.94

u/ml

—

Other and unspecified disorders of psychological development

308

0.72

0.79

1.3

0.83

1.99

u/ml

0.82

196

Venous thromboembolism

327

2923

1.09

0.78

1.1

1.23

1.28

u/ml

0.05

140

1104

Peripheral arterial reconstruction

339

0.74

0.78

1.2

1.1

3.01

2.10

u/ml

0.15

125

Corneal ulcer

174

1554

1.12

0.78

1.1

1.61

1.74

u/ml

0.10

633

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

295

1.29

0.78

1.1

0.16

1.63

u/ml

—

119

Ulcerative colitis, NAS

114

1309

0.87

0.78

1.2

1.1

1.19

1.82

u/ml

0.41

547

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

373

0.76

0.78

1.1

0.60

1.43

u/ml

1.07

140

Other facial nerve disorders

148

1.43

0.78

1.4

1.1

0.17

3.17

u/ml

—

Erythema multiforme

123

1.47

0.78

1.2

1.1

0.07

2.25

u/ml

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.78

0.0

1.0

—

1.94

—

Abnormal results of function studies

593

1.20

0.78

1.1

0.77

1.63

u/ml

1.26

246

Medial epicondylitis

234

1.33

0.78

1.3

1.1

0.38

2.28

u/ml

1.47

Cerebral palsy

233

0.68

0.77

1.1

1.2

3.46

1.81

u/ml

0.31

131

Meralgia paraesthetica

191

1.37

0.77

1.2

1.1

1.75

2.27

u/ml

0.16

Alcohol abuse, main dg

119

1361

0.87

0.77

1.2

1.1

2.12

1.84

u/ml

0.10

591

Systemic lupus erythematosus

245

0.69

0.77

1.2

1.1

1.47

1.70

u/ml

—

100

Aortic aneurysm

637

1.19

0.77

1.1

0.92

2.14

u/ml

1.49

253

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.76

0.0

1.1

—

2.06

—

Polycystic ovarian syndrome, consortium definition

922

5296

1.05

0.76

1.1

1.67

1.52

u/ml

0.16

351

2034

Acquired absence of limb

0.00

0.76

0.0

1.1

—

2.07

—

Hypersomnia

1.55

0.76

1.2

1.1

1.98

1.63

u/ml

—

Exposure to other and unspecified animate mechanical forces

315

1.28

0.76

1.1

1.2

3.65

1.51

u/ml

0.27

135

Vascular disorders of the intestines

132

1.44

0.75

1.2

1.1

2.21

2.05

u/ml

—

Car occupant injured in other and unspecified transport accidents

224

2034

1.10

0.75

1.1

3.37

1.74

u/ml

0.83

835

Ulcerative colitis

212

2339

0.90

0.75

1.1

0.86

1.66

u/ml

1.13

981

Lymphoid leukaemia

244

0.69

0.75

1.4

1.2

1.23

2.45

u/ml

—

137

Viral conjunctivitis

175

1.38

0.75

1.1

2.43

1.06

u/ml

0.25

Secondary hypertension

565

0.80

0.75

1.1

1.42

1.88

u/ml

0.15

270

Actinic keratosis

103

845

1.16

0.75

1.1

1.49

1.25

u/ml

0.10

330

Mixed disorders of conduct and emotions

469

0.78

0.75

1.1

1.2

0.53

1.85

u/ml

2.41

223

Cluster headache, wide,, including avohilmo

441

1.23

0.75

1.1

3.21

1.58

u/ml

0.39

176

Streptococcal septicaemia

437

0.78

0.75

1.1

3.46

2.71

u/ml

0.09

210

Benign neoplasm of major salivary glands

459

1.22

0.74

1.2

1.1

0.29

1.61

u/ml

2.43

181

Vasculitis limited to skin, not elsewhere classified

116

1.47

0.74

1.2

1.1

0.60

3.52

u/ml

—

Spondylopathies

668

3833

1.06

0.74

1.1

1.49

1.45

u/ml

0.03

235

1451

Antenatal screening

372

2258

0.93

0.74

1.1

1.56

1.50

u/ml

0.04

132

896

Ménière disease

414

1.24

0.74

1.2

1.1

2.49

1.67

u/ml

0.14

168

Anomalies of pupillary function

167

1.39

0.74

1.2

1.1

1.28

2.60

u/ml

—

Benign neoplasm of colon, rectum, anus and anal canal

366

2423

1.08

0.74

1.1

0.97

1.17

u/ml

0.22

142

900

Artrosis, including avohilmo

865

4515

1.05

0.74

1.1

1.65

1.46

u/ml

0.19

350

1747

Presence of other functional implants

240

1865

0.91

0.74

1.2

1.1

1.76

1.22

u/ml

0.40

724

Pneumonia due to Streptococcus pneumoniae

210

1.34

0.74

1.0

1.1

10.75

2.33

u/ml

0.56

Melanocytic naevi of upper limb, including shoulder

150

1.41

0.74

1.1

0.59

1.98

u/ml

—

Arthrosis

690

3587

1.06

0.74

1.1

1.60

1.59

u/ml

0.00

280

1337

Dental pulpitis 2

762

3699

1.06

0.74

1.1

1.71

1.63

u/ml

0.07

324

1485

Other specified and unspecified strabismus

100

1.52

0.74

1.1

1.2

0.84

2.16

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

129

1462

0.88

0.73

1.1

1.00

1.34

u/ml

0.35

543

Melanocytic naevi of lower limb, including hip

343

1.26

0.73

1.0

1.1

5.13

1.75

u/ml

0.39

144

Parkinson's disease

346

0.75

0.73

1.1

0.17

1.64

u/ml

—

127

Gout

797

0.85

0.73

1.1

2.36

1.20

u/ml

0.47

318

Other aneurysm

150

1.40

0.73

1.0

1.1

0.11

1.90

u/ml

1.23

Other disorders involving the immune mechanism, not elsewhere classified

228

1.32

0.73

1.2

1.1

4.00

2.73

u/ml

0.15

105

Other specified/unspecified systemic involvement of connective tissue

379

1.25

0.73

1.1

2.30

1.45

u/ml

0.22

148

Supervision of normal pregnancy

354

2183

0.92

0.73

1.1

1.47

1.50

u/ml

0.03

132

863

conjunctival haemorrhage

272

1.29

0.72

1.0

1.1

1.77

1.74

u/ml

0.01

Overexertion and strenuous or repetitive movements

811

1.16

0.72

1.1

0.21

1.56

u/ml

3.57

328

Ingrowing nail

434

1.23

0.72

1.1

1.30

2.02

u/ml

0.48

184

Sulfasalazine

235

2144

1.10

0.72

1.1

1.04

1.28

u/ml

0.17

768

Undescended testicle

262

0.71

0.72

1.2

8.25

3.21

u/ml

—

190

Dental pulpitis 2, only avohilmo

773

3755

1.05

0.72

1.1

1.66

1.62

u/ml

0.03

328

1507

Symptoms and signs concerning food and fluid intake

764

1.17

0.72

1.2

1.21

2.22

u/ml

0.44

379

Cyst of kidney

211

1.33

0.72

1.3

1.1

1.84

1.90

u/ml

—

Diseases of inner ear

362

3293

1.08

0.72

1.1

1.31

1.48

u/ml

0.13

140

1240

Conduction disorders

166

1235

1.12

0.72

1.1

1.66

1.72

u/ml

0.03

509

Acute peritonitis

276

0.72

1.4

1.1

1.42

2.01

u/ml

0.18

124

Convergent concomitant strabismus

686

0.83

0.71

1.1

0.79

2.11

u/ml

2.00

312

Malignant melanoma, excluding all cancers (controls excluding all cancers)

687

0.83

0.71

1.0

1.1

1.03

1.34

u/ml

0.28

264

Explicit bacterial Sepsis

610

0.82

0.71

1.1

2.83

2.11

u/ml

0.12

271

Congenital hydrocephalus

1.95

0.71

1.0

1.2

—

2.60

—

Lung cancer and mesothelioma

263

1.27

0.71

1.1

0.47

1.00

u/ml

0.89

Fracture of lumbar spine and pelvis

966

0.86

0.71

1.1

0.95

1.52

u/ml

0.54

371

Other diseases of blood and blood-forming organs, wide

161

1442

1.12

0.71

1.2

1.1

1.61

1.52

u/ml

0.03

602

Brachial plexus disorders

101

878

1.15

0.71

1.1

1.34

1.26

u/ml

0.08

326

Macular hole

109

1.47

0.71

1.0

1.1

0.14

1.18

u/ml

—

Wide developmental disorders, excluding more controls

612

0.82

0.71

1.1

1.2

3.39

2.35

u/ml

0.30

351

Chronic hepatitis, not elsewhere classified

170

0.64

0.71

1.2

1.1

0.42

2.42

u/ml

—

Type of accident

282

2598

1.09

0.70

1.2

1.1

1.42

1.95

u/ml

0.77

137

1110

Other noninflammatory disorders of uterus, except cervix

130

782

1.14

0.70

1.1

2.02

1.01

u/ml

0.30

279

Open bite

824

1.16

0.70

1.2

0.75

2.86

u/ml

3.26

415

Any event in hilmo or specialist outpatient

1.66

0.70

1.1

0.90

4.32

u/ml

—

Other specified/unspecified inflammatory spondylopathies

418

1.23

0.70

1.2

1.1

0.55

1.51

u/ml

1.02

157

Viral meningitis

337

1.25

0.69

1.1

1.05

2.17

u/ml

0.74

129

Varicella [chickenpox]

473

1.21

0.69

1.1

1.2

2.28

2.32

u/ml

0.01

225

Other bullous disorders

135

1.42

0.69

1.0

1.1

0.65

3.07

u/ml

—

Trigeminal neuralgia

319

1.26

0.69

1.1

0.52

1.62

u/ml

1.03

126

Oral leukoplakia and related diseases

213

1.32

0.68

1.1

0.53

1.77

u/ml

—

Emotional disorders and disorders of social functioning with onset specific to childhood

127

1112

1.13

0.68

1.1

1.2

2.43

2.40

u/ml

0.01

580

Other/unspecified seropositive rheumatoid arthritis

131

1473

0.89

0.68

1.1

1.00

1.34

u/ml

0.34

545

Complications of labour and delivery

783

4157

1.05

0.67

1.1

1.79

1.35

u/ml

0.49

290

1576

Sequelae with surgical and medical care as external cause

122

1079

1.13

0.67

1.1

0.64

1.49

u/ml

2.05

432

Parkinson's disease, including avohilmo

363

0.77

0.67

1.1

0.17

1.56

u/ml

—

137

Palmar fascial fibromatosis [Dupuytren]

438

1.21

0.67

1.1

1.12

2.21

u/ml

0.53

174

Other symptoms and signs involving the nervous and musculoskeletal systems

397

3715

1.07

0.67

1.2

1.1

1.04

1.67

u/ml

0.77

185

1526

Skin changes due to chronic exposure to nonionizing radiation

110

914

1.14

0.66

1.1

1.43

1.34

u/ml

0.03

360

Maternal care for known or suspected fetal abnormality and damage

222

2156

0.91

0.66

1.1

1.53

1.34

u/ml

0.10

829

Congenital malformations of great arteries

473

0.80

0.66

1.2

1.3

1.43

2.68

u/ml

0.44

313

Non-ischemic cardiomyopathy

912

0.87

0.66

1.1

0.74

1.45

u/ml

1.00

380

Congenital deformities of hip

295

1.27

0.66

1.2

0.83

2.20

u/ml

0.93

156

Effects of other external causes

259

1.28

0.66

1.1

0.83

2.18

u/ml

0.86

112

Other and unspecified disorders of white blood cells

197

1.33

0.66

1.1

0.31

2.23

u/ml

—

Bacterial pneumonia (organism specified)

310

2619

1.08

0.66

1.1

1.52

1.55

u/ml

0.01

157

1054

Other congenital malformations of face and neck

277

1.27

0.66

1.1

0.25

1.78

u/ml

1.93

119

Carcinoma in situ of skin of other and unspecified parts of face

111

1.44

0.66

1.1

1.14

0.69

u/ml

—

Aplastic and other anaemias

200

2080

0.91

0.65

1.1

3.71

1.29

u/ml

1.12

845

Gonarthrosis

522

2823

1.06

0.65

1.1

1.93

1.60

u/ml

0.23

215

1011

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

316

0.76

0.65

1.0

1.1

0.74

1.27

u/ml

—

120

Diabetes mellitus in pregnancy

575

3530

1.06

0.65

1.1

1.64

1.38

u/ml

0.31

221

1376

Septal defects

936

0.86

0.65

1.1

1.2

5.62

2.59

u/ml

0.59

551

Pneumonia due to other infectious organisms, not elsewhere classified

137

1.39

0.65

1.2

1.1

2.50

1.88

u/ml

—

Erectile dysfunction

213

0.70

0.64

1.1

4.13

2.35

u/ml

—

Mumps

163

1.36

0.64

1.2

1.1

0.31

2.04

u/ml

1.35

Glaucoma-related operations

120

1.42

0.64

1.0

1.1

0.31

0.86

u/ml

0.91

Ventral hernia

142

1272

1.12

0.64

1.1

2.00

1.43

u/ml

0.38

494

Exclusion endpoint for supernumerary teeth

200

0.69

0.64

1.2

2.76

3.12

u/ml

—

110

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

868

1.15

0.64

1.1

2.19

1.54

u/ml

0.32

312

Contact with other sharp object(s)

688

0.84

0.64

1.2

1.1

3.82

1.37

u/ml

0.52

283

Thoracic aortic aneurysm

459

1.20

0.64

1.1

1.17

2.05

u/ml

0.74

185

Crushed, pushed or stepped on by crowd or human stampede

103

906

1.14

0.64

1.2

1.1

2.61

1.85

u/ml

0.18

422

Cerebral cysts

478

1.20

0.63

1.2

1.1

0.69

1.68

u/ml

0.98

205

Other and unspecified mononeuropathies of lower limb

129

1.40

0.63

1.2

1.1

0.89

2.26

u/ml

—

Infective bursitis

112

1.44

0.63

1.0

1.1

0.63

2.29

u/ml

—

Melanocytic naevi of upper limb, including shoulder

155

1.36

0.63

1.1

0.59

1.97

u/ml

—

Retinoblastoma

0.00

0.63

0.0

1.1

—

4.14

—

Seropositive rheumatoid arthritis

134

1492

0.89

0.63

1.1

0.97

1.32

u/ml

0.35

537

Retinoblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.63

0.0

1.0

—

4.52

—

Neuromuscular dysfunction of bladder

451

1.20

0.63

1.1

0.98

1.50

u/ml

0.50

178

Unstable angina pectoris

108

1013

0.88

0.62

1.2

1.1

3.10

1.16

u/ml

0.52

390

Personality disorders, excluding more controls

328

3060

1.07

0.62

1.2

1.1

0.98

1.62

u/ml

1.44

156

1184

Femoral hernia

138

1.38

0.62

1.3

1.1

0.13

1.25

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

360

1.22

0.62

1.1

0.36

1.66

u/ml

1.84

150

Haemorrhage, not elsewhere classified

121

1.41

0.62

1.2

1.1

0.07

3.39

u/ml

—

Specific development disorders of speech and language

114

974

1.13

0.62

1.2

3.07

2.08

u/ml

0.32

551

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

306

1.25

0.62

1.1

0.16

1.80

u/ml

—

125

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

291

0.75

0.62

1.1

0.67

1.41

u/ml

—

108

Other or ill-defined heart diseases

297

1.25

0.62

1.2

1.1

0.74

1.85

u/ml

1.30

124

Systemic lupus erythematosus, unspecified

199

0.70

0.62

1.2

1.1

1.47

1.79

u/ml

—

Alport

0.00

0.62

0.0

1.3

—

4.01

—

Other congenital malformations of integument

0.00

0.62

0.0

1.0

—

4.42

—

Other disorders of pigmentation

244

1.28

0.61

1.2

1.1

1.24

2.00

u/ml

0.40

110

Viral hepatitis, IBD co-morbidity

522

0.82

0.61

1.2

1.1

1.51

1.80

u/ml

0.12

217

Ankyloglossia

398

1.22

0.61

1.2

2.17

2.24

u/ml

0.02

242

Polyglandular dysfunction

0.00

0.61

0.0

1.1

—

1.86

—

Right ventricular outflow tract obstruction

197

0.70

0.61

1.1

1.3

26.54

2.71

u/ml

—

130

Unspecified lump in breast

119

1060

1.12

0.61

1.1

0.94

0.97

u/ml

0.04

376

Blindness or visual impairment, binocular

0.00

0.61

0.0

1.1

—

1.36

—

Prolonged pregnancy

226

2237

0.92

0.61

1.1

1.60

1.35

u/ml

0.17

101

881

Foreign object accidentally left in body during surgical and medical care

0.00

0.60

0.0

1.2

—

2.13

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.1

—

1.24

—

Unattended death

0.00

0.60

0.0

1.2

—

2.23

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.1

—

1.20

—

Gestational diabetes (for exclusion)

610

4105

1.05

0.60

1.1

1.86

1.49

u/ml

0.39

226

1558

Neuroendocrine tumor and carcinoma of lung

0.00

0.60

0.0

1.2

—

1.52

—

Primary gonarthrosis, bilateral

233

1878

1.09

0.60

1.1

1.23

1.30

u/ml

0.06

671

Noonan syndrome

0.00

0.60

0.0

1.1

—

1.53

—

Nail disorders

648

1.16

0.60

1.1

1.03

1.81

u/ml

0.78

264

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

108

958

1.13

0.60

1.2

1.1

2.03

1.25

u/ml

0.45

348

Retention of urine

123

1163

0.89

0.60

1.2

1.1

0.81

1.46

u/ml

0.98

454

Hereditary hypogammaglobulinemia

0.00

0.60

0.0

1.2

—

3.75

—

Cluster headache, strict

272

1.26

0.60

1.1

2.11

1.57

u/ml

0.11

106

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

411

0.80

0.59

1.1

5.57

1.38

u/ml

0.43

165

Seropositive rheumatoid arthritis, wide

134

1489

0.90

0.59

1.1

0.97

1.33

u/ml

0.38

550

Retinal haemorrhage

1.53

0.59

1.0

1.1

0.43

1.58

u/ml

—

Injury of intra-abdominal organs

197

0.71

0.59

1.1

12.54

1.91

u/ml

—

Perineal laceration during delivery

245

2358

0.92

0.59

1.1

1.53

1.18

u/ml

0.28

104

885

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

377

0.79

0.58

1.0

1.1

2.55

1.61

u/ml

0.20

161

Benign neoplasm: Endocrine pancreas

0.00

0.58

0.0

1.1

—

1.04

—

Carcinoma in situ of skin

166

1.33

0.58

1.0

1.1

0.39

1.88

u/ml

1.02

Cluster headache, wide

282

1.25

0.58

1.1

2.11

1.52

u/ml

0.12

110

Autoimmune diseases related-to ILD

918

7761

1.04

0.58

1.1

1.65

1.64

u/ml

0.00

351

3163

Other complications of labour and delivery, not elsewhere classified

172

1814

0.91

0.58

1.1

1.15

1.23

u/ml

0.05

676

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

847

1.14

0.58

1.1

0.45

1.33

u/ml

2.38

320

Disorders in reading

256

1.26

0.58

1.2

6.57

1.63

u/ml

0.78

135

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

211

1.29

0.57

1.1

4.56

2.84

u/ml

0.18

Other appendicitis

623

1.16

0.57

1.1

1.04

1.46

u/ml

0.35

223

Other peripheral vascular diseases

493

1.18

0.57

1.2

1.1

0.89

1.63

u/ml

0.73

190

Arthropathic psoriasis

776

0.86

0.57

1.2

1.1

0.47

1.32

u/ml

2.03

300

Implicit fungal Sepsis

132

1.37

0.57

1.2

1.1

1.10

1.42

u/ml

—

Hodgkin lymphoma

184

0.70

0.57

1.4

1.1

0.66

2.30

u/ml

—

Pyogenic granuloma

115

1.40

0.57

1.1

2.72

2.87

u/ml

0.02

Colectomy operation

701

0.85

0.57

1.1

0.20

1.82

u/ml

4.13

273

Vitamin deficiency, wide

274

1.25

0.57

1.2

1.1

2.67

1.69

u/ml

0.16

117

Vitamin deficiency

274

1.25

0.57

1.2

1.1

2.67

1.69

u/ml

0.16

117

Maternal care related to the fetus and amniotic cavity and possible delivery problems

663

3725

1.05

0.56

1.1

1.80

1.41

u/ml

0.43

239

1436

Colon adenocarcinoma

286

0.77

0.56

1.1

0.67

1.69

u/ml

—

100

Superficial injury of abdomen, lower back and pelvis

151

1371

1.10

0.56

1.1

3.13

1.83

u/ml

0.35

577

Medical abortion

791

4119

1.04

0.56

1.1

0.64

1.51

u/ml

4.70

311

1580

Mixed disorders of conduct and emotions, excluding more controls

450

0.82

0.56

1.1

1.2

0.52

1.33

u/ml

1.81

215

Hydrocephalus

308

0.78

0.56

1.0

1.2

0.34

2.10

u/ml

2.58

145

Bursitis of shoulder

124

1.38

0.56

1.2

1.1

0.13

3.21

u/ml

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

186

1959

0.92

0.56

1.1

1.2

4.06

2.03

u/ml

0.72

1000

Benign neoplasm: Descending colon

194

1.29

0.56

1.1

4.24

1.18

u/ml

0.36

Alcohol abuse, main dg, excluding more controls

119

1324

0.90

0.55

1.2

1.1

2.12

1.93

u/ml

0.06

549

Other abnormal immunological findings in serum

168

1.32

0.55

1.1

3.07

3.28

u/ml

—

Other disorders of male genital organs

257

1.25

0.55

1.0

1.1

1.24

1.97

u/ml

0.28

122

Postprocedural disorders of nervous system

837

0.87

0.55

1.1

0.56

1.58

u/ml

2.04

342

Degenerative macular diseases

311

1.22

0.55

1.1

1.25

1.56

u/ml

0.18

121

Other Crohn's disease

710

1.14

0.55

1.1

2.12

1.37

u/ml

0.15

288

Memory loss

275

1.24

0.55

1.3

1.1

0.26

1.73

u/ml

2.08

104

Maternal care for known or suspected abnormality of pelvic organs

390

2536

1.06

0.55

1.1

1.63

1.33

u/ml

0.23

147

970

Colorectal cancer

720

0.86

0.55

1.1

0.90

1.85

u/ml

1.18

280

Viral Sepsis

132

1192

1.11

0.55

1.2

1.1

0.80

1.59

u/ml

1.69

522

Combinations of oral blood glucose lowering drugs

113

1260

0.90

0.54

1.1

0.82

1.31

u/ml

0.88

494

Other bacterial intestinal infections

115

1031

1.12

0.54

1.1

0.73

1.42

u/ml

1.23

406

Systemic sclerosis (FG)

116

1.39

0.54

1.1

0.54

1.86

u/ml

—

Sensorineural hearing loss

493

3274

1.05

0.54

1.1

1.65

1.68

u/ml

0.02

192

1254

Tuberculosis

142

1.34

0.54

1.3

1.1

0.45

2.10

u/ml

—

Other viral diseases, not elsewhere classified

243

2253

1.08

0.54

1.2

1.1

0.66

2.31

u/ml

6.89

108

1055

Enterocolitis due to Clostridium difficile

427

0.82

0.54

1.1

0.63

1.41

u/ml

0.82

172

Autoimmune diseases

1395

7347

0.97

0.54

1.1

1.62

1.80

u/ml

0.26

576

3151

Macular pucker

358

1.20

0.53

1.0

1.1

0.61

1.95

u/ml

1.28

140

Acute alcohol intoxication ICD-9

125

1.36

0.53

1.1

0.46

1.79

u/ml

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

143

1.35

0.53

1.2

2.82

1.70

u/ml

—

Fentanyl

294

0.78

0.53

1.1

0.90

2.11

u/ml

0.78

117

Early syphilis

1.53

0.53

1.2

1.1

3.08

1.98

u/ml

—

Other (seronegative) rheumatoid arthritis, wide

1046

0.89

0.53

1.1

0.30

1.18

u/ml

3.38

397

Other and unspecified myopathies

349

0.80

0.53

1.1

1.36

2.07

u/ml

0.50

139

Atrophic disorders of skin

108

968

1.12

0.52

1.1

2.10

1.24

u/ml

0.37

378

Dislocation, sprain and strain of joints and ligaments of head

452

1.18

0.52

1.2

1.1

0.63

1.38

u/ml

1.01

193

KRA_PSY_EATING, excluding more controls

148

1346

1.10

0.52

1.2

1.1

0.88

2.19

u/ml

2.21

565

Social disorders starting during childhood or adolecense, excluding more controls

144

1.34

0.52

1.0

1.2

0.26

1.57

u/ml

1.16

Diabetic retinopathy, strict definition

692

1.13

0.52

1.1

1.30

1.21

u/ml

0.07

282

Mandibular retrognathia

100

891

1.12

0.52

1.2

1.1

0.60

2.69

u/ml

4.20

428

Parkinson's disease, strict definition

304

0.79

0.51

1.1

0.19

1.73

u/ml

—

117

Hodgkin lymphoma, hilmo

180

0.72

0.51

1.4

1.1

0.66

2.26

u/ml

—

Male infertility

453

1.17

0.51

1.2

1.1

2.57

2.04

u/ml

0.09

212

Bell's palsy

790

1.13

0.51

1.1

1.53

1.51

u/ml

0.01

308

Other hearing loss

112

990

1.11

0.51

1.2

1.1

1.06

1.43

u/ml

0.29

375

Phobic anxiety disorders

199

1841

1.08

0.51

1.1

2.28

1.94

u/ml

0.11

776

Implicit viral Sepsis

131

1189

1.10

0.51

1.2

1.1

0.80

1.59

u/ml

1.70

521

Embedded teeth, including avohilmo

152

1391

1.10

0.51

1.1

2.54

1.78

u/ml

0.38

612

Diffuse brain injury

236

0.76

0.50

1.0

1.1

0.41

1.70

u/ml

—

Other disorders of binocular vision

118

1.37

0.50

1.2

1.1

0.74

1.16

u/ml

—

Non-small cell lung cancer

369

0.81

0.50

1.1

0.60

1.49

u/ml

1.20

139

malignant neoplasm of female genital organs

596

0.85

0.50

1.1

0.35

0.98

u/ml

1.16

218

Other embolism and thrombosis

650

1.14

0.50

1.1

1.07

1.71

u/ml

0.59

253

Early lumbar disc prolapse operation

143

1306

1.10

0.50

1.1

3.44

1.45

u/ml

0.76

508

Other/unspecified reactive arthropathies

482

1.17

0.50

1.1

0.60

1.37

u/ml

0.84

195

Etanercept

584

0.85

0.50

1.1

0.45

1.87

u/ml

2.44

244

Pyoderma

101

1.39

0.50

1.2

1.1

3.72

2.93

u/ml

—

Thyrotoxicosis, other and/or unspecified

167

1536

1.09

0.49

1.1

2.17

1.33

u/ml

0.36

581

Chronic tubulo-interstitial nephritis

180

1.28

0.49

1.3

1.1

10.89

1.78

u/ml

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

163

1.31

0.49

1.2

0.09

1.90

u/ml

1.62

Other and unspecified iron deficiency

237

2210

1.07

0.49

1.2

1.1

0.91

1.54

u/ml

1.34

103

893

Failed attempted abortion

154

1.31

0.49

1.1

3.60

0.97

u/ml

—

Laparoscopic right hemicolectomy

136

1.33

0.49

1.1

0.34

2.30

u/ml

—

Bacterial intestinal infections, IBD co-morbidities

114

1030

1.11

0.49

1.1

0.80

1.58

u/ml

1.19

403

244

1.24

0.48

1.1

0.91

1.30

u/ml

0.29

Mandibular prognathia

190

1.27

0.48

1.1

1.2

0.34

2.11

u/ml

1.77

Chronic respiratory disease originating in the perinatal period

0.57

0.48

1.2

1.3

0.11

3.20

u/ml

—

Abnormal findings on antenatal screening of mother

141

1290

1.10

0.48

1.1

3.34

1.18

u/ml

0.96

506

Effects of foreign body entering through natural orifice

241

2253

1.07

0.48

1.1

1.78

1.86

u/ml

0.04

1026

Carcinoma in situ of skin

172

1.28

0.48

1.0

1.1

0.39

1.64

u/ml

0.83

Abdominal aortic aneurysm (AAA)

118

1.35

0.48

1.1

1.2

0.50

2.36

u/ml

—

Other disorders of amniotic fluid and membranes

187

1998

0.93

0.48

1.1

0.60

1.26

u/ml

2.13

777

Gout, strict definition

453

0.84

0.48

1.2

1.1

3.45

1.94

u/ml

0.28

178

Benign neoplasm of ovary

116

1051

1.11

0.48

1.2

1.1

2.22

0.92

u/ml

0.33

386

Oral lichen ruber planus, including avohilmo

290

1.21

0.47

1.1

3.06

1.43

u/ml

0.32

113

Foreign body entering into or through eye or natural orifice

691

1.13

0.47

1.1

0.39

1.94

u/ml

4.01

307

Adjustment and management of implanted device

587

1.14

0.47

1.1

0.72

2.08

u/ml

1.50

241

Respiratory tuberculosis

128

1.33

0.47

1.2

1.1

0.47

1.18

u/ml

—

Respiratory tuberculosis, confirmed and not-confirmed

128

1.33

0.47

1.2

1.1

0.47

1.18

u/ml

—

Bacterial pneumonia, not elsewhere classified

277

2302

1.07

0.47

1.1

1.63

1.66

u/ml

0.02

142

940

Convalescence

318

1.20

0.47

1.2

1.1

1.76

1.26

u/ml

0.13

120

Wet age-related macular degeneration

249

1.22

0.47

1.1

0.20

0.95

u/ml

3.05

Personal history of malignant neoplasm

255

0.78

0.47

1.2

1.1

0.31

1.99

u/ml

—

113

Dystonia

355

1.19

0.47

1.0

1.1

0.48

1.91

u/ml

1.54

150

Viral warts

105

948

1.11

0.47

1.2

1.1

0.92

2.07

u/ml

1.74

412

Hypoplasia of dental enamel, including avohilmo

318

0.80

0.46

1.5

1.3

1.76

4.17

u/ml

1.07

225

Pregnancy examination and test

311

1830

1.06

0.46

1.1

1.66

1.58

u/ml

0.06

120

737

Other specified and unspecified personality disorders

102

920

1.11

0.46

1.2

1.1

0.71

1.58

u/ml

1.37

357

Epilepsy

250

2658

0.94

0.46

1.2

1.1

1.15

2.05

u/ml

1.55

112

1171

Generalized epilepsy, mode (most common among epilepsy diagnosis)

365

1.18

0.46

1.2

1.28

1.95

u/ml

0.27

175

Venous complications and haemorrhoids in pregnancy

232

0.77

0.46

1.1

0.16

1.18

u/ml

—

Striae atrophicae

1.40

0.46

1.2

1.1

1.70

2.06

u/ml

—

Personal history of other diseases and conditions

182

1680

1.08

0.46

1.1

2.48

2.27

u/ml

0.06

801

Systemic sclerosis, icd10

120

1.34

0.46

1.1

0.54

1.96

u/ml

—

Fracture of lower leg, including ankle

451

4708

0.95

0.46

1.1

1.12

1.72

u/ml

1.48

210

1891

Other disorders of ear

841

5408

1.04

0.46

1.2

1.1

1.70

1.75

u/ml

0.04

352

2206

Oral lichen ruber planus

1.39

0.46

1.2

1.1

8.27

1.77

u/ml

—

Vitamin D deficiency

138

1.31

0.46

1.2

1.1

4.45

1.28

u/ml

0.33

Other heart diseases

632

4345

0.96

0.45

1.1

2.61

1.59

u/ml

0.91

278

1855

Benign neoplasm: Rectum

627

1.13

0.45

1.1

0.94

1.74

u/ml

0.71

247

Sudden idiopathic hearing loss

449

1.16

0.45

1.2

1.1

1.39

1.62

u/ml

0.08

182

Dislocation, sprain and strain of joints and ligaments of elbow

675

1.13

0.45

1.3

1.2

3.64

1.78

u/ml

0.36

307

Disorders of tooth development and eruption

842

1.11

0.45

1.3

1.2

0.89

2.53

u/ml

2.38

455

Tooth eruption problems

270

2516

1.06

0.45

1.1

2.50

2.11

u/ml

0.22

134

1192

Abrasion of teeth

266

1837

1.07

0.45

1.1

0.49

1.72

u/ml

3.97

104

715

Obstructed labour due to maternal pelvic abnormality

121

1103

1.10

0.45

1.1

0.51

0.91

u/ml

1.04

359

Viral agents as the cause of diseases classified to other chapters

183

1.26

0.45

1.1

0.16

2.56

u/ml

2.09

Zoster [herpes zoster]

854

0.89

0.45

1.1

2.45

1.67

u/ml

0.20

322

Cardiac arrhythmias

768

5261

0.96

0.45

1.1

1.48

1.69

u/ml

0.21

316

2154

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

431

1.16

0.45

1.1

4.48

1.62

u/ml

0.33

174

Cirrhosis of liver, NAS

165

1.28

0.45

1.0

1.1

0.90

2.01

u/ml

0.63

Lymphangioma, anys site

1.47

0.45

1.0

1.2

0.12

3.43

u/ml

—

Superficial injury of forearm

110

999

1.10

0.45

1.2

1.1

6.32

1.76

u/ml

1.29

449

Other specified congenital malformation syndromes affecting multiple systems

296

0.80

0.45

1.1

1.2

3.51

2.44

u/ml

0.24

173

Other conjunctival vascular disorders and cysts

1.40

0.44

1.2

1.1

0.27

1.92

u/ml

—

Superficial injury of ankle and foot

160

1479

1.08

0.44

1.2

1.1

1.66

2.06

u/ml

0.20

666

Other eating disorders

841

0.89

0.44

1.2

1.1

0.95

2.31

u/ml

1.74

385

Outcome of delivery

274

1802

0.94

0.44

1.1

1.71

1.41

u/ml

0.21

127

722

Graves disease, strict definition

895

1.11

0.44

1.1

3.16

1.08

u/ml

0.59

339

Infectious mononucleosis

145

1336

1.09

0.44

1.1

1.60

2.01

u/ml

0.22

586

Use of memantine

268

0.81

0.44

1.3

1.1

0.29

0.71

u/ml

—

Use of other anti-dementia drugs

268

0.81

0.44

1.3

1.1

0.29

0.71

u/ml

—

Disorders of synovium and tendon in diseases classified elsewhere

1.37

0.44

1.1

5.20

2.98

u/ml

—

Primary open-angle glaucoma

820

0.89

0.43

1.1

0.39

1.33

u/ml

2.57

319

Acute appendicitis, with complications

126

1375

0.92

0.43

1.1

1.24

1.39

u/ml

0.13

523

Crohn disease

143

1317

1.09

0.43

1.1

1.37

1.87

u/ml

0.18

544

Reactive arthropathies, FINNGEN

564

1.14

0.43

1.1

0.56

1.45

u/ml

1.18

218

Other vitreous opacities

148

1.29

0.43

1.1

0.75

1.51

u/ml

—

Other/unspecified disorders of vestibular function

157

1.28

0.43

1.2

1.1

0.11

1.98

u/ml

—

Disorders of lens

392

2598

0.95

0.43

1.1

1.08

1.44

u/ml

0.52

167

966

Recurrent dislocation and subluxation of joint

745

0.88

0.43

1.1

0.58

1.67

u/ml

1.28

280

Social disorders starting during childhood or adolescence

149

1.29

0.43

1.0

1.2

0.26

2.69

u/ml

2.04

Mixed connective tissue disease

424

1.16

0.43

1.1

2.46

1.40

u/ml

0.28

164

Other epidermal thickening

239

1.22

0.42

1.2

1.1

1.31

1.82

u/ml

0.24

Burkitt lymphoma

0.00

0.42

0.0

1.1

—

4.91

—

Burkitt lymphoma, helper endpoint

0.00

0.42

0.0

1.1

—

4.91

—

Congenital malformations of the nervous system

327

0.82

0.42

1.1

1.2

3.31

2.17

u/ml

0.22

179

Maternal care for known or suspected disproportion

528

1.14

0.42

1.1

1.01

0.92

u/ml

0.05

173

Herpesviral keratitis and keratoconjunctivitis

221

1.23

0.42

1.2

1.1

10.23

1.66

u/ml

1.05

Pneumonitis due to solids and liquids

251

0.80

0.42

1.1

0.27

2.26

u/ml

2.60

112

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

1.1

—

4.91

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

434

1.15

0.42

1.1

4.48

1.68

u/ml

0.33

180

Other strabismus

277

2610

1.06

0.42

1.1

0.85

2.22

u/ml

4.44

138

1178

Disorders of lacrimal system and orbit in diseases classified elsewhere

149

1.28

0.42

1.0

1.1

0.73

2.32

u/ml

0.86

Sleep disorders, other/unspecified

332

1.18

0.42

1.2

1.1

1.22

2.14

u/ml

0.32

137

Nontoxic diffuse goitre

140

1.29

0.42

1.1

0.13

1.45

u/ml

—

Other symptoms and signs involving the urinary system

528

1.14

0.42

1.2

1.1

0.79

2.19

u/ml

1.74

212

Chronic pancreatitis

574

0.87

0.42

1.0

1.1

1.90

1.94

u/ml

0.01

241

Extreme obesity with alveolar hypoventilation

184

0.76

0.42

1.1

0.46

2.05

u/ml

—

Cholangitis (primary sclerosing, PSC)

316

0.82

0.41

1.1

5.19

1.87

u/ml

0.29

143

Hypertensive diseases (excluding secondary)

673

4057

0.96

0.41

1.1

2.13

1.51

u/ml

0.59

286

1663

Cerebral oedema

0.00

0.41

0.0

1.1

—

1.97

—

Drug-induced thyroiditis

0.00

0.41

0.0

1.2

—

0.94

—

Fluid overload

0.00

0.41

0.0

1.1

—

2.67

—

Exposure to sunlight

0.00

0.41

0.0

1.3

—

2.79

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.41

0.0

1.0

—

2.46

—

Eccrine sweat disorders

0.00

0.41

0.0

1.3

—

3.65

—

Other and unspecified myoneural disorders

0.00

0.41

0.0

1.2

—

3.42

—

Retinal vascular occlusion

295

1.19

0.41

1.1

0.45

1.70

u/ml

1.74

111

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

2.49

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

1.32

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.41

0.0

1.0

—

1.83

—

Abscess of mediastinum

0.00

0.41

0.0

1.2

—

0.71

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

326

3430

0.95

0.41

1.1

0.98

1.80

u/ml

2.20

137

1323

Dental pulpitis 3

302

2293

0.95

0.41

1.2

1.1

3.23

2.25

u/ml

0.58

157

1164

Injuries to the shoulder and upper arm

784

6358

1.03

0.41

1.1

1.42

1.75

u/ml

0.49

327

2635

Oesophageal varices

161

0.74

0.41

1.0

1.2

0.14

2.38

u/ml

—

Presence of other devices

889

1.10

0.41

1.1

0.30

1.17

u/ml

3.34

325

Supervision of high-risk pregnancy

321

2045

0.95

0.41

1.1

2.58

1.46

u/ml

0.59

110

813

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.41

0.0

1.1

—

2.36

—

Restrictive cardiomyopathy

0.00

0.41

0.0

1.2

—

2.81

—

Injury of muscle and tendon at forearm level

114

1.32

0.41

1.1

0.35

1.75

u/ml

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.41

0.0

1.1

—

1.68

—

Pathological resorption of teeth

204

1.23

0.41

1.0

1.1

0.13

2.47

u/ml

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

0.41

0.0

1.1

—

4.39

—

Osteomyelitis

305

1.18

0.40

1.2

1.1

1.78

1.83

u/ml

0.01

137

Reactive arthropathies

662

1.12

0.40

1.1

0.55

1.57

u/ml

1.33

244

Systemic sclerosis

123

1.31

0.40

1.1

0.54

1.77

u/ml

—

Smoking dependency

540

0.87

0.40

1.1

1.22

1.52

u/ml

0.16

218

Papilloedema, unspecified

168

1.26

0.40

1.1

1.82

1.52

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

901

1.10

0.40

1.1

2.19

1.29

u/ml

0.50

329

Disorders of purine and pyrimidine metabolism

0.00

0.40

0.0

1.1

—

1.68

—

Diabetic nephropathy

564

0.87

0.40

1.0

1.1

0.41

1.29

u/ml

2.55

223

Dipeptidyl peptidase 4 (DPP-4) inhibitors

380

1.16

0.40

1.1

0.72

1.97

u/ml

1.27

152

Postpartum haemorrhage

367

3047

1.05

0.39

1.1

1.81

1.34

u/ml

0.29

135

1138

Mental and behavioural disorders due to tobacco

539

0.87

0.39

1.1

1.22

1.52

u/ml

0.16

217

Use of glatiramer acetate

182

0.76

0.39

1.1

0.60

2.14

u/ml

—

Lack of expected normal physiological development

542

0.88

0.39

1.3

1.2

3.10

2.82

u/ml

0.06

354

Viral encephalitis, not elsewhere classified/unspecified

1.35

0.39

1.0

1.2

0.14

2.07

u/ml

—

Other congenital malformations, not elsewhere classified

142

1.28

0.39

1.2

1.01

3.24

u/ml

1.06

Retinal detachment with retinal break

512

1.13

0.39

1.1

1.63

2.04

u/ml

0.15

210

Anxious personality disorder

204

0.78

0.39

1.1

0.16

2.73

u/ml

—

Abnormal weight loss

484

1.14

0.39

1.1

1.75

1.68

u/ml

0.02

218

Osteoporosis

101

878

1.10

0.39

1.1

1.48

1.46

u/ml

0.01

352

Findings of drugs and other substances, not normally found in blood

0.00

0.39

0.0

1.1

—

0.95

—

Other drug-induced secondary parkinsonism

0.00

0.39

0.0

1.1

—

1.12

—

Vascular diseases of the intestine

1.41

0.39

1.3

1.1

3.11

2.80

u/ml

—

Noise effects on inner ear

196

1.23

0.39

1.2

1.1

1.20

1.87

u/ml

0.28

Impotence

193

0.78

0.39

1.0

1.1

0.23

2.10

u/ml

—

Ascites

259

0.81

0.39

1.0

1.1

0.67

1.19

u/ml

0.59

103

Intracerebral haemorrhage

335

0.83

0.39

1.1

0.23

2.03

u/ml

2.98

135

Benign neoplasm: Cerebral meninges

381

1.16

0.39

1.1

0.70

1.40

u/ml

0.63

147

Nystagmus and other irregular eye movements

124

1.30

0.39

1.0

1.2

0.43

3.70

u/ml

—

Exclusions for E4_PCOS_BROAD

190

1779

1.07

0.39

1.2

2.55

1.89

u/ml

0.21

838

Unspecified haematuria

224

1806

1.06

0.39

1.2

1.1

1.58

1.56

u/ml

0.00

738

Burn and corrosion of hip and lower limb, except ankle and foot

159

0.75

0.38

1.0

1.1

0.47

3.39

u/ml

—

Viral and other specified intestinal infections

346

3223

1.05

0.38

1.2

1.1

1.60

2.27

u/ml

0.68

152

1536

Benign neoplasm of meninges

419

1.15

0.38

1.1

0.70

1.27

u/ml

0.51

163

Infliximab

1.35

0.38

1.1

—

2.12

—

Pedal cyclist injured in collision with motor vehicle

261

1.19

0.38

1.1

3.91

1.52

u/ml

0.33

105

Event of undetermined intent

561

1.13

0.38

1.1

0.64

1.94

u/ml

1.89

230

Gastroduodenal ulcer

863

1.10

0.38

1.1

3.42

1.55

u/ml

0.54

330

Single delivery by forceps and vacuum extractor

257

1654

0.94

0.38

1.1

2.45

1.28

u/ml

0.62

684

Hypokalaemia

542

1.13

0.38

1.1

2.48

1.92

u/ml

0.12

229

Plantar fascial fibromatosis

618

1.12

0.38

1.2

1.1

0.29

1.28

u/ml

1.98

223

Pneumococcal septicemia

203

0.79

0.38

1.3

1.1

5.38

2.55

u/ml

—

Other and unspecified injuries of wrist and hand

345

1.16

0.38

1.2

1.1

0.49

2.23

u/ml

2.35

157

Intestinal stricture

136

1467

0.93

0.38

1.1

1.39

1.44

u/ml

0.04

576

Spontaneous abortion

565

3703

1.04

0.38

1.1

1.50

1.48

u/ml

0.02

205

1393

Fall on same level

1421

8124

0.98

0.38

1.1

1.55

1.82

u/ml

0.49

672

3355

Other disorders of skin and subcutaneous tissue

525

4631

1.04

0.37

1.1

1.47

1.49

u/ml

0.02

225

1815

Other noninflammatory disorders of cervix uteri

234

1.20

0.37

1.2

1.1

1.09

0.70

u/ml

—

Polyhydramnios

572

1.12

0.37

1.1

5.85

1.33

u/ml

0.91

223

Thyrotoxicosis with toxic multinodular goitre

234

1.20

0.37

1.0

1.1

0.46

1.23

u/ml

—

Lupus erythematosus

107

1.31

0.37

1.2

1.1

0.32

1.53

u/ml

—

Cardiomyopathy

841

0.90

0.37

1.2

1.1

0.47

1.34

u/ml

2.46

359

Graves ophthalmopathy

143

1.26

0.37

1.0

1.1

0.73

2.65

u/ml

0.99

Loose body in joint

125

1.28

0.37

1.2

10.40

2.56

u/ml

—

Persons with potential health hazards related to communicable diseases

587

5622

1.04

0.37

1.2

1.1

2.53

1.75

u/ml

0.49

257

2489

Disorders resulting from impaired renal tubular function

169

0.77

0.37

1.1

1.07

2.45

u/ml

—

Endometriosis ASRM stages 3,4

224

2115

1.06

0.37

1.1

0.44

1.11

u/ml

3.34

777

Hyperprolactinaemia

365

1.16

0.36

1.2

1.1

0.40

1.32

u/ml

1.47

138

In situ neoplasms

216

2183

0.94

0.36

1.1

0.74

1.20

u/ml

0.72

801

Visual impairment including blindness (binocular or monocular)

343

0.84

0.36

1.0

1.1

1.18

1.60

u/ml

0.18

164

Lichen sclerosus et atrophicus

525

1.13

0.36

1.1

1.60

1.30

u/ml

0.13

200

Other benign neoplasms of skin

256

2381

1.06

0.36

1.1

2.62

1.07

u/ml

0.84

915

Scabies

384

1.15

0.36

1.2

1.1

3.97

2.33

u/ml

0.24

154

Calcific tendinitis of shoulder

337

1.16

0.36

1.2

1.1

2.89

1.91

u/ml

—

122

Adalimumab

912

0.91

0.36

1.1

0.53

1.56

u/ml

2.39

375

Convulsions, not elsewhere classified

240

2501

0.95

0.36

1.2

1.1

2.25

2.08

u/ml

0.07

124

1163

Fracture of forearm

490

4763

0.96

0.36

1.1

2.36

1.67

u/ml

0.60

223

1947

Other benign neoplasms of connective and other soft tissue

650

0.89

0.36

1.1

1.60

1.57

u/ml

0.01

241

Direct fill therapy

123

1327

0.92

0.36

1.2

2.54

2.17

u/ml

0.10

624

Injury of unspecified body region

526

1.12

0.36

1.1

3.33

2.03

u/ml

0.18

237

Retinal vascular disorders

300

1.17

0.36

1.1

0.45

1.70

u/ml

1.74

111

Chalazion

860

1.09

0.36

1.1

1.79

1.43

u/ml

0.18

341

Congenital malformations of heart and great arteries

151

1564

0.93

0.35

1.1

1.2

4.05

2.13

u/ml

0.60

827

Other disorders of optic [2nd] nerve and visual pathways

470

1.13

0.35

1.2

1.56

2.06

u/ml

0.21

235

Early complications of trauma

255

0.82

0.35

1.0

1.1

0.76

2.10

u/ml

1.32

103

!Aliquae complicationes praecoces traumatis

255

0.82

0.35

1.0

1.1

0.76

2.10

u/ml

1.32

103

Corns and callosities

352

0.85

0.35

1.2

1.1

1.16

1.88

u/ml

—

143

Infections, IBD-co-morbidities

145

984

1.07

0.35

1.1

0.77

2.18

u/ml

2.16

414

Leisure time condition

162

1518

1.07

0.34

1.2

1.1

1.54

1.93

u/ml

0.35

660

Viral haemorrhagic fevers, not elsewhere classified/unspecified

480

1.13

0.34

1.1

0.88

1.75

u/ml

0.91

190

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

341

0.85

0.34

1.0

1.1

2.55

1.57

u/ml

0.20

144

Unspecified misadventure during surgical and medical care

264

1.18

0.34

1.1

0.39

2.12

u/ml

1.87

116

Contusion of ankle

386

1.14

0.34

1.1

2.17

2.37

u/ml

0.05

169

Respiratory and cardiovascular disorders specific to the perinatal period

668

1.10

0.34

1.2

1.3

2.98

3.02

u/ml

0.01

440

Fracture of shoulder and upper arm

259

2721

0.95

0.34

1.1

1.84

2.13

u/ml

0.21

101

1196

Gonococcal infection

209

1.20

0.34

1.2

1.1

0.22

1.56

u/ml

3.67

Assault by unspecified means

200

1.21

0.34

1.1

1.17

2.65

u/ml

0.61

Manic episode

243

0.82

0.34

1.1

0.38

1.85

u/ml

—

100

Inguinal hernia, bilateral

377

1.14

0.34

1.0

1.1

0.97

1.83

u/ml

0.73

158

Operations 2 for CAVS

666

1.10

0.34

1.1

2.97

1.69

u/ml

0.36

271

Calcific aortic valvular stenosis, diagnosis (helper)

666

1.10

0.34

1.1

2.97

1.69

u/ml

0.36

271

Injury of eye and orbit

143

1336

1.07

0.34

1.1

1.18

1.54

u/ml

0.27

587

Need for immunization against other single viral diseases

127

1.27

0.33

1.1

1.2

1.87

2.50

u/ml

0.14

Peripheral artery operations in Hilmo

329

0.85

0.33

1.1

0.83

2.19

u/ml

0.96

126

Erosion and ectropion of cervix uteri

136

1.25

0.33

1.1

0.06

0.91

u/ml

—

Other peripheral vertigo

415

1.13

0.33

1.1

0.34

1.55

u/ml

2.00

170

Paralytic strabismus

329

0.85

0.33

1.1

0.17

1.68

u/ml

3.15

144

Habit and impulse disorders

166

0.78

0.33

1.1

0.49

2.19

u/ml

—

Complications of anaesthesia during labour and delivery

1.32

0.33

1.2

1.1

—

1.09

u/ml

—

Premature rupture of membranes

325

2496

0.96

0.33

1.1

2.23

1.32

u/ml

0.68

120

984

Calcific aortic valvular stenosis

676

1.10

0.33

1.1

2.87

1.72

u/ml

0.33

277

Calcific aortic valvular stenosis, operated

676

1.10

0.33

1.1

2.87

1.72

u/ml

0.33

277

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

253

0.83

0.33

1.0

1.1

3.09

1.46

u/ml

—

severe traumatic brain injury, does not include concussion

949

0.92

0.33

1.1

0.58

1.77

u/ml

2.61

390

Degeneration of macula and posterior pole

140

1077

1.07

0.33

1.1

0.90

1.36

u/ml

0.68

420

Benign neoplasm of urinary organs

166

0.78

0.33

1.2

1.1

2.25

2.41

u/ml

—

Other acute disseminated demyelination

0.67

0.33

1.3

1.1

—

1.81

—

Endometriosis diagnosis and infertility diagnosis occurring together

116

1249

0.93

0.33

1.1

0.56

1.25

u/ml

1.29

449

Pedestrian injured in transport accident

482

1.12

0.33

1.1

0.95

1.63

u/ml

0.76

196

Amputation of toe

177

0.79

0.33

1.1

0.46

2.05

u/ml

—

132

1231

1.07

0.33

1.2

1.1

0.72

1.06

u/ml

0.64

465

Isolated proteinuria

173

1.22

0.33

1.1

7.64

3.68

u/ml

—

Other metabolic disorders

118

1096

1.08

0.33

1.1

1.56

1.34

u/ml

0.08

428

Coxarthrosis [arthrosis of hip](FG)

280

2123

0.95

0.32

1.1

0.93

1.39

u/ml

0.68

771

Artificial opening status

285

0.84

0.32

1.0

1.2

0.71

2.93

u/ml

2.28

136

Shoulder region

1.36

0.32

1.0

1.2

0.65

1.42

u/ml

—

Multiple delivery

843

0.91

0.32

1.1

2.69

0.85

u/ml

0.63

318

Benign neoplasm: Lip

1.36

0.32

1.1

0.69

1.25

u/ml

—

Intracranial trauma

711

5160

1.03

0.32

1.2

1.1

1.57

2.09

u/ml

0.84

314

2189

Fungal Sepsis

146

1.24

0.32

1.2

1.1

1.10

1.24

u/ml

—

Other lesions of median nerve

1.33

0.32

1.3

1.1

1.51

1.64

u/ml

—

Sixth [abducent] nerve palsy

128

1.25

0.32

1.0

1.1

0.20

1.63

u/ml

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

101

1.29

0.31

1.2

1.1

0.34

1.06

u/ml

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

262

0.83

0.31

1.0

1.3

0.54

2.32

u/ml

1.66

144

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

886

1.09

0.31

1.1

0.45

1.31

u/ml

2.35

330

Burn and corrosion of wrist and hand

369

0.86

0.31

1.2

3.69

2.31

u/ml

0.21

181

Motorcycle rider injured in noncollision transport accidents

305

0.85

0.31

1.0

1.1

3.30

2.55

u/ml

0.18

129

Benign neoplasm: Skin, unspecified

211

1.19

0.31

1.0

1.1

0.28

1.16

u/ml

—

Sequelae of infectious and parasitic diseases

465

1.12

0.31

1.3

1.1

0.55

1.77

u/ml

1.60

181

Other and unspecified psoriasis

342

1.14

0.31

1.3

1.1

4.81

2.00

u/ml

0.28

145

Disorder of the sleep-wake schedule

197

0.81

0.31

1.1

1.2

6.18

1.90

u/ml

—

Hernia of abdominal wall, postoperative

117

1089

1.08

0.31

1.1

1.83

1.22

u/ml

0.33

406

Abnormal spermatozoa

295

1.15

0.31

1.0

1.1

4.81

2.31

u/ml

—

134

Other and unspecified intracranial injuries

165

1.22

0.31

1.2

1.1

5.74

2.64

u/ml

—

Need for other prophylactic measures

418

1.13

0.31

1.1

1.2

0.21

2.46

u/ml

3.85

210

Thyrotoxicosis with diffuse goitre

125

1167

1.07

0.31

1.1

3.13

1.26

u/ml

0.69

433

Pleural effusion

443

0.88

0.31

1.1

0.39

2.45

u/ml

2.52

175

Abnormal findings on examination of urine, without diagnosis

258

1.17

0.31

1.1

4.54

2.78

u/ml

0.15

110

Other coagulation defects

590

1.10

0.30

1.2

0.97

1.44

u/ml

0.27

243

Calcific aortic valvular stenosis, including rheumatic fever

670

1.09

0.30

1.1

2.97

1.68

u/ml

0.36

273

Benign neoplasm: Cerebral meninges

390

1.13

0.30

1.1

0.70

1.23

u/ml

0.45

150

Lymphangioma, anys site

1.35

0.30

1.0

1.2

0.12

3.17

u/ml

—

Other and unspecified disorders of skin and subcutaneous tissue

343

1.14

0.30

1.1

0.68

2.14

u/ml

1.48

137

Presbycusis

183

1.20

0.30

1.3

1.1

0.73

0.86

u/ml

—

Use of levodopa decarboxylase inhibitor

272

0.84

0.30

1.1

0.31

1.78

u/ml

—

101

Complications of surgical and medical care, not elsewhere classified

982

6878

1.02

0.30

1.1

1.12

1.63

u/ml

1.41

422

2703

Benign neoplasm: Skin, unspecified

212

1.18

0.30

1.0

1.1

0.28

1.58

u/ml

—

Hypertension, essential

765

4483

0.97

0.30

1.1

2.27

1.29

u/ml

1.14

323

1714

Background retinopathy and retinal vascular changes

1.34

0.30

1.0

1.2

0.58

1.48

u/ml

—

Benign neoplasm: Descending colon

212

1.18

0.30

1.1

4.24

1.11

u/ml

0.37

Other mental disorders due to brain damage and dysfunction and to physical disease

357

0.87

0.30

1.1

0.56

1.97

u/ml

1.60

139

Artificial joint re-operation

175

1.20

0.30

1.1

1.77

1.08

u/ml

0.27

Unspecified nephritic syndrome

1.29

0.30

1.1

0.36

2.16

u/ml

—

Parkinson's disease, excluding more controls

296

0.86

0.30

1.1

0.17

1.70

u/ml

—

105

Disorders of psychological development

229

2022

1.05

0.30

1.2

2.83

2.14

u/ml

0.34

132

1056

Constipation

778

5427

1.03

0.30

1.1

1.42

1.78

u/ml

0.47

310

2276

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

163

0.79

0.29

1.0

1.1

0.17

2.00

u/ml

—

Other other unspecified disorders of the circulatory system

163

0.80

0.29

1.2

0.18

2.62

u/ml

—

Other and unspecified abdominal hernia

157

1.21

0.29

1.2

1.1

0.48

1.71

u/ml

—

Other maltreatment syndromes

292

0.85

0.29

1.1

0.50

2.07

u/ml

1.65

116

Lactose intolerance

269

1.16

0.29

1.1

1.2

3.08

2.11

u/ml

0.13

123

Cholelithiasis

679

4893

0.97

0.29

1.1

1.23

1.34

u/ml

0.16

255

1846

L02BA Anti-estrogens

982

0.93

0.29

1.1

1.34

1.03

u/ml

0.16

335

Iron deficiency anaemia

291

2764

1.04

0.29

1.2

1.1

1.41

1.50

u/ml

0.06

121

1121

Malignant neoplasm of ovary

195

0.82

0.29

1.1

0.76

1.12

u/ml

—

Other congenital malformations of male genital organs

194

0.81

0.29

1.5

1.3

8.88

3.09

u/ml

—

140

Pyothorax

130

1.23

0.28

1.0

1.1

1.44

2.01

u/ml

—

Divergent concomitant strabismus

689

1.09

0.28

1.1

1.07

1.88

u/ml

0.67

281

Fracture of skull and facial bones

173

1825

0.95

0.28

1.1

0.84

1.53

u/ml

1.18

786

Deep endometriosis

834

1.08

0.28

1.2

1.1

0.29

1.35

u/ml

2.48

315

Somnolence

1.28

0.28

1.2

0.71

1.51

u/ml

—

Benign neoplasm: Lip

1.32

0.28

1.1

0.69

1.18

u/ml

—

Subarachnoid haemorrhage

418

0.88

0.28

1.2

1.1

0.28

1.74

u/ml

—

165

Primary open-angle glaucoma, strict

668

0.91

0.28

1.1

0.44

1.44

u/ml

2.03

254

Paroxysmal tachycardia

222

1790

1.05

0.28

1.1

1.30

1.85

u/ml

0.49

739

Other diseases of arteries and capillaries

431

1.12

0.28

1.0

1.1

2.78

1.88

u/ml

0.24

172

Hypertensive heart and/or renal disease

648

0.92

0.28

1.1

1.54

1.17

u/ml

0.36

263

Hallux valgus (acquired)

243

1681

1.05

0.27

1.1

1.12

1.39

u/ml

0.16

564

Intentional self-harm by sharp object

299

1.14

0.27

1.0

1.1

0.85

1.35

u/ml

0.42

124

Other benign neoplasms of connective and other soft tissue

637

0.91

0.27

1.1

1.60

1.59

u/ml

0.00

244

Arthropathies in other diseases classified elsewhere

183

0.82

0.27

1.0

1.1

1.98

2.97

u/ml

—

Other symptoms and signs involving general sensations and perceptions

226

0.84

0.27

1.3

1.2

0.42

2.30

u/ml

—

103

Cardiovascular diseases (excluding rheumatic etc)

1111

6285

1.02

0.27

1.1

1.84

1.66

u/ml

0.21

489

2695

Overjet

497

1.11

0.27

1.4

1.2

5.71

2.95

u/ml

0.39

285

Preparatory care for dialysis

172

0.81

0.27

1.0

1.1

0.36

2.35

u/ml

—

Weight loss

595

1.09

0.27

1.2

1.51

1.83

u/ml

0.09

275

Other malignant neoplasms of skin (=non-melanoma skin cancer)

179

1487

0.95

0.27

1.1

1.27

1.11

u/ml

0.09

559

Thrombocytopenia, unspecified

395

0.88

0.26

1.2

1.1

0.46

2.36

u/ml

2.40

184

Chronic ulcer of skin, not elsewhere classified

236

0.85

0.26

1.2

1.1

0.49

2.42

u/ml

2.19

Inguinal or femoral hernia, bilateral

385

1.12

0.26

1.0

1.1

0.97

1.79

u/ml

0.70

161

Other and unspecified glaucoma

159

1.20

0.26

1.1

0.34

2.52

u/ml

—

Cholelithiasis, broad definition with cholecystitis

712

5001

0.98

0.26

1.1

1.22

1.33

u/ml

0.16

267

1890

Myocardial infarction, with ST-elevation

458

0.89

0.26

1.1

0.69

1.86

u/ml

1.16

184

Other and unspecified haemorrhagic conditions

1.28

0.26

1.0

1.1

0.07

2.77

u/ml

—

Blood alcohol or alcohol intoxication level

214

0.84

0.26

1.0

1.1

2.92

1.08

u/ml

0.78

Congenital musculoskeletal deformities of head, face, spine and chest

169

1.19

0.26

1.1

1.2

0.66

2.26

u/ml

1.30

Congenital deformities of feet

291

1.14

0.26

1.1

1.2

4.35

2.59

u/ml

0.26

135

Dental caries

250

2375

1.04

0.26

1.3

1.1

1.49

2.07

u/ml

0.37

137

1077

Dependence on enabling machines and devices, not elsewhere classified

113

1.24

0.26

1.9

1.3

0.18

2.88

u/ml

—

Malignant melanoma

541

0.90

0.26

1.0

1.1

0.90

1.89

u/ml

0.88

206

Optic neuritis

394

0.89

0.26

1.1

1.45

1.43

u/ml

0.01

160

Psoriatic and enteropathic arthropathies

904

0.93

0.26

1.1

1.14

1.43

u/ml

0.16

338

Postprocedural endocrine and metabolic disorders, not elsewhere classified

106

993

1.07

0.26

1.1

1.75

1.15

u/ml

0.21

377

Twin gestation

105

1120

0.94

0.26

1.1

2.78

1.02

u/ml

0.72

418

Disorders of mineral metabolism

434

1.11

0.25

1.1

0.44

1.62

u/ml

2.29

191

Purpura and other haemorrhagic conditions

955

0.93

0.25

1.2

1.1

0.76

1.64

u/ml

1.00

421

Speech disturbances, not elsewhere classified

362

0.88

0.25

1.1

1.65

2.09

u/ml

0.12

146

Spondylopathies (FG)

142

1344

1.06

0.25

1.1

1.78

1.67

u/ml

0.04

524

Visual field defects

404

0.89

0.25

1.1

0.40

1.93

u/ml

2.12

170

Hypotension

434

1.11

0.25

1.2

1.1

0.87

1.62

u/ml

0.66

164

Methotrexate

903

0.93

0.25

1.1

0.55

1.55

u/ml

2.41

321

Hypertrichosis

254

1.15

0.25

1.0

1.1

7.64

1.59

u/ml

0.55

Conduct disorder

340

0.88

0.25

1.0

1.2

0.76

1.47

u/ml

0.64

160

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1056

7562

0.98

0.25

1.1

2.38

1.61

u/ml

0.96

507

3125

Secondary right heart disease

114

1.23

0.25

1.3

1.1

0.63

2.55

u/ml

—

1.26

0.25

1.1

1.2

1.55

1.99

u/ml

—

Procreative management

448

3669

1.03

0.24

1.2

1.1

1.53

1.88

u/ml

0.37

229

1659

Congenital iodine-deficiency syndrome/hypothyroidism

170

1.18

0.24

1.2

1.1

0.14

1.70

u/ml

—

Other dialysis

191

0.84

0.24

1.7

1.1

0.19

2.13

u/ml

—

100

Encephalitis

191

0.84

0.24

1.1

0.59

2.68

u/ml

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

170

1.18

0.24

1.1

2.23

2.50

u/ml

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

148

0.81

0.24

1.0

1.1

0.77

1.02

u/ml

—

Other endocrine disorders

884

1.07

0.24

1.2

1.81

2.74

u/ml

0.41

521

Autism

433

0.90

0.24

1.2

3.24

1.94

u/ml

0.30

210

Benign neoplasm of meninges

436

1.10

0.24

1.1

0.70

1.13

u/ml

0.37

166

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

0.72

0.24

1.3

1.0

—

0.83

—

Other heart diseases, wide

1105

6980

0.98

0.24

1.1

1.89

1.67

u/ml

0.23

471

2904

Labour and delivery complicated by umbilical cord complications

523

1.09

0.24

1.1

0.54

0.97

u/ml

0.81

182

Congenital malformations of pulmonary and tricuspid valves

179

0.83

0.24

1.1

1.3

23.90

2.93

u/ml

—

116

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

300

2897

1.04

0.24

1.1

2.65

1.57

u/ml

0.60

123

1197

Other and unspecified disease of Bartholin gland

152

1.19

0.23

1.2

1.1

4.25

2.55

u/ml

0.23

Other specified transport accidents

1.36

0.23

1.0

1.1

1.36

1.77

u/ml

—

Malignant neoplasm of urinary organs

286

0.87

0.23

1.0

1.1

2.97

1.89

u/ml

—

114

Nonspecific lymphadenitis

475

1.10

0.23

1.1

1.18

1.56

u/ml

0.20

182

Problems related to social environment

180

1.17

0.23

1.2

1.1

3.88

1.21

u/ml

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

115

1.22

0.23

1.3

1.1

5.05

2.65

u/ml

—

Injuries involving multiple body regions

284

1.13

0.23

1.1

4.50

1.47

u/ml

0.63

119

Parapsoriasis

115

1.22

0.23

1.1

1.50

3.46

u/ml

—

Impacted maxillary molar

909

0.93

0.23

1.1

0.46

2.34

u/ml

4.77

391

Corneal scars and opacities

115

1.22

0.23

1.1

1.78

3.41

u/ml

—

Contusion of other and unspecified parts of foot

562

1.09

0.23

1.2

1.1

2.07

2.18

u/ml

0.03

251

Follow-up examination after treatment for malignant neoplasms

328

0.88

0.23

1.2

1.1

0.48

1.09

u/ml

—

111

Other and unspecified injuries of head

443

0.90

0.23

1.2

1.1

1.34

1.82

u/ml

0.23

197

Melanocytic naevi of trunk

971

0.94

0.23

1.1

2.91

1.43

u/ml

0.42

386

Emotional disorders starting during childhood or adolescence

114

1068

1.06

0.23

1.1

1.2

2.67

2.57

u/ml

0.03

555

Vestibular neuronitis

443

0.90

0.23

1.1

4.17

1.67

u/ml

0.28

175

Azathioprine

133

1402

0.95

0.23

1.2

1.1

1.94

1.88

u/ml

0.02

584

Viral infections of the central nervous system

572

1.09

0.23

1.1

0.80

1.54

u/ml

0.78

236

Benign neoplasm: Skin of lower limb, including hip

136

0.81

0.23

1.1

0.66

2.17

u/ml

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

127

1187

1.06

0.23

1.2

0.64

2.50

u/ml

5.73

664

Artificial joint operation, meniscal resection

687

4467

1.02

0.23

1.1

1.19

1.36

u/ml

0.22

277

1697

Symptoms and signs involving the urinary system

584

4624

0.98

0.23

1.2

1.1

1.50

1.59

u/ml

0.09

257

1863

Benign neoplasm: Rectum

659

1.08

0.23

1.1

0.94

1.35

u/ml

0.36

268

Iridocyclitis in diseases classified elsewhere

1.24

0.23

1.1

0.36

3.28

u/ml

—

Tuberculosis, IBD comorbidity

190

1.16

0.23

1.2

1.1

0.41

2.08

u/ml

—

Ulcerative rectosigmoiditis

681

0.92

0.23

1.1

2.60

1.37

u/ml

0.37

263

Premature separation of placenta [abruptio placentae]

247

1.14

0.23

1.1

5.11

0.98

u/ml

—

Neovascular glaucoma

162

1.17

0.23

1.1

0.21

1.78

u/ml

—

Glaucoma secondary to other eye disorders

162

1.17

0.23

1.1

0.21

2.42

u/ml

—

Diabetic neuropathy

359

1.11

0.22

1.2

1.1

0.62

1.40

u/ml

1.11

138

Malnutrition

153

1.18

0.22

1.4

1.3

6.84

2.13

u/ml

0.45

All dysplastic lesions of the vulva

316

0.88

0.22

1.1

0.97

1.37

u/ml

—

119

Benign neoplasm: other/unspecified salivary gland

1.27

0.22

1.3

1.1

0.08

0.76

u/ml

—

Benign neoplasm: other/unspecified salivary gland

1.27

0.22

1.3

1.0

0.08

1.00

u/ml

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

583

1.08

0.22

1.1

0.82

1.91

u/ml

1.30

228

Basal cell carcinoma

186

1547

0.96

0.22

1.1

0.86

1.17

u/ml

0.51

584

Androgen resistance syndrome

0.00

0.22

0.0

1.1

—

0.07

—

Polycystic ovarian syndrome

834

0.93

0.22

1.2

1.1

1.98

1.27

u/ml

0.31

333

Other specific arthropathies, wide

116

1.21

0.22

1.1

1.34

2.58

u/ml

—

Disorders of calcium metabolism

305

0.88

0.22

1.1

0.66

1.76

u/ml

1.23

132

Benign neoplasm: Skin of lower limb, including hip

135

0.81

0.22

1.1

0.66

2.15

u/ml

—

Spontaneous rupture of synovium and tendon

343

1.11

0.22

1.1

1.75

1.94

u/ml

—

132

Other infectious diseases

399

0.90

0.22

1.0

1.1

2.03

1.66

u/ml

0.10

170

Strabismus

299

2889

1.03

0.21

1.1

0.81

2.07

u/ml

4.38

146

1299

Anisometropia and aniseikonia

248

1.13

0.21

1.1

0.18

1.84

u/ml

—

109

Other noninfective disorders of lymphatic vessels and lymph nodes

199

0.85

0.21

1.3

1.1

0.66

2.43

u/ml

—

Deficiency of other/unspecified vitamins

0.00

0.21

0.0

1.2

—

3.93

—

Diffuse (eosinophilic) fasciitis

0.00

0.21

0.0

1.0

—

2.97

—

Rifle, shotgun and larger firearm discharge

0.00

0.21

0.0

1.1

—

0.23

—

Inflammatory diseases of the central nervous system

596

0.92

0.21

1.1

2.67

1.79

u/ml

0.17

245

Benign neoplasm of thyroid gland

163

1.17

0.21

1.2

1.1

0.14

1.63

u/ml

—

Inflammatory bowel disease, strict (require KELA)

238

2468

0.96

0.21

1.1

1.57

1.73

u/ml

0.07

1045

Personal history of certain other diseases

241

0.87

0.21

1.1

11.06

0.75

u/ml

—

Chondrosarcoma

0.00

0.21

0.0

1.0

—

3.31

—

Use of riluzole

0.00

0.21

0.0

1.4

—

1.27

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

3.24

—

Mixed and other personality disorders

817

1.07

0.21

1.2

1.1

1.28

1.50

u/ml

0.11

317

Carcinoma in situ of prostate

0.00

0.21

0.0

1.1

—

0.49

—

Foreign body on external eye

126

1197

1.05

0.21

1.1

2.47

1.52

u/ml

0.27

531

Lipodystrophy, not elsewhere classified

0.00

0.21

0.0

1.1

—

4.00

—

Assault by drugs, medicaments and biological substances

0.00

0.21

0.0

1.3

—

2.43

—

Gonarthrosis, primary, with knee surgery

231

1817

1.04

0.21

1.1

1.28

1.41

u/ml

0.12

647

Benign neoplasm of urinary organs

156

0.83

0.21

1.2

1.1

2.25

2.82

u/ml

—

Failure of sterile precautions during surgical operation

0.00

0.21

0.0

1.1

—

2.65

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

2.88

—

Other and unspecified pemphigus

0.00

0.21

0.0

1.1

—

3.19

—

Dental caries 3 and operation codes, only avohilmo

454

2220

1.03

0.21

1.1

2.02

1.59

u/ml

0.29

186

948

Cachexia

0.00

0.21

0.0

1.0

—

1.18

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

411

1.10

0.21

1.0

1.1

1.25

1.55

u/ml

0.17

163

Emotionally unstable personality disorder

159

1662

0.96

0.21

1.2

1.1

0.91

1.49

u/ml

0.94

658

Other disorders starting during childhood or adolescence

125

1179

1.05

0.21

1.2

0.64

2.64

u/ml

6.31

659

Psoriatic arthropathies, ICD10

709

0.93

0.21

1.2

1.1

0.46

1.63

u/ml

2.15

269

Transient synovitis

1.24

0.21

1.0

1.2

0.40

2.19

u/ml

—

Fracture of foot, except ankle

252

2434

1.04

0.21

1.1

1.65

1.79

u/ml

0.08

122

1021

Coxarthrosis

267

1874

0.97

0.21

1.1

0.95

1.37

u/ml

0.55

665

Other and unspecified bullous disorders

1.17

0.21

1.0

1.1

—

4.40

u/ml

—

Granulomatous disorders of skin and subcutaneous tissue

177

0.85

0.21

1.2

1.1

0.51

2.45

u/ml

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.21

0.0

1.2

—

0.10

—

Benign neoplasm: Rectum, anus and anal canal

740

1.07

0.21

1.1

1.03

1.76

u/ml

0.69

292

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.21

0.0

1.0

—

3.34

—

Gingival hyperplasia

293

0.88

0.21

1.2

0.45

2.29

u/ml

2.15

159

Special screening examination for other diseases and disorders

711

1.07

0.21

1.1

2.35

2.48

u/ml

0.04

285

Coxarthrosis, primary, with hip surgery

147

1459

0.95

0.21

1.1

0.64

1.13

u/ml

1.20

547

Carcinoma in situ of prostate

0.00

0.21

0.0

1.1

—

0.52

—

Contact with sharp glass

387

0.90

0.21

1.1

0.78

2.10

u/ml

0.99

162

Postprocedural musculoskeletal disorders, not elsewhere classified

272

0.88

0.20

1.1

0.56

1.53

u/ml

1.06

106

IBD patients in KELA-register

238

2465

0.96

0.20

1.1

1.57

1.75

u/ml

0.08

1038

Ulcerative enterocolitis

230

1.13

0.20

1.2

1.1

0.37

2.34

u/ml

1.66

Bacterial pneumoniae

294

2521

1.03

0.20

1.1

1.57

u/ml

0.00

149

1027

LSIL lesion of the cervix uteri, vagina or vulva

154

1609

0.96

0.20

1.2

1.1

1.92

1.17

u/ml

0.41

571

Autoimmune polyglandular failure

0.00

0.20

0.0

1.1

—

1.86

—

Postinflammatory hyperpigmentation

0.00

0.20

0.0

1.3

—

2.24

—

Vitamin B12 deficiency anaemia

345

0.90

0.20

1.2

1.1

0.33

1.75

u/ml

1.77

132

Other and unspecified epidermal thickening

164

1.16

0.20

1.3

1.1

1.66

1.05

u/ml

—

Ectopic pregnancy

172

1650

1.04

0.20

1.2

1.1

1.52

1.20

u/ml

0.20

598

Other hyperalimentation

0.00

0.20

0.0

1.2

—

0.56

—

Thromboangiitis obliterans

0.00

0.20

0.0

1.2

—

0.58

—

Maternal care for known or suspected malpresentation of fetus

309

2234

1.03

0.20

1.1

2.13

1.30

u/ml

0.70

109

863

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.1

—

0.26

—

Pyogenic arthritis

345

1.10

0.20

1.3

1.1

0.96

2.93

u/ml

1.60

137

Use of antiglaucoma preparations and miotics

187

0.85

0.20

1.1

0.41

1.04

u/ml

—

Abnormal findings on examination of blood, without diagnosis

279

2528

1.03

0.20

1.1

1.70

1.73

u/ml

0.02

115

1051

Diabetic retinopathy

147

886

1.05

0.20

1.1

1.51

1.18

u/ml

0.29

348

Sequelae of other and unspecified infectious and parasitic diseases

432

1.09

0.20

1.3

1.1

0.58

1.86

u/ml

1.51

169

Myeloproliferative diseases

313

0.89

0.20

1.1

0.13

1.65

u/ml

—

125

Benign neoplasm of breast

861

0.94

0.20

1.2

1.1

0.68

1.03

u/ml

0.44

317

Cutaneous abscess, furuncle and carbuncle

230

2381

0.97

0.20

1.1

2.43

1.65

u/ml

0.37

119

1004

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

197

0.86

0.19

1.2

1.30

2.07

u/ml

—

118

Conductive and sensorineural hearing loss

557

3772

1.02

0.19

1.1

1.50

1.75

u/ml

0.20

220

1471

Chronic Coagulation defects

218

0.87

0.19

1.2

1.1

0.12

2.34

u/ml

—

Foreign body in ear

146

1.17

0.19

1.2

1.07

1.92

u/ml

—

Other pulmonary heart/vessel disease

146

1.17

0.19

1.2

1.1

0.62

2.78

u/ml

—

Malignant neoplasm of kidney, except renal pelvis

270

0.89

0.19

1.0

1.1

2.97

1.96

u/ml

—

109

Burn and corrosion of head and neck

175

0.85

0.19

1.1

1.2

0.43

3.27

u/ml

—

Bacterial, viral and other infectious agents

783

1.06

0.19

1.1

1.90

1.84

u/ml

0.02

334

Injury of other and unspecified intrathoracic organs

322

0.90

0.19

1.2

1.1

4.53

1.91

u/ml

0.33

131

Rare circulating lymphoid malignancy

196

0.87

0.18

1.2

1.30

2.13

u/ml

—

113

Ankylosing spondylitis

676

1.07

0.18

1.0

1.1

2.48

1.27

u/ml

0.33

256

Radial styloid tenosynovitis [de Quervain]

453

1.08

0.18

1.1

2.82

1.56

u/ml

0.34

168

Hidradenitis suppurativa

353

0.90

0.18

1.2

1.1

0.52

1.86

u/ml

1.58

136

Chromosomal abnormalities, not elsewhere classified

393

0.91

0.18

1.2

8.81

2.35

u/ml

0.72

240

Unspecified jaundice

194

1.14

0.18

1.1

1.2

0.48

2.03

u/ml

—

Exposure to other specified electric current

128

1.18

0.18

1.0

1.1

0.23

2.66

u/ml

—

Aneurysms, operations, SAH

776

0.94

0.18

1.1

2.45

1.53

u/ml

0.17

304

Ulcerative ileocolitis

342

0.90

0.18

1.1

0.26

1.90

u/ml

2.38

142

Exclusion endpoint for clefts

331

0.90

0.18

1.1

1.2

2.93

2.78

u/ml

0.03

192

Toxic effect of ethanol

373

0.91

0.18

1.1

0.48

1.74

u/ml

1.52

151

Foreign body in respiratory tract

425

1.08

0.18

1.2

1.91

2.13

u/ml

0.05

202

Other obstructed labour

703

0.94

0.18

1.2

1.1

1.88

0.88

u/ml

0.33

248

Other specified disorders of kidney and ureter

153

0.85

0.18

1.2

1.1

12.46

1.20

u/ml

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

348

1.09

0.18

1.1

0.62

1.76

u/ml

0.86

137

Sequelae of injuries of head

352

0.91

0.18

1.1

1.11

1.57

u/ml

0.33

145

Hypertensive Heart Disease

567

0.94

0.18

1.1

1.59

1.17

u/ml

0.37

233

Pedal cyclist injured in other and unspecified transport accidents

941

1.05

0.18

1.1

1.42

1.61

u/ml

0.08

389

Causalgia

119

1.18

0.18

1.1

0.08

1.63

u/ml

—

Torticollis

157

1.15

0.17

1.2

0.24

2.52

u/ml

1.53

Dental caries 1 and operation codes, only avohilmo

369

1808

1.03

0.17

1.1

1.81

1.43

u/ml

0.23

149

774

Filling of root of tooth

195

1.13

0.17

1.2

1.1

1.29

1.37

u/ml

—

Transient global amnesia

262

1.11

0.17

1.2

1.1

0.62

1.29

u/ml

0.91

102

Multiple gestation

111

1162

0.95

0.17

1.1

2.53

1.00

u/ml

0.68

433

Specific development disorders of scholastic skills

845

1.06

0.17

1.2

3.18

2.03

u/ml

0.39

462

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

611

1.07

0.17

1.2

0.50

2.54

u/ml

3.36

316

Somnolence, stupor and coma

226

0.88

0.17

1.2

1.1

0.52

1.94

u/ml

—

Kela reimbursement Agammaglobulinemia (D80-84)

0.75

0.17

1.2

1.1

0.64

1.44

u/ml

—

Cerebral palsy and other paralytic syndromes

855

0.95

0.17

1.1

1.41

1.81

u/ml

0.21

373

Foreign body or object entering through skin

504

1.07

0.17

1.1

1.83

2.03

u/ml

0.10

214

Transitory endocrine and metabolic disorders specific to fetus and newborn

437

1.08

0.17

1.3

5.14

3.11

u/ml

0.24

297

Dental pulpitis 3, only avohilmo

286

2146

0.97

0.17

1.2

1.1

3.45

2.21

u/ml

0.74

146

1089

Hypo-osmolality and hyponatraemia

609

1.06

0.17

1.2

1.1

0.80

1.55

u/ml

0.85

261

Congenital malformations of genital organs

135

1397

0.96

0.17

1.2

1.1

1.92

1.99

u/ml

0.02

665

Burns and corrosions

142

1365

1.04

0.17

1.1

1.61

1.71

u/ml

0.04

618

Injuries to unspecified part of trunk, limb or body region

738

1.06

0.16

1.1

3.13

1.92

u/ml

0.19

316

Labour and delivery complicated by fetal stress [distress]

404

2757

0.98

0.16

1.1

1.60

1.27

u/ml

0.29

168

1042

Haemorrhagic and haematological disorders of fetus and newborn

599

0.93

0.16

1.3

3.69

2.91

u/ml

0.18

402

Carcinoma in situ of cervix uteri

106

1109

0.95

0.16

1.1

1.05

1.32

u/ml

0.15

413

Complications following abortion and ectopic and molar pregnancy

196

1.12

0.16

1.1

0.69

1.29

u/ml

—

Other disorders of bladder

466

1.07

0.16

1.2

1.1

1.30

1.98

u/ml

0.33

188

Maternal care for cervical incompetence

321

1.09

0.16

1.1

7.16

1.05

u/ml

—

118

Volume depletion

381

0.92

0.16

1.3

1.2

1.35

2.03

u/ml

0.33

172

Tuberculosis, wide

196

1.12

0.16

1.2

1.1

0.41

2.09

u/ml

—

Focal brain injury

321

1.09

0.16

1.2

1.1

0.65

2.14

u/ml

1.18

122

Open wound of head

443

4273

1.02

0.16

1.1

3.62

1.71

u/ml

1.54

200

1876

Family history of certain disabilities and chronic diseases leading to disablement

525

1.07

0.16

1.1

3.09

1.49

u/ml

0.46

210

Spondyloarthritis

153

1475

1.04

0.16

1.1

3.11

1.65

u/ml

0.40

587

Crohn's disease NAS

613

1.06

0.16

1.2

1.1

0.25

1.74

u/ml

3.55

264

Injury of urinary and pelvic organs

111

1.17

0.16

1.1

1.2

1.07

2.17

u/ml

—

Lung diseases due to external agents

496

1.07

0.15

1.2

1.1

2.54

2.12

u/ml

0.08

200

Missing teeth due to accident, extraction or parodontitis

574

1.06

0.15

1.2

1.1

0.71

1.87

u/ml

1.45

208

Parkinson's disease, strict definition, excluding more controls

261

0.90

0.15

1.1

0.19

1.83

u/ml

—

Phlebitis and thrombophlebitis (not including DVT)

130

1352

0.96

0.15

1.2

1.1

1.31

1.34

u/ml

0.01

514

Parodontitis, under 40 years, or operation codes

152

1575

0.96

0.15

1.2

1.1

3.36

1.44

u/ml

1.05

689

ILD medications: azathioprine

133

1382

0.96

0.15

1.2

1.1

1.94

2.10

u/ml

0.05

576

Malignant neoplasm of thyroid gland

390

0.92

0.15

1.0

1.1

1.64

1.49

u/ml

0.07

154

Recurrent dislocation of patella

702

1.06

0.15

1.1

0.50

1.29

u/ml

1.65

277

Autism spe, excluding more controls

410

0.92

0.15

1.2

3.24

1.54

u/ml

0.43

214

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

544

0.94

0.15

1.2

1.1

1.41

1.39

u/ml

0.01

215

Senile cataract

315

1906

1.02

0.15

1.1

1.13

1.41

u/ml

0.42

138

704

Female infertility, associated with anovulation

122

1173

1.04

0.15

1.1

2.50

1.28

u/ml

0.53

452

Golimumab

317

0.91

0.15

1.1

0.60

2.25

u/ml

1.34

128

Orchitis and epididymitis

482

0.93

0.15

1.1

0.54

1.87

u/ml

2.27

231

Other renal tubulo-interstitial diseases

171

0.88

0.14

1.1

0.22

1.87

u/ml

—

Disorders of continuity of bone

752

1.05

0.14

1.1

0.94

1.55

u/ml

0.61

297

Benign neoplasm of brain and other parts of central nervous system

399

0.93

0.14

1.1

0.87

2.13

u/ml

0.70

178

Neoplasms

1239

6564

1.01

0.14

1.1

2.33

1.81

u/ml

0.65

534

2852

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

422

1.07

0.14

1.2

1.3

3.51

2.96

u/ml

0.06

287

Glomerulonephritis

676

0.95

0.14

1.2

1.1

0.97

1.96

u/ml

0.89

317

Endovascular or surgical operations to intracerebral aneurysms

306

0.91

0.14

1.2

1.1

0.25

1.49

u/ml

—

125

Primary ovarian failure

198

1.11

0.14

1.1

0.48

1.41

u/ml

—

Nephrotic syndrome

254

0.90

0.14

1.5

1.2

0.80

1.83

u/ml

—

147

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

757

0.95

0.14

1.2

1.1

2.95

0.98

u/ml

0.35

281

Other disorders of the genitourinary system

532

0.94

0.14

1.1

0.65

1.45

u/ml

0.73

199

Amenorrhoea

101

969

1.04

0.14

1.1

0.63

1.73

u/ml

2.54

396

Complications of internal orthopaedic prosthetic devices, implants and grafts

802

1.05

0.14

1.1

1.03

1.79

u/ml

0.79

320

Motorcycle rider injured in other and unspecified transport accidents

636

1.05

0.14

1.3

1.1

0.83

1.96

u/ml

1.75

264

Conductive hearing loss, unspecified

587

1.06

0.14

1.1

1.17

1.79

u/ml

0.29

251

Pneumonia derived septicemia

191

0.89

0.14

1.2

1.1

5.38

1.62

u/ml

—

Problems related to lifestyle

1011

0.96

0.13

1.2

1.1

3.77

1.15

u/ml

0.52

403

Cyst of Bartholin Gland

334

1.08

0.13

1.2

1.1

1.79

1.44

u/ml

0.09

117

Nutritional anaemias

323

3075

1.02

0.13

1.2

1.1

1.31

1.45

u/ml

0.10

135

1229

Fall on and from ladder

334

1.08

0.13

1.3

1.1

3.77

1.54

u/ml

0.29

134

Other diseases of pericardium

170

0.88

0.13

1.1

0.23

1.87

u/ml

—

Parodontitis, under 40 years

152

1569

0.97

0.13

1.2

1.1

3.36

1.44

u/ml

1.05

686

Placenta praevia

582

0.94

0.13

1.0

1.1

2.00

0.88

u/ml

0.44

219

Myocardial infarction, without ST-elevation

120

1067

1.04

0.13

1.2

1.1

3.05

1.16

u/ml

0.62

410

Congenital malformations of uterus and cervix

263

0.91

0.13

1.1

0.35

1.51

u/ml

—

Bicuspidal aortic valve syndrome

257

1.09

0.13

1.1

0.86

3.38

u/ml

1.92

133

Pneumonia, organism unspecified

948

6773

1.01

0.13

1.2

1.1

2.51

1.62

u/ml

1.04

455

2801

Other overlap syndromes

1.17

0.13

1.3

1.1

0.68

1.44

u/ml

—

Anterior Iridocyclitis

147

1517

0.97

0.13

1.2

1.1

1.23

1.60

u/ml

0.19

608

Other diseases of biliary tract

335

1.08

0.13

1.1

1.48

2.29

u/ml

0.42

143

Benign neoplasm of breast

846

0.96

0.13

1.2

1.1

0.68

0.97

u/ml

0.35

311

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

European house dust mite IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS